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Abstract
All microorganisms require transition metals for key metabolic processes, thus
during infection microbial access to essential metals is tightly regulated by the host
in a process termed nutritional immunity. Iron acquisition is critical to the
pathogenesis of the formidable human pathogen, Staphylococcus aureus, which
utilizes heme-uptake systems and two high affinity iron-scavenging siderophores,
staphyloferrin A (SA) and staphyloferrin B (SB) for iron acquisition. In this study, I
identify sbnI as encoding a transcription factor required for expression of genes in the
sbn operon, the biosynthetic operon for SB synthesis. I also show that SbnI is a novel
hemoprotein, where binding to heme abrogates its ability to bind DNA. Thus this
work proposes a novel mechanism in which S. aureus controls SB synthesis in
response to heme. Although free iron is scarce in the host, copper at the hostpathogen interface is found in excess. Copper is highly reactive and in macrophages
is imported into phagosomes where it exerts bactericidal effects. S. aureus flourishes
within macrophages and therefore must resist copper-mediated killing. I
demonstrate that the USA300 strain of Community-Associated MRSA relies on CopAZ
and CopBL for copper detoxification; where CopA and newly identified CopB are
copper-translocating efflux pumps, CopZ is a copper-binding chaperone, and CopL is
a novel copper-responsive lipoprotein. Finally, CopAZ, in accord with CopBL, aid in S.
aureus survival in murine macrophages. This study examines two important facets of
nutritional immunity and the virulence factors used by S. aureus to overcome
obstacles posed by the host in maintaining metal homeostasis.
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Chapter 1
1

Introduction

1.1 Staphylococci
In the late 19th century, staphylococci were first identified as causative agents in wound
infections and surgeons initially named them Coccobacteria septica, then Micrococcus,
and only years later eventually gave the name Staphylococcus (1). The Staphylococcus
genus is comprised of over 80 species of catalase-producing, coccoid-shaped bacteria
that are found in a wide range of ecological and physiological niches. The group is broadly
and commonly categorized by the ability, or not, of species to produce coagulase, a
secreted polypeptide that activates prothrombin (2). Many staphylococci are found as
commensals, such as the coagulase-negative (CoNS) skin commensal S. epidermidis.
However, this genus has garnered notoriety due to the ability of many species to cause
severe to lethal infections, such as those caused by coagulase-positive (CoPS) S. aureus.
CoNS are the most prevalent skin commensals on the human body and are the most
frequently identified bacteria in clinical samples (3). Until 1975, CoNS were considered
either S. epidermidis or S. albus and were distinguished from S. aureus based on their
inability to clot plasma (4). In 1981, additional CoNS were characterized due to their high
prevalence in human blood samples including S. haemolyticus, S. hominis, S. warneri, S.
simulans, and S. xylosus. These CoNS appeared to originate from the skin and for the
majority of cases only caused internal infections in humans when a foreign device was
present, such as a catheter or shunt (5). The increasing use of implanted devices has led
CoNS to be prevalent agents in nosocomial infections and, particularly in
immunocompromised individuals, can cause severe infections. Notable among the CoNS
is S. lugdenensis, known to cause infrequent but aggressive infectious endocarditis, with
a mortality rate reaching 42% (6). S. lugdenensis stands out from the CoNS, as it was
initially misidentified as S. aureus due to the presence of a membrane-bound, coagulaselike enzyme referred to as “clumping factor”, that caused false positive results in
coagulase tests (7).
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Although most commonly found as commensals, CoNS have an array of virulence factors.
Nevertheless, they are typically less virulent than CoPS and, like their CoPS counterparts,
can have widespread antibiotic resistance, and can form persistent, metabolically
repressed small colony variants in the course of infection (1). Furthermore, there are a
number of CoPS staphylococcal species, the most characterized and clinically relevant of
them being S. aureus due to its high prevalence in human and domesticated animal
infection.

1.2 Staphylococcus aureus
S. aureus is the most characterized of the staphylococci. Despite living commensally in
the nasopharynx, throat, and intestinal tract of roughly 30% of the population, S. aureus
is also a human pathogen capable of causing severe diseases such as septicemia,
necrotizing fasciitis, osteomyelitis, pneumoniae, and endocarditis (8–10). People who
are persistent or intermediate carriers of S. aureus are significantly more likely to
develop S. aureus infections, with numerous studies showing the infectious strains are
often isogenic to the commensal (11). The ability of S. aureus to persist as an
asymptomatic commensal and then, by some environmental cue, transition to pathogenic
and cause symptoms, has given S. aureus the status as “pathobiont” (11).
Currently, S. aureus is the most frequent cause of bloodstream infections in Canada and
the United States, the most common agent of post-operative infection, and responsible
for 10% of all hospital acquired infections (HAI) (8, 12–14). S. aureus is particularly
formidable as many strains have acquired antibiotic resistance, with the World Health
Organization ranking methicillin-resistant S. aureus (MRSA) among the seven most
threatening infectious bacterial agents in the world (14).
1.2.1 S. aureus antibiotic resistance
Treatment options for S. aureus infections are largely restricted to antibiotics, against
which resistance is quickly spreading. First-line penicillin antibiotics were effectively
introduced in 1940 to treat S. aureus; however, as early as 1942, resistance to β -lactams
began to spread among S. aureus strains rendering many penicillin-based drugs
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ineffective (15). Methicillin was introduced in 1959 and was greatly effective against S.
aureus infections; however, MRSA were first reported just two years later with the
acquisition of the mec mobile element in many strains (16). The mec genes, (mecA, mecB,
and mecC), which are now widespread among CoNS and CoPS, encode novel penicillinbinding protein (PBP2a) that renders these strains resistant to all β-lactam antibiotics
(17).
The first methicillin-resistant strains were Hospital Acquired (HA) MRSA, and were first
identified in the 1960’s in immunocompromised, hospitalized individuals (13, 18, 19). In
the 1990’s a new MRSA strain was identified outside of a hospital setting, called
Community Acquired (CA) MRSA, and CA-MRSA now comprise between 30-50% of all
MRSA infections in Canada (13, 20). CA-MRSA, compared to its HA-MRSA counterpart,
can infect otherwise healthy individuals, are typically more virulent, and are not
contained within the hospital environment as they are frequently found in the
community setting (13, 18, 19). With these recent statistics, S. aureus infections are a
severe public health concern and financial burden. The most frequent site of CA- and HAMRSA infections is the skin and soft tissue (so called skin and soft tissue infections or
SSTIs), which can range from mild to severe. About 1-4% of CA-MRSA infections are of
greater severity such as osteomyelitis, endocarditis, necrotizing pneumonia, urinary
tract infections, and sepsis (21). One CA-MRSA strain, USA300, is the most commonly
isolated CA-MRSA strain worldwide and as such is incredibly adept at infection and
transmission and is globally known for its enhanced virulence and antimicrobial
resistance (8, 22).
1.2.3 CA-MRSA strain USA300
In North America, the epidemic spread of CA-MRSA can be attributed to USA300, where
by 2004 this single strain was the most common agent for SSTIs in the United States (22).
Its increased virulence can be attributed to the presence of novel genetic mobile
elements; unique to this clone are the SEK (sek) and SEQ (seq) enterotoxins, PantonValentine leucocidin (PVL) toxin, and the arginine catabolic mobile element (ACME)
cassette (23).
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It is generally thought that USA300 acquired the ACME genetic island through horizontal
gene transfer from S. epidermidis, or another CoNS, as a homologous ACME sequence was
identified in S. epidermidis (23). The ACME cassette is a 30.9 kb genetic island that derives
its name from the arc gene cluster that is comprised of genes necessary for arginine
catabolism, referred to as the arginine deiminase pathway (ADI) (23).
As all sequenced S. aureus strains have a chromosomally-encoded arc operon, the
acquisition of the ACME cassette confers USA300 with two sets of arc genes. Whereas the
chromosomal arc operon is expressed under anaerobic growth conditions, ACMEencoded arc is expressed constitutively under conditions of both anaerobic and aerobic
growth (24–26). The ADI pathway involves the catabolism of arginine for use as a
nitrogen source, and is a prevalent metabolic pathway found in both eukaryotic and
prokaryotic species (27); although, its exact role in bacterial survival has not been fully
elucidated. The arc operon contains five genes in total, arcA, arcB, arcD, arcC, and arcR:
arcA, arcB, and arcC are catabolic enzymes, that break arginine into L-ornithine,
ammonium, carbon dioxide, and one molecule of ATP. Arginine is transported into the
cell by the arginine/ornithine antiporter ArcD, and the entire operon is regulated by the
transcriptional regulators ArcR and divergently transcribed gene, argR (24, 28).
In addition to the arc operon, the ACME cassette also encodes a spermidine
(Spd)/spermine (Spm) acetyltransferase, designated SpeG (25, 26). Spd and Spm are
polyamines, low-molecular weight, aliphatic molecules that exert pleiotropic effects on
bacteria, including inhibition of microbial growth (29). In addition to polyamines already
present on the skin, during skin colonization, increased arginine catabolism from the arc
operon results in secretion of high levels of L-ornithine, which induces the host’s
production of polyamines (25). ACME-encoded SpeG is able to detoxify the polyamines
Spd and Spm, resulting in enhanced growth of USA300 during skin colonization (30, 31).
Thus, it is generally believed that the ACME cassette confers USA300 with a
hypervirulent, skin colonization phenotype. However, the exact role of the ACME cassette
in virulence is unclear, as USA300 ACME-deficient strains had no changes in virulence in
rat models of necrotizing pneumonia or dermonecrosis, compared to isogenic WT (32).
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Thus, the ACME cassette may be important for enhanced transmission and not
necessarily for enhanced virulence at later stages of infection, although research is still
ongoing. The ACME cassette is unique to USA300; however, all S. aureus strains contain
a vast array of virulence factors that aid in colonization, transmission, and infection in
the host.

1.3 S. aureus and host innate immunity
To survive in the host, S. aureus must evade being killed by the primary immune
response. Integral members of innate immunity are professional phagocytes, such as
macrophages and neutrophils, that are critical to bacterial clearance during infection.
Phagocytes have a large arsenal of antimicrobial effectors; however, remarkably, S.
aureus is often able to survive macrophage and neutrophil-mediated killing (33, 34).
Discussed below are some of the effectors employed by neutrophils and macrophages
against S. aureus, and ways in which this pathogen withstands such effectors.
1.3.1 Phagocyte extravasation
The first step of phagocyte-mediated clearance is extravasation to the site of infection.
Microbes that have penetrated the skin barrier and are localized to tissues cause the
release of chemoattractants, cytokines, bacterial products, and selectins that all activate
β2 integrins on the surface of phagocytes (33). β2 integrins bind with high affinity to the
intercellular adhesion molecule 1 (ICAM-1) of endothelial cells. Thus, phagocytes that
were “rolling” along the blood vessel wall through temporary contact of glycoproteins on
the neutrophil and with P- and E-selectins on endothelial cells, suddenly become
adherent through β2 integrin/ICAM-1 interaction. The result of this adherence is the
extravasation of neutrophils from the blood-stream across the endothelial layer (35).
S. aureus interferes with diapedesis through staphylococcal superantigen-like 5 (SSL-5),
which blocks interaction of phagocytes to P-selectin glycoprotein ligand-1 (PSGL-1); this
prevents cell adherence and the “rolling” phenomenon needed for eventual extravasation
(36). Furthermore, SSL-5 thwarts chemokine/chemokine receptor interaction by binding
to chemokines through a highly conserved glucosaminoglycan (GAG)-binding site (37).
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Finally, the Eap protein of S. aureus binds to ICAM-1 on endothelial cells, which inhibits
the firm adhesion of neutrophils to the endothelium, preventing translocation of
neutrophils (33).
1.3.2 Priming and activation of phagocytes
Phagocytes that cross the endothelial barrier are met with a plethora of chemoattractants
that direct them to the site of infection, and proinflammatory stimulants that prime and
activate them for killing. Priming of phagocytes is predominantly through microbial
factors. Priming, although not essential to phagocyte function, results in amplification of
neutrophil responses, including altering the composition of surface receptors and
adhesion molecules, heightened oxidative burst and actin polymerization, and
augmented degranulation of secretory vesicles and subsets of granules (38).
Staphylococci release a number of molecules that can activate the transmembrane,
glycoprotein toll-like receptors (TLRs) on neutrophils; these include, but are not limited
to, bacterial lipoproteins that activate receptors TLR1, TLR2, and TLR6, and bacterial
CpG-rich DNA that activates TLR9 (39).
1.3.3 Phagocytosis and oxidative burst
At the site of infection, phagocytes aid in bacterial clearance through engulfing the
invading pathogen in a process termed phagocytosis. Phagocytosis is enhanced through
the opsonization of the microorganism through components of the complement system,
typically immunoglobulins, or other innate immune components (38). Phagocytosis is a
receptor-mediated process, where receptors on the surface of the phagocyte, such as
TLRs that can recognize bacterial components, or immunoglobulin Fc receptor that
recognizes the constant region of IgG, bind to molecules on the bacterial cell surface (38).
The result of this binding is formation of cell membrane extensions, or pseudopods, on
the phagocytic membrane. Pseudopods form around the microorganism and then
envelope the microbe into a membrane-bound vacuole termed the phagosome.
S. aureus inhibits opsonization through staphylococcal complement inhibitor (SCIN) that
blocks the C3 convertase, or secretes the metalloprotease aureolysin to cleave and
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inactivate C3 (40, 41). Additionally, S. aureus uses multiple virulence factors to bind and
activate clotting factors, such as fibrin, fibrinogen, fibronectin, and prothrombin, that
form around the bacteria and protect the cells from phagocytosis by forming a protective
“shield” (42).
If phagocytosis of S. aureus occurs, phagocytosis alone is not sufficient to kill microbes,
as phagosomes still contain an appreciable amount of nutrients; therefore, it is the
process of phagosome maturation in the macrophage, or fusion with preformed granules
in the neutrophil, that is needed to kill engulfed bacteria (33, 43). Neutrophil granules
contain enzymes that have cytotoxic effects on bacteria, these include: lysozymes that
degrade the cell wall, proteases that damage bacterial toxins and surface associated
virulence factors, enzymes such as myeloperoxidase that assist in metabolic burst, and
antimicrobial peptides called defensins (44).
Along with granule fusion with the phagosome, neutrophils are also characterized by
production of reactive oxygen species (ROS), in a process defined as the oxidative burst.
Reactive oxygen species are the byproduct of the stepwise reduction of oxygen to water
producing the active intermediates superoxide (HO2·), hydrogen peroxide (H2O2), and
hydroxyl radical (OH·) (45). The production of ROS in phagocytes is primarily performed
through the activity of the membrane-bound, multiprotein Nicotinamide Adenine
Dinucleotide Phosphate (NADPH)-oxidase. NADPH-oxidase is found in the phagosomal
membrane and catalyzes the production of superoxide (O2- ), which serves as a catalyst
for other reactive oxidants. NADPH is typically dormant in polymorphonuclear cells
(PMNs) but is induced in the presence of pro-inflammatory cytokines (46). ROS is not
only released into bacteria-containing phagosomes but can be excreted extracellularly
into the environment. The oxidative burst is deleterious to bacterial cells, causing
damage to membranes, DNA, RNA, and proteins (47).
S. aureus has a number of protective strategies against ROS. Staphyloxanthine, the
molecule responsible for the golden pigment of S. aureus, shields the membrane against
peroxide and singlet oxygen (48). Inside the bacterial cell, S. aureus synthesizes enzymes
that help to detoxify ROS. The main enzyme responsible for ROS detoxification in the
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cytoplasm is catalase. Catalase scavenges hydrogen peroxide and converts it to water and
oxygen (49). S. aureus also encodes alkyl hydroperoxide reductase (ahpC) and surface
factor promoting resistance to oxidative killing (SOK), both enzymes are involved in
resistance to ROS (45, 50). In addition, S. aureus also encodes two superoxide dismutases,
SodA and SodM (51, 52).
1.3.4 Calprotectin
The host actively sequesters Mn2+ through calprotectin (Cp), which comprises 50% of the
total proteinaceous content of the neutrophil cytoplasm. Calprotectin is upregulated
during infection in neutrophils, as well as epithelial cells, and works to sequester
essential transition metals Zn2+, Mn2+, and Fe2+ (57–59). The process of withholding
essential micronutrients from invading microbes is defined as nutritional immunity, and
is critical to bacterial clearance. Nutritional immunity results in decreased survival of the
pathogen; it was shown that Cp-deficient mice had increased S. aureus bacterial burden
in the liver compared to WT mice (60). Calprotectin is a S100 class protein that is a
heterodimer of S100A8 and S100A9 and is a member of the EF-hand Ca2+ binding
proteins (61, 62).
Cp affects the pathogenesis of S. aureus. All staphylococci encode the superoxide
dismutase SodA; however, only S. aureus possesses SodM (53). Previously, it was shown
that SodA and SodM bind to Mn2+ as an essential coordinating metal, where SodM can
also use Fe2+ in place of Mn2+ (54). Manganese is an important micronutrient in resistance
to oxidative burst, where it is not only essential to the function of superoxide dismutase,
SodA, but itself can neutralize ROS (55). Manganese in S. aureus is taken up by the ABC
transporter MntABC and NRAMP-like transporter MntH (56). Deletion of both mntC and
mntH resulted in a significant decrease in bacterial burden in the liver and kidneys (55).
Because of the close relationship between Mn2+ and resistance to ROS, S. aureus must
overcome metal sequestration by Cp to survive oxidative burst. This is achieved by
upregulation of mnt manganese transporters during infection and, perhaps, through use
of the Fe2+-containing SodM in place of SodA (55). Additionally, S. aureus also steals Zn+
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from Cp through use of the zinc-binding metallophore staphylopine (to be discussed in
greater detail in section 1.5.5 ) (63).
1.3.5 Neutrophil extracellular traps
Neutrophils can expel their intracellular contents in what is defined as neutrophil
extracellular traps (NETs). NETs comprise nucleic acid, granule proteins, and other
cytosolic components that work to ensnare nearby microbes, preventing bacterial
dissemination and sepsis. Although it is not entirely clear what causes the formation of
NETs, stimuli have been identified that include phorbol myristate acetate,
lipopolysaccharide (LPS), interleukin-8 (IL-8), and certain bacteria (33); however, the
greatest activator of NET formation is by platelet activation through TLR4 (64). S. aureus
secretes a nuclease, encoded by nuc, that degrades NETs (65); the degradation product
of nuclease activity is modified by S. aureus adenosine synthase A, encoded by adsA, to
produce 2’-deoxyadenosine (dAdo) (66). The dAdo molecule was found to be toxic to
macrophages and thus prevents macrophage recruitment into S. aureus abscesses, where
strains that lack nuc and adsA are more susceptible to macrophage killing in vivo (66).
S. aureus has many ways to hinder every step of neutrophil-mediated killing, including
neutrophil chemotaxis, activation, priming, and phagocytosis (33). S. aureus is also fully
capable of flourishing inside the macrophage, eventually escaping the phagosome and
causing macrophage lysis (67). The exact mechanisms involved in macrophage survival,
however, are not fully delineated and, like neutrophil evasion, are most likely the result
of multiple virulence factors working in concert.
1.3.6 Additional key virulence factors of S. aureus
Already discussed are some of the key factors used by S. aureus in resistance to killing by
professional phagocytes. However, S. aureus has a vast array of virulence factors that aid
in resistance to many facets of the innate immunity. Figure 1-1 and the following sections
highlight just some of these key virulence mechanisms.
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Fig 1-1. Mechanisms by which S. aureus subverts host immune defenses. The S. aureus
cell wall is comprised of a thick peptidoglycan (PGN) layer that provides structural
integrity and protection against osmotic pressure, and PGN-anchored lipotechoic and
teichoic acid that regulate autolysis. DltABCD and MprF modify positive charges on the
cell wall and afford resistance to cationic antimicrobial peptides. Capsular
polysaccharide gives an additional layer of protection from antimicrobials. Secreted,
pore-forming toxins, a, b, d (including other phenol-soluble modulins) g, and leukocidins
cause lysis of target host cells. Exo-enzymes, such as V8 protease, aureolysin, and
phospholipase C, cleave and degrade host proteins and lipids. Secreted exotoxins interact
with MHC class II-T cell receptor complexes and cause non-specific activation and
proliferation of T cells. Covalently anchored adhesion determinants, fibrinogen binding
protein, fibronectin binding protein, clumping factor, VonWillebrand (VW) factor binding
protein, and Efb bind to host factors such as fibrinogen, fibronectin, VW factor, and
elastin. Opsonization by phagocytes is hindered by Efb and staphylococcal complement
inhibitors (SCIN) that bind to complement factor, C3, and inhibit classic and alternative
C3 convertases; additionally, protein A binds to Fc domains of immunoglobulin in a nonopsonization orientation. Siderophores, staphyloferrin A and B, and Isd protiens aid in
acquisition of ferric iron and heme, respectively. Essential amino acids and peptides are
transported inside the cell through dedicated transporters, such as BrnQ. Inside the cell,
catalase and superoxide dismutase aid in detoxification of reactive oxygen species, and
penicillin binding proteins provide resistance to b-lactam antibiotics.
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Secreted virulence factors
S. aureus secretes a number of exotoxins, perhaps the best known being α-toxin (αhemolysin), a 293-amino acid protein that forms distinguishing β-sheet conformations.
α-toxin is a receptor-mediated toxin, and thus receptor ADAM10 is required on the target
cell for proper pore formation, although it has been suggested that high concentrations
of α-toxin may diminish the need for ADAM10 (68). Upon binding to the receptor, α-toxin
monomers oligomerize to form a β-barrel configuration that comprises the mature pore
in the cellular membrane. This pore allows the passive transport of molecules less than
2 kDa, and thus the cell undergoes osmotic lysis and subsequent necrosis (69, 70).
Other pore-forming toxins produced by S. aureus are γ-hemolysin and leukocidins. Unlike
α-toxin, γ-hemolysin and leukocidins are comprised of a hetero-octamer comprised of 4
units of each polypeptide, defined as slow (S) and fast (F) based on their electrophoretic
mobility (68). γ-hemolysin has two different S components (HlgA and HlgC) that pairs
with the F component, HlgB. S. aureus produces three different leukocidins, the most
characterized of these being the Panton-Valentine leukocidin (PVL) (71). PVL is
comprised of LukS-PV and LukF-PV, the other two leukocidins are LukED and LukGH
(LukAB). Like α-toxin, the individual monomers of γ-hemolysin and leukocidins
assemble into a β-barrel structure that forms a pore, causing lysis of the target host cell.
Toxins are generally observed in the supernatant of cells and function as a secreted
factor. LukGH/AB, however, is anchored to the bacterial cell membrane (72–75). βhemolysin differs from α- and γ-hemolysin in that it does not cause cell lysis by poreformation but degrades sphingomyelin in the target cell membrane into ceramide and
phosphorylcholine. This degradation is thought to alter membrane fluidity and
destabilize the membrane bilayer (76).
δ-hemolysin and other phenol-soluble modulins (PSM) are amphipathic, α-helical
peptides that are secreted by the ABC transporter phenol-soluble modulin transporter
(Pmt) (77). There are seven PSMs identified in S. aureus, broadly characterized as short
peptides (~20 amino acids), one of which is δ-hemolysin, and are referred to as PSMα,
and long peptides (~40 amino acids) designated PSMβ (78). Roughly 60% of CA-MRSA
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secreted protein mass is comprised of PSMs, and as such they are key virulence factors.
They degrade a wide array of eukaryotic cells, including osteoblasts, endothelial cells,
epithelial cells, PMNs, monocytes, and erythrocytes (78–80). A S. aureus mutant deficient
in PSMα exhibited a severe reduction in abscess size in a murine skin infection model
(78) and in a rabbit skin infection model (81); moreover, in a CA-MRSA psmα mutant,
mice had a significant delay in morbidity compared to mice infected with the isogenic WT
strain in a murine bacteremia model (78). The profound cytolytic activity of PSMs may
rely on other secreted virulence factors, as PSM activity was enhanced in the presence of
β-toxin (82), PVL (83), and antimicrobial peptides (84).
Lastly, S. aureus produces immuno-stimulatory superantigens that work to activate large
populations of T cells by indiscriminately binding MHC II molecules and the Vβ-region of
T cell receptors (TCRs) (85). The trimolecular complex of superantigen-MHC II-TCR
induces large-scale T cell proliferation resulting in massive secretion of cytokines,
referred to as a cytokine storm. This results in extensive damage to epithelial cells and
capillary damage leading to hypotension and, in many cases, morbidity (86). A large
number of superantigens have been identified in staphylococci, named as exotoxins A-C
(with antigenic variant D and E) and G-Q. However, perhaps the most well-known is toxic
shock syndrome toxin-1 (TSST-1) which, as its name suggests, is the causative agent of
toxic shock syndrome, a severe toxigenic state marked by rapid onset of fever and multiorgan failure (87, 88).
Secreted Exo-proteins
Staphylococcus aureus produces a number of proteins that serve as secreted virulence
factors that can work to degrade host proteins, lipids, and interfere with signaling
cascades. As previously mentioned, staphylococci utilizes coagulase that clots plasma by
facilitating the conversion of fibrinogen to fibrin by activating host enzyme prothrombin
(89). Staphylokinase (Sak) is a serine protease that functions as a plasminogen-activator
and causes the conversion of plasminogen to plasmin. S. aureus also produces glycerol
ester hydrolases and lipases that degrade triglycerides, and nucleases that aid in
degradation of NETs (90).
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Surface-associated factors
Cell wall anchored (CWA) proteins are linked to peptidoglycan through the enzymatic
activity of sortases. Each CWA protein has a carboxy-terminal sorting signal, the majority
of which is the LPXTG motif recognized by sortase A, whereas sortase B is active only
during iron-starvation and recognizes a NPQxN/P motif found on the IsdC protein (91).
The sorting signal is essential for secretion and anchoring of the protein to the cell wall.
Microbial surface components recognizing adhesive matrix molecules (MSCRAMMs) are
a large family of surface-associated factors that aid in infection by facilitating adherence
to host cells. Many MSCRAMM-family proteins contain tandemly-linked IgG-like folds in
the N-terminal region (92), and interact with host clotting factors that serve to protect S.
aureus from primary immune responses (93). Fibronectin binding proteins (FnBPs) A
and B bind to fibronectin on the surface of cells, which acts as a bridge to integrin α5β1,
a phagocytic receptor. This interaction with integrin α5β1 results in remodeling of the
cytoskeleton that allows internalization of S. aureus (94, 95). Clumping factors A and B
bind to fibrinogen and are responsible for platelet adhesion and aggregation. von
Willebrand factor binding protein (vWbp) also activates prothrombin and can bind
fibrinogen and von Willebrand factor (2). Serine-aspartate repeat proteins (SdrC, SdrD,
and SdrE) are adhesins that have been implicated in nasal colonization (96).
Protein A (SpaA) is one of the most studied S. aureus surface proteins; it binds to the Fc
portion of IgG, an immune evasion tactic that impairs opsonization and phagocytosis.
Protein A can also bind to von Willebrand factor and complement protein C3, which
increases S. aureus adhesion to platelets (97). A second binder of immunoglobulin
protein (Sbi) is both an anchored and secreted Ig-binding protein that, in addition to
antibody binding, works synergistically with extracellular fibinogen-binding protein
(EfB) to bind plasmin and leads to the degradation of complement proteins C3a, C3b, and
C3 (98). In addition, most S. aureus strains, but not the aforementioned USA300 due to
mutations in cap5D and cap5E genes, produce a polysaccharide capsule, typically
serotype 5 or 8, that protects the cell from damaging host factors. The capsule is
important in abscess formation (99, 100).
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S. aureus biofilms
Most S. aureus strains produce biofilms, which are comprised of cells embedded in thick
extracellular polymeric matrices produced by sessile microbial communities that allow
attachment to hard surfaces or other cells. Biofilms are a particular threat in the context
of medical implants or catheters, where they are challenging to remove and protect the
cells from antibiotic treatment. They are generally comprised of host factors,
polysaccharides, proteins, and extracellular DNA (eDNA) (101). S. aureus biofilm
formation on hard surfaces is largely facilitated by the accumulation-associated protein
(Aap), autolysins AtlA and AtlE, and wall teichoic acid (WTA) and lipoteichoic acid (LTA)
(92). Biofilms on cell surfaces predominantly consist of CWA proteins and secreted
proteins that activate and bind to clotting factors, such as FnBPA and FnBPB, ClfA and
ClfB, and SdrCDE (102). Additionally, all PSM surfactant peptides are capable of aiding in
biofilm formation and, as such, are critical biofilm-structuring factors. As viewed using
confocal laser-scanning microscopy (CLSM), psm mutants had significantly reduced
biofilm formation compared to isogenic WT (103), demonstrating how S. aureus utilizes
virulence factors for multiple roles during infection.
1.3.7 Regulation of virulence factors
During infection, S. aureus tightly regulates expression of its virulence factors. Adhesion
proteins are largely produced in the early phase, or establishment, of infection, where
manipulation of host cells and clotting factors create a favorable growth environment.
Toxins and enzymes are secreted at the later stages of infection when tissue destruction
and bacterial dissemination are necessary (104). Regulation in the cell is achieved
through two broadly categorized families of transcriptional regulators i) two-component
systems (TCS), comprised of an environmentally “sensing” transmembrane histidine
kinase and cytoplasmic response regulator and ii) SarA-family, single-component
regulators (105).
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Accessory gene regulator (Agr) system
The majority of exoproteins produced by S. aureus are regulated by the accessory gene
regulator (agr) system, which functions as a global regulator and activator of many
virulence genes (106,107). The agrBDCA operon encodes two, divergent transcriptional
products, RNAII and RNAIII, where RNAII encodes agrBDCA that are involved in celldensity sensing. AgrD is a 46-amino acid peptide that is processed by the membrane
protease AgrB, to the autoinducing thiolactone pepetide (AIP), 7-9 amino acids in length.
AIP is a quorum sensing molecule and is constitutively secreted (108). Quorum sensing
in S. aureus relies on the TCS AgrCA where AgrC is a transmembrane histidine kinase and
AgrA is the cognate response regulator.
At high cell-density, AIP is sensed by AgrC, which causes autophosporylation of an
intracellular histidine kinase domain, which then phosphorylates AgrA causing release
of AgrA from AgrC allowing transcriptional activation of the agr operon. RNAIII carries
the open reading frame for δ-hemolysin and encodes one of the largest regulatory RNAs
(109). Thus, the combined regulon of RNAIII and AgrA is hundreds of genes, many
involved in virulence, that generally result in the upregulation of toxins and
downregulation of surface proteins (110, 111). Not surprisingly, agr is essential for
virulence in vivo (112–114).
Staphylococcal accessory regulator (Sar) family
The transcription of RNAII and RNAIII is partially reliant on another regulatory system,
designated the staphylococcal accessory regulator (sar). The sar locus, roughly 1.2 kb, is
comprised of three overlapping genes, sarA, sarB, and sarC, each having their own
promoter (115). The expression of both sarA and sarB is required for full expression of
agr, and SarA has been shown to interact with both RNAII and RNAIII promoters. SarA is
also responsible for the regulation of many other genes, either through direct binding to
the gene promoter, through indirect regulation, or through mRNA stabilization (104).
Phenotypically, SarA activates expression of fibronectin and fibrinogen binding proteins
and toxins, while repressing expression of protein A and proteases (105).
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Another notable member of the SarA family of transcriptional regulators is MgrA, which
is a regulator of autolysis in S. aureus. Autolysins are peptidoglycan hydrolases that are
specific for various structural components of the peptidoglycan wall (116). Important
genes upregulated by MgrA are capsule polysaccharides, serine proteases, sortase A,
leukotoxins, and α-hemolysins, although RNAseq of an mgrA mutant revealed that over a
hundred genes were affected by MgrA regulation (117, 118). MgrA itself is upregulated
by the autolysis-related locus, ArlRS TCS (118).
Repressor of toxins (Rot) is a DNA-binding protein that belongs to the SarA-family of
regulators. Rot, like many regulators in the SarA family, performs dual regulation, as it
both activates the expression of surface proteins and immunomodulators, such as
Protein A and superantigens, and represses expression of exotoxins and secreted
enzymes (119).
S. aureus exoprotein (Sae) regulator
Sae (S. aureus exoprotein expression) locus encodes the TCS SaeRS, where SaeS is the
sensor kinsase and SaeR is the response regulator. Two auxiliary genes, saeP and saeQ,
encode lipoprotein SaeP and transmembrane protein SaeQ (120). SaePQ is needed for
SaeS phosphorylation activity by forming an SaeSPQ ternary complex. A major activation
signal of the Sae system is the human neutrophil peptide 1, 2, and 3, which are
antimicrobial peptides produced by neutrophils and constitute 30-50% of the total
protein in azurophilic granules. A second major activation signal is calprotectin, also
produced by neutrophils, that sequesters metals zinc, manganese, and iron, and thereby
inhibits S. aureus proliferation (120). The Sae system activates a number of virulence
genes, including fbnA, coA, and sbi, and represses virulence factors, including hla and hlb,
and its regulation is growth-dependent but agr-independent (120, 121).
Regulation of biofilms
The formation of biofilms in S. aureus is controlled by overlapping regulatory pathways,
where repression or inactivation of SarA results in decreased biofilms and inactivation
of agr results in heightened formation of biofilms. Rot has been implicated as a key
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regulatory factor in biofilm formation, and inactivation of ArlRS and MgrA leads to
decreased biofilm formation (118).
During infection and the battle for survival, S. aureus relies on a plethora of virulence
factors to ultimately avoid immune destruction and acquire essential nutrients; one such
essential nutrient is iron. Iron homeostasis in S. aureus, and in the host, will be discussed
in sections 1.4 and 1.5.

1.4 Iron
All organisms require certain metals to survive. The function of transition metals in the
cell is broken down into three main functions: redox catalytic cofactors, non-redox
catalytic cofactors, and non-catalytic functions (122). Although transition metals are
essential to the cell, at high concentrations they are also toxic, as they readily participate
in Fenton chemistry and can cause formation of reactive oxygen and nitrogen species
(123).
H2O2 + Fe2+ ® Fe3+ + OH- + ·OH (Fenton)
Iron is the most abundant metal in the human body and the fourth most abundant metal
in the earth’s crust. With the exception of some lactobacilli and spirochetes, all organisms
require iron for key metabolic pathways, including DNA replication and transcription
(122, 124). In an attempt to conserve iron for host functions and reduce the amount of
available iron for invading microbes, the amount of free iron is very limited within the
human body and is present at concentrations too low to sustain bacterial growth, with
estimates ranging from 10-8 M to some as low as 10-24 M (125). The intricate system of
iron sequestration by the host is referred to as nutritional immunity and is a crucial
component of microbial control and clearance (123). In addition to the active
sequestration of iron, at physiological pH and in the presence of oxygen, iron is readily
oxidized from ferrous (Fe2+) to biologically inactive, ferric (Fe3+) iron. Therefore, a
defining characteristic of pathogens is the ability to acquire iron from the host despite
the extreme efforts of the human body to keep iron away from invading microbes.
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1.4.1 Host sequestration of iron
Iron is an essential nutrient in the human body, where 20-26 mg of iron is used daily; the
largest portion of this iron (~80%) is found intracellularly associated to heme (126–
128). The heme prosthetic group is a planar molecule coordinated by Fe2+ iron.
Spontaneous auto-oxidation of heme results in formation of ROS that can cause severe
damage to cells and tissue; thus heme has intrinsic toxic properties that are ameliorated
by binding to large globular proteins, such as hemoglobin (Hb) (129). Hemoglobin is
typically contained within red blood cells; however, during destruction of senescent
erythrocytes or hemolysis, Hb is released into the blood where it can have cytotoxic
effects. Although the concentration of extracellular Hb is usually low in the body, during
conditions of rapid erythrocyte destruction, free Hb and free heme in the plasma can
increase to harmful concentrations. To combat this, haptoglobin (Hp) scavenges
hemoglobin in the blood, whereas hemopexin (Hx) is involved in sequestration of free
heme. Through receptor-mediated endocytosis, Hp-Hb and Hx-heme complexes are then
taken up by cells (129, 130).
Although heme is a critical source of intracellular iron, the extracellular cycling of iron is
another important pathway of iron control in the host. Most dietary iron is in the Fe3+
form and must be reduced to Fe2+ iron through ferroxidases on the surface of enterocytes
in order to be taken up by the divalent metal ion transporter-1 (DMT-1) (126, 130).
Within enterocytes, ferrous iron typically follows one of three possible pathways: i) it is
used to produce biliverdin, ii) it is incorporated into the multimeric, iron-storage protein,
ferritin, or iii) it is oxidized back to ferric iron and is exported out of the cell by
ferroportin. Ferroportin is the only iron exporter characterized in humans and is
expressed in enterocytes, macrophages, hepatocytes, cells of the central nervous system,
and placenta syncytiotrophoblasts (130, 131).
Once released into the blood stream by ferroportin, ferrous iron is converted by
ceruloplasmin to ferric iron, which is then bound by transferrin (Tf). Transferrin
scavenges free ferric iron in the blood stream, reducing formation of reactive oxygen
species, and delivers iron to various cells and tissues. Transferrin is also considered a
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member of the innate immune system as it sequesters free iron in the serum limiting
access to invading organisms (126, 130). Diferric-Tf can be taken up by cells via binding
to the transferrin receptor 1 (TfR1) followed by receptor-mediated endocytosis. Free
iron can also be bound by the transferrin-like glycoprotein, lactoferrin (Lf); Lf is
commonly found in mucosal secretions but is also found intracellularly stored in the
secondary granules of neutrophils (132).
A homologous transferrin receptor to TfR1 is TfR2, present on the surface of hepatocytes,
where endocytosis of diferric-Tf via TfR2 is thought to stimulate hepcidin release (126,
130, 133). Hepcidin is a hormone secreted by the liver that directly regulates
internalization and degradation of ferroportin. Therefore, hepcidin is most frequently
released in response to excess levels of extracellular iron, either to combat transferrin
saturation or as part of an inflammatory response (133). Upon ferroportin degradation,
iron is stored intracellularly, dietary iron uptake is halted, and iron release from
macrophages, specifically macrophages involved in phagocytosis of senescent or
degraded erythrocytes, is stopped. Binding of hepcidin to ferroportin has been shown to
decrease serum iron levels by as much as 30% (133).
NGAL is a member of the lipocalin family of proteins, secreted by many cells in the human
body, such as neutrophils (134). NGAL serves to scavenge and bind catecholate- and
phenolate-type siderophores. Siderophores are small iron chelators produced by
bacteria as a means to obtain ferric iron (to be discussed in section 1.5.2), where NGAL is
characteristically known to bind enterobactin, a widely synthesized siderophore among
Enterobacteriaceae (134, 135). Mice that are NGAL deficient, NGAL-/-, are much more
susceptible to infections by Gram-negative bacteria than mice with a functional NGAL
mechanism (136, 137), demonstrating the importance of siderophore-mediated iron
acquisition in establishing infection (134).
Although NGAL associates with complexed-iron it does not have the intrinsic ability to
bind iron directly, necessitating the function of the endogenous human siderophore, 2,5DHBA. The likely purpose of 2,5-DHBA is to scavenge free iron, preventing formation of
ROS, and make iron readily available to tissue and cells of the innate immune system
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(138, 139). Similar in structure to 2,3-DHBA is the iron carrier molecule synthesized by
E. coli, 2,5-DHBA, that is capable of promoting growth of E. coli in a mammalian model;
therefore, it is not surprising that synthesis of 2,5-DHBA is downregulated during
infection, freeing NGAL to bind to bacterial siderophores (138, 140). Figure 1-2 highlights
the battle over iron during infection and illustrates strategies used by the host and S.
aureus to maintain iron homeostasis.

1.5 Bacterial Iron acquisition systems
Due to stringent iron sequestration exerted by the host, perhaps the most challenging
obstacle for most pathogens to overcome during infection is iron acquisition. Therefore,
a defining characteristic of pathogens is their ability to acquire iron bound by host
proteins. Below I discuss some of the pathways bacteria use to acquire this essential
metal.
1.5.1 Uptake of ferrous iron
Uptake of free ferrous iron in many bacteria is facilitated by the Feo transporter.
Although characterized extensively in members of Enterobacteriaceae, homologs of Feo
have been observed in Gram-positive pathogens such as S. aureus, Bacillus anthracis, and
Listeria monocytogenes (123). The iron-regulated feoABC genes encode proteins
necessary for Fe2+ iron transport. FeoA is a small cytoplasmic protein that is often
encoded in close proximity to feoB. The exact role of FeoA in Fe2+ uptake is unknown;
however, deletion of feoA in E. coli resulted in a 60% decrease in Fe2+ uptake (141), and
in Vibrio cholerae and Salmonella enterica, deletion of feoA completely abrogated Fe2+
transport (142, 143). This suggested that FeoA plays a critical, and in some instances
essential, role in Fe2+ transport.
FeoB in many Gram-negative species interacts directly with FeoA (144). FeoB is an ironregulated, multi-domain, transmembrane permease. It is comprised of three main
domains: the cytoplasmic G-protein domain that is responsible for GTP hydrolysis; the
cytoplasmic GDP dissociation inhibitor (GDI) domain that functions as a linker region
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Fig 1-2. The host-pathogen battle for iron. Illustration of the various strategies used by
the host to sequester iron from invading pathogens and the counter-strategies used by
pathogens to obtain host iron. On mucosal surfaces, lactoferrin sequesters iron, yet
bacteria can obtain iron from lactoferrin by secreting siderophores or by secreting
reductases that reduce iron from Fe3+ to Fe2+, releasing it from lactoferrin. Bacteria can
obtain iron bound to heme by secreting hemolysins, which release intracellular
hemoglobin and heme into the blood. While the host uses hemoglobin- and hemescavenging proteins to sequester these iron sources, bacteria have mechanisms to
counter these systems. Macrophages move iron from the phagosome and the cell using
natural resistance macrophage protein 1 and ferroportin, respectively, to keep iron from
intracellular pathogens. In response to binding by the iron homeostasis hormone
hepcidin, membrane-bound ferroportin is degraded, thus withholding iron in
intracellular compartments. Fe2+ that is secreted is rapidly oxidized by ceruloplasmin
(Cp), and the Fe3+ is quickly picked up by transferrin. Transferrin-bound iron is
scavenged by bacteria using transferrin-binding proteins or through secretion of
siderophores. Bacteria can also obtain iron using the mammalian siderophore 2,5-DHBA.
Neutrophils secrete NGAL which serves to capture some bacterial siderophores. Some
bacteria synthesize and secrete stealth siderophores, which are not NGAL substrates and
can remove transferrin-bound iron even in the presence of NGAL. Lf, lactoferrin; Tf,
transferrin; sid, siderophore; Hp, haptoglobin; Hx, hemopexin; Hb, hemoglobin; Hm,
heme; Cp, ceruloplasmin. This figure is published in Sheldon, J. R., Laakso, H. A., and
Heinrichs, D. E. (2016) Virulence Mech. Bact. Pathog. (123)..
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between the G-protein and transmembrane domains and enhances GDP binding; and the
transmembrane domain that functions as the channel for iron transport (144).
feoC (yhgG) is only found in γ-proteobacteria, and was thought to encode a
transcriptional repressor of the feo operon because of the winged-helix DNA-binding
motif found in the protein (144). In Klebsiella pneumoniae, however, FeoC was shown to
not interact with DNA, but rather was bound tightly to the G-protein and GDI domains of
FeoB (145). In Salmonella enterica, FeoC binds and protects FeoB from FtsH-mediated
proteolytic degradation in iron-deplete, anoxic environments. Reduction of Fe-S clusters
in aerobic environments targets FeoC itself to oxygen-sensitive, Lon-mediated
proteolysis. Thus, FeoC may function as an oxygen sensor to Fe2+ uptake. In iron-limiting,
anoxic conditions, an environment that favors Fe2+ iron, FeoC is resistant to proteolysis
and stabilizes the FeoB transporter. In aerobic environments, FeoC undergoes
proteolytic degradation resulting in destabilization of FeoB and reduced ferrous iron
import (146).
Fe2+ is rarely found in the host because of the presence of oxygen, and thus Fe2+ is rapidly
oxidized to insoluble Fe3+. Therefore, in response to this, bacteria have developed
multiple mechanisms to take up Fe3+.
1.5.2 Siderophores
One of the key pathways utilized by pathogens to acquire ferric iron is through use of low
molecular mass, iron-chelators, called siderophores. Siderophores are endogenously
synthesized and are secreted into the extracellular milieu where they can bind free ferric
iron or remove iron from proteins such as transferrin and lactoferrin (123). The
siderophore-iron complex is too large to diffuse through membrane porins, and thus
must be actively transported inside the cell by specific, ATP-dependent transporters
(147). Over 500 different siderophores have been identified in nature observed in
bacteria, fungi, yeast, and recently animals, such as 2,5-DHBA previously described (139,
148).

24

Siderophores are typically characterized by the chemical structure of the iron-binding
moieties they contain. There are five common siderophore types: (α-hydroxy-)
carboxylate, catecholate, phenolate, hydroxamate, and mixed siderophores that contain
two more moieties (149). Due to their high electronegativity, most siderophores have
high affinity for ferric iron, exceeding the affinity of transferrin or lactoferrin. The
hexacoordinated structure of siderophores encompasses the Fe3+ ion in an octahedral
geometry, where the number of bound Fe3+ ions varies on the type and number of
moieties present (125). Bacterial siderophores are synthesized through one of two
different pathways: the non-ribosomal polypeptide synthetase (NRPS) pathway, or
through NRPS-independent (NIS) pathway. NRPS involves large multi-domain proteins
that use non-proteinogenic amino acids to build polypeptide siderophores in the absence
of a RNA template; whereas NIS synthesis involves a series of condensation reactions
from dicarboxylic acid and diamine or amino alcohol building blocks that are linked by
ester or amide bonds (150).
1.5.3 NRPS siderophores
The NRPS pathway uses large multidomain enzymes, that assemble siderophore
complexes from a broad array of amino, carboxy, and hydroxy acids. This allows for
molecules of generally higher molecular weight and also high structural variability that
can be increased through various substrate modifications. NRPS siderophores are
typically aryl-capped through a domain of one of the enzymes (151). Well studied NRPS
siderophores

include

enterobactin,

a

common

siderophore

produced

by

Enterobacteriaceae, yersiniabactin from Yersinia spp., pyochelin and pyoverdine from
Pseudomonas aeruginosa, and vibriobactin produced by Vibrio cholerae. Other NRPS
compounds include common antibiotics such as penicillins, vancomycin, and
cyclosporine (123, 150).
Enterobactin was first isolated in the 1970’s from S. enterica sv. Typhimurium and E. coli,
and has been extensively studied since (152, 153). It is a hallmark NRPS siderophore that
is found in many Gram-negative enteric bacteria, but has also been isolated from three
Gram-positive species, Corynebacterium glutamicum, Bacillus subtilis, and two
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Streptomyces species (154–156). The synthesis of enterobactin was among the first
siderophore synthesis pathways to be elucidated in vitro and relies on the activity of
three enzymes that form seven domains (157). The synthesis starts with the aromatic
amino acid precursor, chorismic acid, which is converted into 2,3-DHB by enzymes EntC,
EntB, and EntA, through stepwise reactions with intermediates isochorismate and 2,3dihydro-2,3-dihydroxybenzoate (158). Following the formation of 2,3-DHB, L-serine
forms an amide linkage with 2,3-DHB through catalytic action of EntD, EntE, EntF, and
the C-terminal aryl carrier of EntB. The final enterobactin molecule is released from the
terminal thioesterase domain of EntF following the hydrolysis of three DHB-serine
molecules by intramolecular cyclization. Enterobactin binds iron through three
catecholate moieties that are linked in a triserine macrocycle. Iron release from
enterobactin is achieved through the action of a cytoplasmic esterase (158).
Enterobactin’s affinity for iron is one of the highest characterized with a binding constant
of 1052 M, which is considerably higher than that of transferrin at 1023 M.
Most NRPS siderophores are constructed as described above and are key virulence
factors in many pathogens. For example, enterobactin in Campylobacter jejuni and
Salmonella enterica (159, 160), pyoverdine in Pseudomonas aeruginosa and Pseudomonas
syringae (161, 162), and yersiniabactin in Yersinia pestis, Klebsiella pneumoniae and
Proteus mirabilis (163–165), are all essential for virulence in animal models of infection.
1.5.4 NIS siderophores
The NIS siderophore pathway has been much less characterized and does not require the
large multi-domain enzymes of NRPS but instead relies on smaller condensation
reactions of alternating subunits of dicarboxylic acids with diamines, amino alcohols and
alcohols (125). The synthetases involved in NIS pathways have been characterized based
on common function. Aerobactin, a mixed-type siderophore that contains two
hydroxamate moieties and one carboxylate moiety, found in many Gram-negative
bacteria and often essential for virulence, is a hallmark of the NIS pathway (150). Type A
enzymes, such as IucA, found within the iucABCD operon that encodes enzymes involved
in aerobactin synthesis, catalyze the condensation of a prochiral carboxyl group of citrate
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to form either an amide bond to an amine group, or ester bond to an alcohol group of the
second substrate. Type B synthetases catalyze the substitution reaction of the C5
carboxyl of α-ketoglutarate for the citrate carboxyl. Lastly, type C enzymes, represented
by IucC, catalyze condensation of monoamide/monoester derivatives of citrate or
succinate to carboxyl groups on molecules with an amine or an alcohol (150, 166).
The synthesis of aerobactin was the classic example of NIS siderophore synthesis for
nearly a decade; however,in recent years, seven other gene clusters have been uncovered
that encode NIS biosynthetic genes. All NIS biosynthetic pathways contain at least one,
and typically two or three, IucA and IucC enzymes (150). Discussed below are the
siderophores utilized by S. aureus, of which two, staphyloferrin A and staphyloferrin B,
are NIS siderophores.
1.5.5 Staphylococcal siderophores
The preferred iron source for S. aureus is heme; however, deletion of heme uptake
pathways only partially abrogates virulence suggesting that other iron acquisition
mechanisms are utilized (167, 168). A key mechanism of S. aureus iron acquisition is the
use of siderophores, of which three siderophores have been characterized in S. aureus:
staphyloferrin A, staphyloferrin B, and staphylopine. A fourth siderophore, named
aureochelin, has also been discovered, but its function in metal homeostasis is currently
unknown (169, 170). The major siderophore pathways utilized by S. aureus are outlined
in figure 1-3.
Staphyloferrins
Staphyloferrin A (SA) and staphyloferrin B (SB) are the two predominant siderophores
used by S. aureus for iron uptake (169, 171, 172). Both SA and SB are polycarboxylatetype siderophores and are synthesized by NIS pathways. Despite their similarities, both
siderophores have distinct sets of synthetases and molecular precursors (125, 173–176).
One of the notable advantages of carboxylate siderophores is that they have lower pKa
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Fig 1-3. Summary of siderophore synthesis and transport pathways in S. aureus. S. aureus
endogenously

produces

three

siderophores:

polycarboxylate

siderophores

staphyloferrin B (biosynthetic operon sbn) and staphyloferrin A (biosynthetic operon
sfa), and the nicotianamine siderophore, staphylopine (biosynthetic operon cnt) that
each have their own efflux and import transporters. In addition to its endogenous
siderophores, S. aureus can also uptake hydroxamate and catecholate xenosiderophores
through Fhu and Sst transport systems, respectively.
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values than the other siderophore moieties, ranging from 3.5-5, compared to other
siderophores that have pKa values that are upwards of 8. This makes carboxylate
siderophores ideal for acidic environments (151).
Staphyloferrin A
Staphyloferrin A, first identified in S. hyicus, is found in all S. aureus strains and is
widespread among coagulase-negative staphylococci (177). SA is comprised of two
citrate molecules bridged by a D-ornithine and has the chemical formula N2,N5-di-(1oxo-3-hydroxy-3,4-dicarboxylbutyl)-D-ornithine

(48

kDa)

(128,

178).

The

biosynthetic proteins for SA were identified through BLAST searches of iucABC genes
in the S. aureus chromosome, and are encoded on the sfaABC operon, and divergently
transcribed sfaD. SfaD and SfaB are NIS synthetases that use the substrates Dornithine, citric acid, and ATP to generate SA; SfaC is a racemase, and SfaA is
transmembrane efflux pump that secretes SA. SA transport into the cell is facilitated
by HtsABC ATP-dependent transporter (177).
Staphyloferrin B
Staphyloferrin B is comprised of one unit each of citric acid, alpha-ketoglutaric acid,
1,2-diaminoethane, and 2,3-diaminopropionic acid (128, 173–176, 179). The sbn
operon encodes the biosynthetic proteins and efflux protein for SB, and the sir operon
encodes proteins needed for SB import into the cell (173–176, 178, 179). The operon
is comprised of nine genes, sbnA-I. The gene product of sbnD is an efflux pump
involved in secretion of SB, and the gene products of sbnABCEFGH are all involved in
SB synthesis: the gene product of sbnA is a O-phospho-L-serine sulfhydrylase, sbnB
encodes a NAD+-dependent dehydrogenase, sbnC, sbnE, and sbnF all encode NIS
synthetases, sbnG encodes a citrate synthase, and the gene product of sbnH is a
decarboxylase (172–174, 180). The functions of these genes are well established as
SB has been entirely synthesized in vitro using only the purified enzymes
SbnABCEFGH and precursor molecules O-phosphoserine, glutamate, oxaloacetate,
and acetyl-CoA (171, 173). Interestingly, the terminal gene in the sbn operon, sbnI, is
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not required for SB synthesis in vitro, and prior to this study, had not been
characterized.
Mutation of the SA biosynthetic genes in S. aureus does not affect its growth in ironrestricted media due to the functional redundancy with SB. Furthermore, SB is the
primary siderophore utilized by S. aureus during growth in serum due to limited
availability of citrate in the cell. SA, unlike SB, relies on citrate made by CitZ, an
essential protein in the TCA cycle that uses substrates oxaloacetate and acetyl-CoA to
produce citrate (180, 181). During growth in iron-restricted media, and in the
presence of glucose, the iron-sparing response is initiated causing downregulation of
iron-consuming, but non-essential pathways, such as the TCA cycle. In the ironsparing response, glycolysis is utilized as the central carbon metabolism pathway,
which does not produce citrate as a by-product, resulting in no available citrate
substrate for SA. SB overcomes the necessity for CitZ, and the TCA cycle, by having its
own dedicated citrate synthase on the sbn operon, SbnG (172, 180). The activity of
SbnG is thought to be specific to SB, and cannot be used in both siderophore
pathways. Therefore, growth in serum is not permissive for SA production, as serum
is iron-restrictive and glucose-rich. This has been corroborated in vivo, where
mutation of sbnE alone significantly abrogates the ability of S. aureus to cause
abscesses in murine infection model (169). Despite this, however, SA is not
indispensable and seems to be important for formation of abscesses in a murine skin
colonization model (182).
Staphylopine
Staphylopine (Stp) is a newly identified nicotianamine-like siderophore that not only
binds iron, but also nickel, cobalt, zinc, and copper (183). This non-proteinogenic
amino acid chelator, nicotianamine, is one of the most common metal chelators found
in plants (184). Homologues of Stp have been identified in human pathogens,
nonetheless, such as Y. pestis and P. aeruginosa (185). Nicotianamine is synthesized
through nicotianamine synthase (NAS): a pathway of three S-adenosyl methionine
molecules (SAM) that form an azetidine ring from condensation of three α31

aminobutyric acid moieties (184). The enzymes responsible for Stp synthesis in S.
aureus are encoded on the cobalt and nickel transporter (cnt) genes cntK, cntL, and
cntM. CntL is a NAS-like enzyme; CntM is related to octopine dehydrogenase, and is a
NAD(P)H-dependent enzyme; and CntK is a diaminopimelate epimerase. Thus the
formation of Stp starts with the CntK epimerase converting L-His into D-His; D-His is
then modified by CntL through the nucleophilic attachment of one α-aminobutyric
acid moiety onto D-His to produce the intermediate xNA; lastly CntM condenses the
intermediate, xNA, with a molecule of pyruvate, resulting in the final metallophore
structure (183).
cntKLM genes are on the same loci as the nickel and cobalt importer, encoded on
genes cntA-F. CntABCDEF importer was previously shown to be important for S.
aureus virulence (186, 187). The cnt genes are upregulated in metal-deplete media,
where mutations to either cntL and cntA-F caused decreased intracellular
accumulation of iron, nickel, zinc, copper, and cobalt, as shown by ICP-MS,
demonstrating importance of Stp for import of these essential metals (183).
Chemically synthesized Stp had affinity for all five heavy metals with Kd affinity
greatest for Cu2+, followed by Ni2+, Co2+, Zn2+, and lastly Fe2+. Although Stp is capable
of binding to iron, its affinity for iron is far lower than SB or SA. Recent work has
demonstrated that Stp is largely responsible for zinc import, and is thought to remove
zinc from host-derived protein, calprotectin; thus in the context of infection, Stp may
primarily function as a zincophore (188).
Xenosiderophores and stress hormones
In addition to taking up its own siderophores, S. aureus is also able to take up other
iron-containing

compounds,

including

hormones

(also

referred

to

as

pseudosiderophores) and xenosiderophores; the latter are siderophores produced by
other organisms. This ability is not limited to S. aureus but has been observed in other
bacteria, attesting to the resourcefulness of microbes to obtain essential nutrients
(123). S. aureus utilizes the ferric hydroxamate uptake (Fhu) pathway to take up
xenogenous ferric-hydroxamate complexes (189). Fhu is widely conserved, found in
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many Gram-positive and -negative bacteria. The three genes in the fhuCBG operon
encode proteins of an ABC transporter, where FhuC is a promiscuous ATPase, FhuB
and FhuG form a bipartate transmembrane permease, where mutation of FhuG
abrogates substrate uptake, and FhuD1 and FhuD2 are membrane-anchored
receptors that bind and transfer ferric-hydroxamate complexes to FhuCBG for
transport (189–191). FhuD1 and FhuD2 have unique binding affinities, where FhuD1
appears to bind a limited subset of siderophores, namely ferrichrome and
desferrioxamine, whereas FhuD2 is involved in the acquisition of a wide range of
hydroxamate substrates, including ferichrome, desferioxamine B, aerobactin and
coprogen (190, 192).
S. aureus also is able to take up xenogenous catecholate-type siderophores and
catecholamine stress hormones, such as epinephrine and norepinephrine. S. aureus is
not the only pathogen capable of this; Listeria spp. and Bacillus spp. are also capable
of catecholate substrate transport (193–198). Catecholamine stress hormones, such
as epinephrine and norepinephrine, are able to remove ferric iron from transferrin
and lactoferrin, not due to a higher affinity for ferric iron, such as bacterial
siderophores, but through reduction of ferric iron to ferrous iron (199). Catecholate
substrates are taken up by S. aureus by a highly conserved staphylococcal
siderophore transporter, SstABCD (199). In vivo studies done in mice demonstrated
that an sstABCD mutant had significantly lower colony forming units in the heart
compared to WT; however, no significant differences were seen in other organs,
namely the liver and kidneys (199).
1.5.6 Removal of transferrin/lactoferrin-bound iron by Tbp and Lbp
Part of the success of mucosal pathogens like Neisseria spp., Moraxella spp.,
Haemophilus spp., and Pasteurella spp. is their ability to obtain iron directly from
transferrin or lactoferrin. This feat is achieved through transferrin binding proteins
(Tbp) or lactoferrin binding proteins (Lbp). Tbp and Lpb are surface-expressed, ironregulated proteins that directly interact with extracellular host glycoproteins.
Transferrin binding is mediated by the outer membrane receptor protein, TbpA, and
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surface-associated lipoprotein TbpB (200, 201). In this pathway, TbpB binds
holotransferrin and transfers it to lipoprotein TbpA, which can bind either holo- or
apo-transferrin (202). TbpB is not required in this pathway, but greatly aids in
transferrin capture.
Unlike siderophore-iron complexes, transferrin is not brought into the cell cytoplasm,
thus the iron is liberated prior to transport across the outer membrane. Initial binding
of TbpB to human transferrin at the C-lobe prevents protonation of H349, a critical
residue in iron liberation, and thus serves to stabilize holo-transferrin for transfer to
TbpA (123). TbpA also binds transferrin at the C-lobe at a non-overlapping site for
TbpB binding, causing a substantial conformational change in transferrin. α-helical
extensions of TbpA extend into the iron-binding cleft of transferrin, widening the cleft
and facilitating iron release. The free iron is then transferred to the periplasm through
TonB-dependent transporter (TBDT), and then in the periplasm taken up by ferric
binding protein A (FbpA). FbpA escorts iron to the inner membrane ABC transporter,
FbpB/C, that ultimately brings the ferric iron into the cytoplasm (202). The
lactoferrin-iron uptake pathway is very similar to transferrin, although requires its
own designated receptors, namely lactoferrin binding protein A (LbpA) and LbpB.
As mentioned in section 1.4.1, the largest pool of iron in the human body is iron
complexed to protoporphyin IV, or heme (130). Thus most bacterial pathogens have
developed mechanisms to acquire iron from this tightly controlled, but abundant iron
source (130). Acquisition of heme generally follows a three-step process: i) bacteria
secrete hemolysins or cytolysins to lyse heme-containing host cells, such as
erythrocytes, causing release of free hemoglobin, and traces of free heme into the
environment; ii) through either proteases that disrupt hemoglobin-heme interaction,
hemophores that bind free heme or take it from hemoproteins, or through direct
binding of heme/hemoglobin to receptors on the cell surface, heme is brought to the
cell membrane; iii) heme at the cell membrane is transported into the cytoplasm
where the iron is then liberated from the protoporphyrin ring through degradation
or oxidation (203, 204).
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1.5.8 Gram-negative bacteria heme uptake
Gram-negative bacteria commonly acquire heme through direct uptake of heme, or
removal of heme at the cell surface, by the outer membrane, TonB-dependent
transporters (TBDTs) that may work in collaboration with hemophores. Hemophores
have been characterized in many Gram-negative bacteria and work similarly to
siderophores, in that they are freely diffusible and scavenge for free heme or remove
it from host proteins. The most well characterized hemophore is HasA, first identified
in Serratia marcescens (205), and has since been identified in a number of Gramnegative species including P. aeruginosa, P. fluorescens, Y. enterocolitica, and Y. pestis
(203).
HasA is secreted by inner membrane ABC transporters, HasD and HasE, and outer
membrane complex HasF, into the extracellular milieu (203). In the environment,
HasA sequesters free heme or strips heme bound to host hemoproteins. Crystal
structures of HasA demonstrate that the heme molecule is almost completely
surrounded by unstructured loops, in contrast to most heme-binding proteins that
use helices in the binding pocket. The structure of the HasA protein has been
described as a fish, where the “mouth” of the fish is the heme-binding site, and the
“body” of the fish is comprised of two domains, i) 7 twisted β-sheets, and ii) four α –
helices (206).
Heme-complexed to HasA interacts with membrane receptor, HasR, that facilitates its
import into the cell (207, 208). HasR is capable of interacting with a variety of
hemoproteins, including albumin, hemoglobin-haptoglobin, and free heme; however,
the heme-transport process is made 100-fold more efficient with HasA (209, 210).
HasR is a member of a large and crucial family of transporters in Gram-negative
species, the TonB-dependent transporter (TBDT) family, to be discussed in detail
later in section 1.5.11.
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1.5.9 Heme uptake strategies of Gram-positive bacteria
Few heme uptake systems have been identified in Gram-positive bacteria; however,
one that has been extensively characterized is the iron-surface determinant (Isd)
system. The best characterizations of this pathway are from studies in S. aureus and
B. anthracis. The Isd proteins form a protein shuttle cascade that imports heme from
the environment, across the peptidoglycan layer, and uses ABC transport into the
cytoplasm. Highly conserved in this pathway are the near-iron transporter (NEAT)
domains that allow for heme ligation. NEAT domains are 120-125 amino acids that
assemble into an eight-stranded β-sandwich fold. Heme is ligated by tyrosine
residues in a YXXXY motif within a hydrophobic pocket (211, 212).
B. anthracis contains six Isd proteins: IsdC, a peptidoglycan-anchored heme receptor,
ABC transporter IsdDEF, and two secreted hemophors, IsdX1 and IsdX2 (213). The
two hemophores transfer heme to IsdC at the membrane; although heme transfer
between IsdX1 to IsdX2 has also been characterized, suggesting a redundant role for
IsdX2 as a heme receptor (214). Interestingly, mutation of IsdX1 and IsdX2 impaired
cells for growth in vitro where hemoglobin was the sole iron source; however, this
mutant was not attenuated in vivo in animal models of infection (213, 215). Following
this work, two other NEAT-domain proteins were discovered: B. anthracis S-layer
protein K (BslK) and BAS0520. BslK contains three S-layer homology domains (SLH),
which mediates the non-covalent association of proteins to the cell wall, thus BslK in
the peptidoglycan layer binds to heme/hemoglobin and passes it to IsdC receptor for
import (216, 217). The role of BAS0520 NEAT-domain has yet to be determined.
The first identified heme-acquisition system in Gram-positive bacteria, due to its
sequence similarity to Gram-negative pathways, was in C. diphtheriae (204).
Mutations in one of the three heme-uptake (hmu) genes, hmuT, hmuU, and hmuV,
resulted in an inability of the strains to grow with heme as the sole iron source. These
three genes were identified as parts of an ABC transporter, where HmuT was a
lipoprotein capable of binding heme and hemoglobin, and HmuUV formed the
transmembrane permease and ATPase (218, 219). Three other genes were
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discovered in this region, htaA, htaB, and htaC (220). HtaA was found to be another
membrane-anchored heme receptor, HtaB also had heme-binding capabilities and is
suggested to be a heme receptor, although, its overall importance appears marginal,
and the function of HtaC has yet to be elucidated (221).
1.5.10 S. aureus heme uptake
Because of the thick peptidoglycan wall in Gram-positive bacteria, movement of
molecules from the environment to the cell membrane is restricted, and thus requires
peptidoglycan anchored receptors to facilitate transport. A screen to identify the
enzyme(s) responsible for the covalent attachment of proteins to the peptidoglycan
wall uncovered sortase A (SrtA) (222). SrtA specifically cleaves a conserved, Cterminal, five-amino acid recognition motif, LPXTG, forming a sortase-substrate acylenzyme intermediate. This intermediate undergoes nucleophilic attack by the free
amino group of lipid II-linked to pentapeptide, a key building block of the cell wall.
The lipid II-linked protein is then incorporated into the peptidoglycan via the normal
transpeptidation reaction of cell wall biosynthesis (223–226).
This important discovery of SrtA led to database searches of the S. aureus genome to
identify other sortases. These searches uncovered sortase B (SrtB), which was
encoded in what seemed to be an eight-gene operon (226). Three genes in this
operon, named isdA, isdB, and isdC, had gene products that were anchored to the cell
wall and were also capable of binding heme (224). IsdA and IsdB are anchored via
SrtA, whereas IsdC is anchored by SrtB. IsdB is the most surface-exposed, followed by
IsdA and IsdC, forming a heme shuttle pathway: IsdB binds heme and transfers it to
IsdA, that then transfers heme to IsdC at the cell membrane (224, 227–231).
Discovered later was another peptidoglycan anchored protein, IsdH, which also
participated in the heme transport assembly line (232). IsdB contains two NEAT
domains, N1 binds hemoglobin and hemoglobin-haptoglobin complexes, and N2
binds only to heme. IsdH contains three NEAT domains, where N1 and N2 both bind
hemoglobin and haptoglobin, where N3 interacts only with heme (233). Thus, the
proposed model is that N1 (and N2 in the case of IsdH) bind to hemoproteins and
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transfer the extracted heme molecule to the downstream NEAT domains (N2 for IsdB,
and N3 for IsdH). IsdA is partially surface-exposed and contains only one NEAT
domain that binds only to heme. Thus, IsdH and IsdB bind to host hemoproteins at
the surface of the peptidoglycan layer, remove the heme and transfer it to IsdA, which
then shuttles heme to IsdC (234). Transport into the cell is achieved through a threeprotein complex with homology to ABC transporters, designated IsdDEF. IsdE is a
membrane anchored heme receptor, IsdD is a transmembrane permease, and IsdF
the associated ATPase (222).
The last piece of the puzzle was the discovery of isdG and isdI genes. IsdG and IsdI are
heme oxygenases that degrade heme to release iron, resulting in staphylobilin. IsdG
and IsdI are expressed during infection and are required for growth where heme is
the sole iron source (235, 236). The S. aureus Isd pathway is illustrated in figure 1-4.
Like siderophores, heme can be transported as an intact molecule into the cell where
the iron is subsequently removed.
1.5.11 Transport of iron complexes
Iron complexed to siderophores or heme is too large to passively diffuse through
porins in the membrane, and thus needs to be transported into the cell by designated
transporters. The main transporters characterized in this process are the ATPbinding cassettes (ABC) and the Gram-negative TonB-dependent transporters,
depicted in figure 1-4.
In Gram-negative bacteria, iron-complexes are brought into the cell through TonB
dependent transporters (TBDT). Approximately 50 different TBDTs have been
characterized, all with different ligands, although the majority of TBDTs are
responsible for siderophore uptake (237). Other identified ligands for TBDTs are
heme, vitamin B12, carbohydrates, and nickel chelates. Due to porin channels, the
outer membrane lacks a proton motive force and thus does not have the energy
source needed for active transport. Therefore, TBDTs rely on ATP generated from the
inner membrane to supply the energy required to transport iron-complexes into the
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Fig 1-4. A,B. Model of iron uptake mechanisms in Gram-negative and Gram-positive
bacteria. Diagrams depicting the envelope proteins required for the uptake of iron, or
iron scavenged from siderophores or heme. This is a composite diagram and
represents mechanisms used by many pathogenic bacteria. A. Model of TonBdependent transport in Gram-negative bacteria. An iron siderophore complex
entering through a TonB-dependent transporter (TBDT) in the outer membrane
(OM). Movement through the TBDT requires an interaction of the TonB box with the
TonB protein, with the energy for conformational changes provided by the proton
motive force captured by the ExbB and ExbD proteins. Intracellular iron, via Fur,
negatively regulates transcription of genes encoding iron acquisition systems. In
some TBDTs, an N-terminal extension is present to provide an extra layer of control
of gene expression, in addition to Fur. This involves an anti-σ- factor and
extracytoplasmic function σ-factor, allowing for gene expression in response to the
uptake of particular iron chelates. B. Gram-positive bacteria rely on ABC transporters
for iron-complex import. In the case of heme transport in Staphylococcus spp. and
Bacillus spp., heme is shuttled across the peptidoglycan (PG) layer by isd encoded
hemoproteins. Depicted is the Isd pathway characterized in S. aureus. OM, outer
membrane; PG, peptidoglycan; CM, cytoplasmic membrane; sid, FeIII-siderophore;
Hm, heme; Hb, hemoglobin; Hp, haptoglobin. This figure is published in Sheldon, J. R.,
Laakso, H. A., and Heinrichs, D. E. (2016) Virulence Mech. Bact. Pathog. (123).
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periplasm (238). Energy generated from the inner membrane is transduced to the
outer membrane by TonB, ExbB and ExbD.
The first characterized TBDTs were FhuA and FepA, which are responsible for import
of ferrichrome and ferric-enterobactin, respectively (239–241). FhuA and FepA are
comprised of twenty-two stranded, β-barrel structures that span the outer
membrane, and consist of a N-terminal periplasmic “plug” domain, referred to as the
TonB-box. In the resting state, the plug domain fully obstructs the β-barrel interior
and prevents transport (242, 243). When the ligand, a ferric-siderophore, binds to the
extracellular substrate-binding residues of the transporter, it transduces a signal
across the membrane that causes defolding, or “unplugging”, of the TonB box from
inside the barrel, allowing for transport of the substrate into the periplasm. This
process is reliant on the TonB-ExbB-ExbD proteins of the inner membrane that
supply the necessary energy (244). TonB contains three functional domains: Nterminal signal sequence that directs TonB to the inner membrane, a proline-rich
periplasmic spacer region that is thought to confer flexibility to TonB and allows it to
span the periplasm, and lastly a C-terminal domain that interacts with TonB-boxes of
TBDTs. The unfolding of TonB-box upon substrate binding causes it to interact with
TonB-ExbB-ExbD complex and signals that the substrate is ready for transport. This
energizes the transporter to bring the iron-complex into the periplasm. The exact
mechanism behind the domain rearrangement of TonB-box is currently unknown
(240, 242, 243).
Some TBDTs also possess an N-terminal extension domain, or signaling domain, that
signal to cytoplasmic transcription factors binding of the substrate, causing
downstream activation of appropriate genes. This N-terminal extension has been
found in the E. coli ferric-citrate receptor, FecA (245), the ferric-pyoverdine receptor,
FpvA, of P. aeruginosa (246), and in heme-iron transporter HasR of S. marcescens
(247). The α-/anti-α-factor is localized to the cytoplasmic membrane where it
sequesters an associated and often co-transcribed extracytoplasmic function (ECF)
sigma factor. Upon binding of the ferric-substrate to the TBDT, the TBDT interacts
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with the anti-α-factor causing liberation of the ECF sigma factor that is then free to
direct RNA polymerase to genes involved in the substrate-specific uptake, such as
genes encoding inner membrane ATPase transporters or siderophore biosynthetic
enzymes (237). This additional domain allows regulation of iron-responsive genes
beyond the classical ferric uptake regulator (Fur) regulation and is a way for the cell
to fine-tune the iron-acquisition mechanism in response to the iron source available.
1.5.12 Iron-substrate import with ABC transporters
TBDT-dependent uptake of iron-substrates is specific to Gram-negative bacteria and
is a specific way to import iron-complexes into the periplasm. Once in the periplasmic
space, the substrate is directed by periplasmic-binding proteins to a specific ATP
binding cassette (ABC) transporter in the cytoplasmic membrane for import into the
cytoplasm (123). In an analogous process, Gram-positive bacteria rely on ABC
transporters and substrate-specific membrane-anchored lipoproteins to bring ironsubstrates inside the cell. ABC transporters consist of a cytosolic ATP-binding
lipoprotein, a transmembrane permease, and, for Gram-negative bacteria, a soluble
periplasmic protein, or an analogous membrane anchored lipoprotein in Grampositive bacteria (248). ABC transporters are ubiquitous and are responsible for the
import of many essential nutrients such as amino acids, peptides, sugars, organic and
inorganic ions, polyamine cations, opines, vitamins, and metals (248).
The transmembrane permeases share high structural similarity and typically consist
of two hydrophobic membrane-spanning, or integral membrane (IM), domains that
constitute roughly 65% of the permease, and two hydrophilic domains in the
cytoplasm. These four domains are typically independent polypeptide chains that are
assembled to form a multimeric complex in transporters responsible for substrate
influx. For exporters, however, these four domains are usually derived from a single
polypeptide chain (249). Slight differences in the amino acid sequence of the IM
domain provide the specificity needed to transport the appropriate substrate.
Typically, there is only one ABC transporter per substrate, which confers the cell with
greater precision for iron-substrate uptake. Along with transport across the
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membrane, the permease must recognize the specific periplasmic protein, or
lipoprotein, extract the substrate for transport, and utilize the corresponding ATPase
to achieve active transport of the substrate (248).
ATP-binding proteins are readily identified by a conserved, homologous 200-amino
acid sequences flanked by “Walker A” and “Walker B” consensus sequences. These
sequences are characterized by the presence of nucleotide-binding sites, and located
internal to the “Walker” sequences is a signature motif, unique to ABC proteins (250).
The precise molecular mechanism for ATP hydrolysis is controversial, although all
ABC structures contain a highly conserved structural fold, suggesting that they
hydrolyze ATP by a common mechanism.
The periplasmic binding proteins (PBPs) of Gram-negative bacteria are diverse, often
sharing only a 10% sequence similarity (203). Despite this, the structure of PBPs is
conserved: PBPs are bi-lobed proteins comprised of β-sheets flanked by α-helices that
are connected by a short polypeptide chain that functions as a flexible linker domain.
This linker domain gives movement to the lobes via a hinge mechanism that encloses
around the substrate in a “Pac-Man” type motion (251). Specificity and recognition of
the substrate is achieved through slight rearrangements of the β-sheets and α-helices
of the two globular domains. Periplasmic proteins interact directly with the
transmembrane permease, where they deliver and release the bound substrate for
transport into the cytoplasm.
Lastly, essential to the transport of iron-complexes in Gram-positive bacteria are
membrane anchored lipoproteins. Lipoproteins serve in a wide range of functions
from uptake of other essential nutrients, sensing and signaling of the environment,
protein secretion, and antibiotic resistance (252). Much like the analogous
periplasmic-binding proteins of Gram-negative bacteria, the protein portions
recognize with high specificity their iron-substrates, whereas the N-terminal,
covalently-linked lipid portion is anchored to the membrane preventing diffusion.
The hydrophilic protein is acylated to promote the coalescence of lipid to the
phospholipid bilayer in the membrane, positioning the lipoprotein in close proximity
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to the designated ABC transporter. Once bound to the substrate, lipoproteins transfer
the substrate to the ABC transporter for import (252, 253).
1.5.13 S. aureus iron acquisition mechanisms and virulence
The preferred iron source for S. aureus is heme (254). Heme is acquired through use
of the Iron-surface determinant (Isd) system as previously described in section
1.5.10. The utilization of heme is an important virulence factor for S. aureus, and thus
its internalization is mediated through redundant pathways; even isd mutants can
still uptake heme for use as an iron source, although the mechanism behind this is
currently unknown (255). An isdB mutant, however, still had significantly lower CFU
counts in kidneys and spleens in a systemic mouse model of infection, compared to
the isogenic WT (256). This finding highlights the importance of the Isd system, and
specifically heme acquisition, in S. aureus survival in vivo.
S. aureus utilizes polycarboxylate siderophores, staphyloferrin A (SA) and
staphyloferrin B (SB), for uptake of free ferric iron or to remove ferric iron from host
glycoproteins, transferrin and lactoferrin. Both SA and SB are stealth siderophores,
and thus are not recognized by the host protein NGAL (125). S. aureus siderophores
are described in section 1.5.5. Both SA and SB are important virulence factors in vivo.
Following intravenous injection, a SB-deficient strain (sbnE mutant) had significantly
fewer CFUs than WT in a murine kidney abscess model (199), suggesting that SB is
critical for systemic infection. SA is important for skin infections, as a SA-deficient
strain had significantly fewer recoverable CFUs than isogenic WT, and a SB-deficient
strain, in a murine skin abscess model (182). Thus, differential siderophore
production by S. aureus may represent another means by which this pathogen adapts
to different host environments. Table 1-1 lists the key iron acquisition mechanism
utilized by S. aureus.
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Table 1-1 Predominant iron uptake pathways in S. aureus.
S. aureus gene (s)

Role in iron acquisition

Reference

sbnA-I

Staphyloferrin B (SB)

(171–173, 180,
257, 258)

sbnA-C, sbnE-H

Biosynthesis proteins

sbnD

SB Efflux

sirABC

ABC transporter for SB import

(257, 259, 260)

sfa

Staphyloferrin A (SA)

sfaBCD

Biosynthetic proteins

(177, 179, 229,
261)

sfaA

SA Efflux

htsABC

ABC transporter for SA import

(262)

cnt

Staphylopine (Stp)

(63, 183, 187, 263)

cntE

Stp Efflux

cntKLM

Biosynthetic proteins

cntABCDF

ABC transporter for Stp import

isdA-I

Heme uptake pathway

isdA-C, isdH

Surface associated heme-binding proteins

isdDEF

ABC transporter for heme import

isdG,I

Heme oxygenases

fhuABC

Uptake of ferric-hydroxamate complexes

(189–191)

sstABCD

Uptake of ferric-catecholate complexes

(199)

feoABC

Ferrous iron uptake

(267)

(128, 168, 235,
264–266)

1.5.14 Regulation of iron uptake systems
Iron-uptake systems are tightly regulated in response to the intracellular levels of
iron. A very well characterized gene regulator in Gram-negative and -positive bacteria
is Fur. Fur was first identified in E. coli, where a single mutation in the fur gene
resulted in constitutive expression of iron acquisition genes (268–270). Since the
initial discovery, Fur has been extensively characterized in many bacterial species.
Based on a Pfam sequence search, there are currently 9,049 sequences of Fur
belonging to 3,802 different species from all domains of life.
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Fur typically functions as a homodimer and regulates gene expression in response to
intracellular iron levels by binding to the promoter region of target genes (252, 271).
Each Fur monomer is comprised of two domains: a canonical helix-turn-helix motif
necessary for DNA binding and a carboxy-terminal domain that contains the metalbinding residues and is essential for dimerization. Zinc is the coordinating metal for
Fur dimerization and is bound in a tetrahedral fashion to two cysteine residues (272,
273).
When iron is replete in the cell, Fur binds to ferrous iron, altering its dimer
conformation to promote DNA binding to a 19-bp Fur-binding consensus site,
referred to as the Fur box. Fur boxes are typically A/T-rich, 19-bp inverted repeat
sequences usually overlapping the -10 and -35 promoter elements (274). Fur bound
to the Fur box effectively blocks RNA polymerase from accessing the promoter,
leading to repressed transcription of target genes. In iron deplete conditions, levels
of intracellular free iron are low and thus Fur does not interact with ferrous iron. This
prevents Fur from forming the conformation conducive to DNA binding, resulting in
disassociation from the Fur box, thereby allowing expression of target genes (275).
Nearly all genes that encode products that participate in iron-uptake, such as hemebinding proteins and heme transporters, and biosynthesis, export and import of
siderophores, are regulated via Fur. In S. aureus, nearly all genes involved in
siderophore-mediated iron uptake, heme uptake, and ferrous iron uptake are Furregulated; such operons include fhu, sir, sbn, sfa, hts, isd, and feo (169, 179, 199, 257).
Fur has been shown to regulate genes not only directly implicated in iron-acquisition,
but also genes involved in the TCA cycle, glycolysis, respiration, chemotaxis, redox
stress and DNA synthesis (276, 277). In E. coli, Fur represses 53 genes and activates
48; these genes generally fall into two categories: those that contribute to iron
metabolism and those implicated in energy metabolism. As a profound, global
transcription factor, Fur is very abundant with approximately 5,000 copies per E. coli
cell (278).
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A key aspect to Fur’s global regulation, specifically its activation of certain genes, is
the expression of a highly-conserved, small untranslated RNA (sRNA), named ryhB
(279). This sRNA is repressed by Fur; however, in iron deplete conditions when Fur
is inactive, RyhB binds to target mRNA. Notable genes regulated by RyhB are sodB,
which encodes superoxide dismutase, genes acnA and fumA, which encodes enzymes
of the TCA cycle, ftnA and bfr, which encode proteins involved in iron storage, and the
succinate dehydrogenase operon, sdhCDAB (280). Binding of RhyB to mRNA targets
them for degradation. This process is a part of what is called the “iron-sparing
response”, in which iron-containing enzymes and iron-storage proteins are
negatively regulated during metal-starvation to prioritize cytoplasmic iron for
essential pathways (281). RhyB regulation is found in many Gram-negative bacteria;
however, very little has been done to characterize the iron-sparing response of Grampositive bacteria.
There is a large number of Fur homologs that have been identified. Some of the
widespread Fur-homologs are Zur, regulator of zinc-homoestasis (282), PerR that
regulates genes in response to oxidative stress (283), Mur, gene regulation in
response to manganese (284), Nur, a nickel-responsive regulator (285), and Irr of
Bradyrhizobium spp. (286). Irr is upregulated in response to iron-starvation and
functions as a negative regulator of hemB, a gene encoding the heme biosynthetic
enzyme δ-aminolevulinic acid dehydratase, and genes in bacterioferritin production
(286–289). In the presence of heme, Irr disassociates from DNA causing derepression
of regulated genes. In some species, Irr can also activate genes involved in iron
uptake. Unlike other metalloregulators that function as repressors in the presence of
their metal ion, instead, when Irr is complexed to its response substrate, namely
heme, it undergoes degradation causing derepression of target genes (290).
In some GC-rich, Gram-positive bacteria, such as Streptomycetes, Corynebacterium
spp., and Mycobacterium spp., another iron-responsive regulator is utilized named
DtxR (diphtheria toxin regulator). DtxR transcription factors regulate similar gene
clusters to Fur, often repressing genes that encode siderophore biosynthesis and
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transport, heme transport, and ferric iron transport in response to intracellular iron
(291, 292). DtxR is not a member of the Fur family, and contains no sequence
similarity to Fur, although the structures of these two regulators are similar. Both
regulators contain two metal binding sites per monomer; are assumed to bind to
ferrous iron, have the canonical helix-turn-helix motif that is critical for DNA-binding,
and function as dimers (202, 293). There are a number of DtxR homologs, such as SirR
in S. epidermidis (294), and IdeR of Mycobacterium tuberculosis (295).

1.6 Copper
Like iron, copper is an essential micronutrient for living systems and plays an
important role in central metabolism, oxidative phosphorylation, iron metabolism,
hydrolytic pathways, and is a key metal cofactor for many enzymes (122). Despite
being required by biological systems, copper is also incredibly toxic at high
concentrations due to its readiness to accept electrons. In aerobic conditions, copper
produces hydroxyl radicals via Fenton and Haber-Weiss chemistry (296).
Cu1+ + H2O2 ⟶ Cu2+ + OH- + ·OH (Fenton)
Cu2+ + ·O2 ⟶ Cu1+ + O2 (Haber-Weiss)
Production of reactive oxygen species causes destruction of most macromolecules,
leading to damage of proteins, nucleic acid, and lipids. In the cytoplasm, copper can
react with thiol groups to drive the oxidation of disulfide bond formation and can also
interact with S-nitrosothiols groups to generate nitric oxide; as copper is more
reactive than most transition metals, including iron, its presence in biological systems
can have considerable deleterious effects (297).
1.6.1 Copper treatment in a health care setting
In 2008 the US Environmental Protection Agency (EPA) granted recognition to
copper as having antimicrobial efficacy, approving over 300 different copper surfaces
(298). Test results showed that most microbes examined were killed within hours on
copper surfaces, and this was exacerbated with decreased humidity, increased
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temperature, and increased copper alloy content. Specifically, MRSA killing time
varied from 45 min to 180 min on “wet” surface testing (298, 299). The deletion of
copper resistance mechanisms, as expected, decreased killing time, suggesting that
free copper ions are present in the cytosol of microbes (299). The presence of oxygen
also increased lethality, suggesting that the formation of ROS is an important
consideration in microbial killing. Although the process of contact killing is not
completely resolved, it is thought to begin with membrane damage, followed by the
influx of copper ions, formation of ROS, cell death and DNA fragmentation, although
this specific sequence is tentative (299).
Based on these results and others, studies examined the potential efficacy of copper
surfaces in health care settings to reduce hospital acquired infections. Stainless steel
is the predominant metal coating used in hospital settings, despite having no clear
antimicrobial properties. A study in Birmingham, UK, showed that compared to
stainless steel, and other surfaces commonly used, copper-coated surfaces
dramatically decreased the bacterial burden, having a 90-100% reduction up to 6
months after installation (300). A study in Hamburg, Germany, measured the survival
of microbes and, in particular, the survival of ciprofloxacin-resistant Staphylococcus
(CRS) as a reporter for multi-drug resistant pathogens common to hospitals. They
found dramatic differences in the bacterial burden of the overall microbe population
(63% reduction); however, there were no significant differences observed with CRS,
although it trended to lower counts on copper surfaces compared to the control
(301).
Beyond surfaces, copper is also being examined as a water treatment option. One of
the first studies to exam this looked at the copper and silver ionization of drinking
water in 16 hospitals to prevent hospital-acquired Legionnaires disease. Prior to
installation in 1995, all 16 hospitals had reported hospital-acquired legionnaires
disease, and 47% of hospitals reported having more than 30% of distal water sites
test positive for Legionella contamination. During the study, 50% of hospitals
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reported no Legionella contamination in the water supply, and all 16 hospitals
reported 0% hospital-acquired legionnaires disease (302).
1.6.2 Copper and the environment
There is an increasing amount of copper and zinc usage in agriculture, particularly in
animal feed, where excess amounts of these heavy metals end up in manure and seep
into water and soil (303). Due to this, there is a rising number of heavy metal-resistant
bacteria emerging within livestock and crops (304). Unlike metals, antibiotics
transiently persist in soil and water as they are prone to degradation and
sequestration. Recent work has suggested that the presence of copper, mercury, zinc,
and arsenic may in fact aid in persistence of antibiotic-resistant genes (ARG), as both
metal-resistance proteins and antibiotic-resistance proteins share high functional
and structural similarities and are frequently found on the same mobile genetic
elements (303, 305, 306). Moreover, among the heavy metals tested, copper had the
greatest impact on antibiotic resistance compared to other heavy metals, including
nickel, zinc, lead, and iron (305).
Although still in the early stages, examination of copper surfaces and copper
treatment as a possible means to reduce microbial growth in the health care setting
and livestock feed appears to be effective against most microbes. However, as was
seen in the German hospital study (301), copper’s ability to kill antibiotic-resistant
pathogens may be limited and may in fact aid in persistence of antibiotic-resistance
genes (301, 303). Therefore, long-term copper exposure could increase the number
of highly resistant strains over time, although further work is required to examine the
long-term effects of copper treatment.
1.6.3 Copper homeostasis in humans
Like iron, copper is essential to the human body, as it is not only involved in key
metabolic functions, but also plays a role in blood clotting, iron transport, peptide
hormone production, pigmentation, and brain development (307). Similar to iron,
most of the copper in the human body is acquired through diet, where copper is
absorbed through enterocytes that line the intestine and is transported, typically via
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albumin and histidine, through the portal blood to the liver (297). The total copper
content in the body is around 100 mg, with the daily uptake being around 1-2 mg. It
is not entirely clear if copper absorption in the intestine is in response to hormones
secreted by the liver when there are low copper levels, like hepcidin-regulation of
iron, and a copper-responsive hormone has been suggested in mice (308). In the liver,
much of the newly acquired copper is loaded onto ceruloplasmin, a serum protein
that binds 6-7 copper ions and holds 90-95% of copper in the human body. The
remainder of the hepatic copper is transported to key enzymes in the cell by copperbinding chaperones. Unlike iron, copper is not stored in the human body, and thus
intake of dietary copper is essential, and excess copper is removed through biliary
excretion (309).
Ceruloplasmin is an acute-phase protein that, along with binding hepatic copper, also
binds to free copper in the serum and delivers it to cells and tissues in the body. It has
been well documented that during infection hepatic secretion of ceruloplasmin into
the serum increases (310–312); furthermore, high levels of ceruloplasmin observed
in the urinary tract are thought to prevent urinary tract infections (313).
Ceruloplasmin is not required for copper absorption or copper uptake in the liver, as
aceruloplasminemic mice did not display decreased ability in these pathways. These
mice, however, did display a defect in iron mobilization, a result of ceruloplasmin
functioning as an essential ferroxidase (314–316). Additionally, unlike ferrictransferrin, ceruloplasmin is not endocytosed into cells, with the exception of
hepatocytes, but is membrane-bound and deposits the copper at the cell surface for
import into the cell via surface receptor copper transport receptor 1 (CTR1) (315).
CTR1 is an essential gene for embryonic development, as homozygous deletion of the
ctr1 gene in mice resulted in mortality half way through gestation. CTR1 is the
primary human transporter of copper; however, even in CTR1-deficient cells, copper
uptake remains about ~20%, suggesting that there are alternative, minor copper
transport systems (317, 318).
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Free copper is rarely found inside cells because of its high redox potential, where the
amount of free copper in the cell is estimated to be less than 10-18 M, as it is actively
sequestered by copper binding chaperones (319). There are a number of cytoplasmic
chaperones that sequester and deliver copper to target proteins, for instance
ATOX1/HAH1 delivers copper within the trans-golgi network to ATP7A, Sco1/COX17,
delivers copper to enzymes involved in the synthesis of cytochrome C oxidase, and
copper chaperone for SOD (CCS) transports copper to superoxide dismutase (SOD)
(319, 320). Transport of copper within cells is largely facilitated through the Cuactivated, P-type ATPase transporters, ATP7A and ATP7B, which are critical for
proper copper homeostasis (320).
1.6.4 Copper usage by macrophages
Although essential for central metabolism, copper is also critical for bacterial
clearance. Unlike iron, which is actively sequestered away from invading pathogens
as a part of nutritional immunity, copper is used as a defense mechanism due to its
potent antimicrobial properties. Early work demonstrated that rodents fed copperdeficient diets had decreased oxidative burst and impaired macrophage function and
thus were much more susceptible to bacterial infection and infection-related
mortality (321, 322).
Copper plays many roles in immune function (323); recently characterized was the
transport of copper within macrophages from the cytosol into phagosomes, where
the combination of free copper ions and acidifying environment results in decreased
survival of engulfed microbes (296). This mechanism is performed through the
concerted effort of outer membrane copper-transporter CTR1, which imports copper
from the extracellular milieu to cytoplasmic chaperone ATOX1, which shuttles the
copper either to the golgi, or, in the case of infection, to the phagosome for efflux by
ATP7A into the phagosome (324). Due to the high levels of copper experienced by
microbes inside the phagosome, and in the environment, bacteria have developed
sophisticated copper detoxification systems.
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1.7 Copper detoxification systems in bacteria
The major players in bacterial copper detoxification systems are P1B -type ATPases
that are involved in extrusion of copper from the cytoplasm; copper-binding
chaperones that sequester and deliver copper to efflux pumps for secretion, or to
cuproenzymes for enzymatic function; and multicopper oxidases (MCOs) that bind
free copper ions and convert reactive cuprous (Cu+) copper to less active, oxidized
cupric (Cu2+) copper (325).
1.7.1 Enterococcus hirae copper detoxification pathway
The majority of heavy metal efflux pumps are a sub-class of P-type ATPases, that
receive their name due to a universally conserved aspartic acid residue in the
phosphorylation domain, DKTGT sequence, that is phosphorylated in the course of
the reaction cycle (326). These transporters also have a distinguishing CPC/CPH/SPC
motif located in the middle of a membrane helix (327). Other conserved domains are
the TGE sequence making up the actuator domain, and the GCGINDAP sequence that
comprises the nucleotide binding domain (328).
The copper efflux system of Enterococcus hirae is the most well studied copper
detoxification system in prokaryotes, in which E. hirae CopA and CopB were the first
copper ATPases described (329). Copper detoxification mechanisms in E. hirae are
representative of many copper systems in Gram-positive bacteria, including S. aureus.
The E. hirae copper efflux mechanisms are encoded on the copABZY operon, where
copA and copB encode ATPase efflux pumps, copY is a copper responsive repressor,
and copZ is a copper binding chaperone (330).
It is generally considered that CopA in E. hirae functions in both the uptake and efflux
copper. This observation was based on two experiments: i) a copA mutant had
reduced growth in copper limiting media, and ii) copA mutants were less sensitive to
growth in silver, suggesting that both copper and silver may be imported through this
transporter (331). CopA possesses a CXXC motif at the N-terminus that is responsible
for heavy metal binding. The cysteines in this motif were also necessary for CopA
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interaction with copper chaperone, CopZ (332). The other ATPase copper efflux
pump, CopB, does not contain a CXXC motif but has a histidine-rich N terminus that
aids in metal binding. This same histidine-rich N-terminal motif was also observed in
CopA and CopB from P. syringae (333). The CopB in E. hirae effluxes copper and silver,
where maximal transport for both metals was observed at a pH 6.0 (334, 335).
The founding member of prokaryotic copper chaperones was CopZ from E. hirae and
has since been found in many Gram-positive and -negative bacteria (336). The CopZ
structure is a βαββαβ ferredoxin-like structure, that also contains the CxxC motif.
CopZ functions as a dimer, where copper is complexed between four cysteines, with
two cysteines donated from each CopZ monomer (337). In conditions of high copper,
CopZ delivers copper to both CopY, a copper-responsive regulator that de-represses
the copABZY operon when complexed to copper, and to CopA for efflux of copper out
of the cell (332, 338).
1.6.2 Copper detoxification in E. coli
Like E. hirae, the copper detoxification system of E. coli is well studied (339). Figure
1-5 is a schematic of the major copper detoxification systems in E. coli and is
representative of many Gram-negative bacteria. Although E. coli is not characterized
as a macrophage-specific intracellular pathogen, it commonly infects the
gastrointestinal tract of mammals, which contains relatively high amounts of copper
that may have enhanced potency due to the acidic environment of the intestine (340).
Therefore, many enteric pathogens have developed enhanced copper detoxification
systems.
Copper ions enter E. coli through the porin in the outer membrane, OmpC (341). It is
also thought that copper and zinc may enter the cell through siderophores via a TonBdependent transport. Once inside the cell, homeostasis is maintained to avoid copper
toxicity. E. coli requires copper for key metabolic proteins, such as the cytochrome bo
terminal oxidase (342) and NADH:oxidoreductase II Ndh-2 (343). The vast majority
of copper-binding domains of metabolic enzymes, and other copper binding proteins,
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Fig 1-5. Copper homeostasis mechanisms in E. coli. Copper enters the bacterial cell
through an outer membrane importer. CueO, a multicopper oxidase, and CopA, a Ptype ATPase transports copper from the cytoplasm into the periplasm, are
upregulated in response to copper via the copper-binding regulator, CueR. In the
periplasm, CueO oxidizes Cu+ to Cu2+. Alternatively, the two-component regulatory
system CusRS, where CusS is a histidine kinase, that senses periplasmic Cu+ and
subsequently phosphorylates (P) CusR, a response regulator, to activate transcription
of cusCFBA genes. CusF, a Cu+-binding metallochaperone, shuttles periplasmic copper
to CusCBA, a RND-family exporter.
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are largely restricted to the periplasm. This suggests that E. coli requires copper in
the periplasm, but copper concentrations in the cytoplasm are limited; a convenient
compartmentalization that may serve to protect nucleic acid in the cytoplasm from
the damaging effects of copper-mediated oxidation (340).
Copper in the periplasm is readily oxidized from Cu+ to Cu2+ by proteins of the
electron transport chain (344). Cuprous copper is also oxidized by CueO, a
multicopper oxidase (MCO) that uses molecular oxygen to oxidize copper (345).
Additionally, metal chaperones in the periplasm sequester copper and prevent
uncontrolled oxidation. Examples of copper chaperones found in E. coli and other
bacterial species include the PcoC/CopC-like and PcoE/CopE-like chaperones, as well
as the CusF chaperone (340).
The final fate of periplasmic copper is efflux from the periplasm by metal-specific
transporters. As the oxidation of Cu+ to Cu2+ by oxidases requires oxygen, efflux of
copper from the cell is particularly important under anaerobic conditions. Two
different efflux systems have been characterized in E. coli that work to rid the cell of
copper. The first system is the Cu-sensing, or cusRS locus that encodes a twocomponent regulatory system, where CusS is a membrane-bound histidine kinase
and CusR the cytoplasmic response regulator (346). This two-component system
regulates the cusCFBA operon, and the plasmid encoded pco operon. The cusCFBA
operon encodes a RND-family of proton-cation antiporters that are involved in the
excretion of metal ions in anaerobic conditions. CusC is a trimeric outer membrane
component, CusA, a trimeric inner membrane component, and CusB is a hexameric
membrane fusion and adaptor protein. CusF, a periplasmic copper-binding
chaperone, delivers copper to CusB where the metal ion is transported out of the
periplasm by the CusCBA complex (347). E. coli also utilizes ATPase CopA for efflux
of copper out of the cytoplasm into the periplasm.
Multicopper oxidase (MCO) CueO (YacK) was initially identified in a genome-wide
search to uncover MCOs (348). CueO binds six copper ions per polypeptide chain and
works to sequester free copper in the periplasm (349). Due to the limited number of
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copper ions bound by CueO, however, it was hypothesized that it may serve an
additional function in the cell other than to sequester and oxidize copper (350).
Experiments revealed that the copper bound by CueO had enzymatic function, as
CueO had both ferroxidase and phenoloxidase activity. Thus, in addition to
functioning as a MCO, CueO also functions as a ferroxidase and oxidizes chelated iron
from phenolate siderophores, namely 2,3-dihydroxybenzoate and enterobactin
(349). The proposed mechanism is that copper may enter the cell non-specifically
through divalent metal ion transporters, such as Feo. In high concentrations of
copper, Cu+ ions may compete with Fe2+ for transport, resulting in decreased iron
inside the cell. Therefore, CueO may function as a way to compensate for a decrease
in iron, as it liberates chelated iron from phenolate siderophores whilst sequestering
free copper, helping to maintain the balance of copper and iron concentrations in the
periplasm (349).
1.7.3 Copper-responsive regulation in bacterial systems
Copper regulation can be broadly divided into two groups: copper monitoring that
occurs in the periplasm, which is largely achieved through two-component regulatory
systems, or regulation that occurs in the cytoplasm, comprised of mostly singlecomponent regulators or activators.
CopY transcription factors
CopY is the founding member of copper-responsive transcription factors, and was
originally identified in E. hirae, and has since been characterized in other Grampositive organisms, namely Enterococcus faecalis, Lactococcus lactis, Streptococcus
mutans, and Streptococcus pneumoniae (351). As previously discussed in section
1.7.1, in E. hirae CopY regulates the copABZY operon, that encodes two ATPases, CopA
and CopB, CopZ, a copper chaperone that transfers copper to CopY, and lastly, its own
expression (331).
CopY typically functions as a dimer of two bipartite monomers; each monomer is
comprised of a N-terminal DNA-binding motif, similar to β-lactamase repressors, and
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also a putative QQ motif that interacts with ACA triplets in the DNA binding site. In
vitro DNA binding assays with CopY showed that mutation of ACA to TCA abrogated
DNA binding, supporting the notion that the putative QQ motif is needed for DNA
interaction (331). The C-terminal portion of CopY contains multiple Cys residues
arranged as CxCx4CxC, which is necessary for metal binding. In vitro the “resting state”
CopY binds to one molecule of Zn2+, allowing DNA binding and repression of the cop
operon. When copper becomes available in the cytoplasm, CopZ transfers two copper
ions to Zn2+-CopY, most likely through direct CopZ-CopY interaction, displacing Zn2+
and releasing CopY from DNA, resulting in expression of cop genes (338).
Two component CusRS copper regulators
Two-component regulatory systems (TCS) are found in all prokaryotic organisms and
are key factors to environmental adaptation. As previously described, TCS typically
consist of a membrane-spanning sensor kinase, that “senses” an outside signal,
causing phosphorylation of a conserved aspartate residue on the associated response
regulator. This phosphorylation event causes release of the response regulator that
then activates transcription of genes necessary for the cellular response (351). CusRS
is a copper-sensing TCS that has been identified in many prokaryotes. These include
proteobacteria P. flourescens, P. putida, P. syringae (352–355), H. pylori (356), the
cyanobacterium Synechocystis sp. PCC 6803 (357), and the Gram-positive bacterium
C. glutamicum (358). It is best characterized in E. coli where the cusRS genes are
divergently transcribed from the cusCFBA operon, which encodes components of the
RND-family copper exporter (CusCBA) and copper chaperone (CusF) (359).
E. coli encodes at least two copper regulators, CusRS and cytoplasmic CueR. Although
both are responsive to copper, the CusRS TCS is responsive during growth in
anaerobic environments, whereas CueR is active during aerobic growth. Thus, the
main function of CusRS is to provide copper tolerance under anoxic environments, a
condition where copper toxicity is heightened, by upregulating the cus system. CusRS
is also active when copper concentrations are incredibly high and overwhelm CopA
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and CueO, and thus, in these instances, CusCBA is needed to maintain copper
homeostasis (360).
Cornybacterium glutamicum is another organism that has a dual copper regulatory
system. In addition to the single-component, cytoplasmic regulator CsoR, C.
glutamicum also expresses the TCS, CopRS. CopS of C. glutamicum shares a 21%
sequence identity to CusS of E. coli, and CopR contains a 34% sequence identity to
CusR (358). CopRS regulates two gene clusters, cg3281-3285 and cg3286-cg3289.
The cg3281-3285 operon encodes CopR, CopS, putative copper chaperone CopZ,
putative lipoprotein, and copper efflux ATPase CopB. The cg3286-cg3289 gene
cluster encodes multicopper oxidase CopO, whereas the function of the remaining
gene products are currently unknown. CsoR regulation, to be discussed later in this
section, regulates expression of copZ, the lipoprotein, and copB; however, does not
affect expression of CopRS (362).
CueR-like transcriptional regulators
CueR copper regulators are MerR-type transcription factors that are found in many
proteobacteria. MerR is a large family of transcription factors that respond to a wide
array of environmental stimuli. These regulators consist of three domains: the Nterminal domain that contains the classical helix-turn-helix DNA-binding motif, a
central dimerization domain, and the C-terminal metal binding domain (363). The
CueR regulator was first described in E. coli and was the sole activator of the copA
gene. The CueR DNA binding site in E. coli contained a 19 bp extended spacer region
located between the -10 and -35 promoter elements, that contains a 7 bp dyad of
perfect symmetry and 7 bp dyad of non-symmetrical sequence. It is at the dyad
sequences where protein binding is observed. CueR coordinates one copper ion per
monomer, where both the holo- and apo-forms of the CueR can complex with DNA;
however, only the holo-form of the protein can recruit RNA polymerase and activate
transcription (364). Along with activating expression of copA and cueO in response to
copper, genome-wide transcriptomics in E. coli demonstrated that CueR could
potentially regulate hundreds of genes involved in iron metabolism, energy
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metabolism, general stress response, and flagellar biosynthesis; in addition, 197
putative CueR promoter sites have been found in the chromosome, suggesting a
global regulatory role for CueR (364, 365).
CsoR transcription factors
Regulation of many copper detoxification systems is facilitated through the coppersensitive operon repressor (CsoR) (366). In bacteria lacking the CueR transcription
factor, CsoR is the primary single-component, copper-sensing transcription factor.
CsoR regulators were first identified in Mycobacterium tuberculosis, and are now
widespread in Gram-positive bacteria, namely B. subtilis, L. monocytogenes, S. aureus,
and Streptococcus lividans (351). Although CsoR structures lack any canonical DNAbinding motifs, they all form antiparallel four-helix bundles that are thought to act as
a DNA-binding domain. CsoR family members adopt a flat disc-shape dimer, and
typically function as homodimers, or tetramers, where each dimer binds two copper
ions; copper binding occurs through binding of two conserved cys residues (367,
368). CsoR, unlike CueR which functions as an activator of gene expression in the
presence of copper, is mechanistically similar to Fur: CsoR represses gene expression
in the absence of copper, but when intracellular copper is present, undergoes a
conformational change that decreases its affinity for DNA, causing derepression of
genes (369).
1.7.4 Copper detoxification pathways and intracellular survival
The first connection of copper to the innate immune system was neutropenia
observed in humans and animals that were copper deficient (370, 371). Interestingly,
neutrophils of copper-deficient patients had impaired function presenting as
decreased phagocytosis and bacterial clearance; these defects could be restored,
however, with increase in dietary Cu (372, 373). Copper deficiency had similar effects
on macrophage function, resulting in decreased phagocytosis and respiratory burst
(321). Furthermore, Pasteurella haemolytica infection in mice with copper-deficiency
showed depressed LD50, significantly higher bacterial counts in the spleen, and
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reduced fever (374). Further studies showed similar results demonstrating that
hypercupremia leads to greater susceptibility to infection (375–377).
Since these early discoveries, mutation of key copper efflux systems have
demonstrated that these are important virulence factors in E. coli (324),
Mycobacterium tuberculosis (378, 379), Pseudomonas aeruginosa (380), S. enterica
(381, 382), and Streptococcus pneumoniae (383). Examination of the metal content of
the phagosome following phagocytosis of M. smegmatis showed a notable increase in
copper concentration that was further enhanced through activation by IFN-! (384).
The mechanism behind copper, macrophage function, and infection was uncovered
by work done in murine macrophages infected with E. coli. White et al. made two
important discoveries: (i) that IFN-! activation of macrophages, resulted in
upregulation of ATP7A, that directly affected the intracellular survival of E. coli,
whereas silencing ATP7A increased bacterial counts; and (ii) E. coli strains lacking
the P-type ATPase CopA had attenuated survival (324). After decades of observations
that linked copper to macrophage and neutrophil efficacy, this was the first study to
propose a mechanism behind copper-mediated bacterial killing by phagocytes. In this
mechanism, ATP7A effluxes excess copper into the phagosome that results in
deleterious effects on microbial growth. Although the exact mechanism behind
copper-mediated killing is still unresolved, it is hypothesized that the generation of
OH· from hydrogen peroxide and copper in the phagosome aids in clearance. The
physiological concentrations of hydrogen peroxide in the phagosome are typically too
low to cause cell death. Therefore, inside the phagosome, copper may be needed to
increase the concentration of hydrogen peroxide and potentiate hydrogen peroxidemediated killing (385).
1.7.5 Copper homeostasis in Mycobacterium tuberculosis
One of the most studied bacterial copper homeostasis systems is that of M.
tuberculosis (Mtb). Mtb survives in macrophages, as it is able to arrest phagosomal
maturation and hijack intracellular systems essential to pathogen clearance (386).
Like all other organisms discussed, Mtb requires copper for proteins in respiration,
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specifically the cytochrome C oxidase; however, at high concentrations copper is toxic
to the cell, and Mtb is acutely sensitive to copper compared to many other
microorganisms (387). Interestingly, Mtb has a cytochrome bd oxidase, which is
upregulated in oxygen limited environments. This cytochrome bd oxidase can also
function as the terminal electron acceptor in the ETC. However, it does not require a
copper cofactor, suggesting that Mtb is capable of changing to a copper free
metabolism when oxygen is limited as a possible means to protect the cell from
copper in conditions that exacerbate copper toxicity (388). The outer membrane of
Mtb functions to protect the cell from copper, by preventing diffusion of copper into
the cell; instead, copper is transported through a designated porin, MspA (389).
Despite these additional levels of protection, Mtb still requires copper detoxifying
mechanisms to survive the copper concentrations inside the phagosome. Mtb
overcomes copper toxicity through two main mechanisms: i) through reducing
copper influx, and ii) through efflux of excess copper from the cytoplasm.
Although considered a Gram-positive bacterium, Mtb has a protective outer
membrane that is comprised of lipids and mycolic acids, and thus structurally
resembles Gram-negative bacteria. MctB is an outer membrane transporter with
specificity to copper and silver that is thought to work similarly to the CusABC system
of E. coli, in which copper in the cytoplasm is effluxed into the periplasmic space and
then excreted by MctB (378, 390). Also in the periplasm is MmcO, a homologue of
CueO, that oxidizes highly reactive Cu+ to less reactive Cu2+ (391)
Mtb encodes eleven P-type ATPases, three of which can secrete copper from the
cytoplasm, CtpA, CtpB, and CtpV (392); however, only CtpV and putative zinc efflux
pump, CtpG, are upregulated in response to copper (390). In the cytoplasm is the
metallothionein MymT, the first characterized metallothionein in Gram-positive
bacteria. Mammalian metallothioneins are cysteine-rich proteins, typically 30% of
their amino acid residues, that allows them to bind to roughly 7 divalent ions or 12
monovalent ions, making them efficient metal chelators. MymT is upregulated in
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response to copper, cadmium, cobalt, lead, and zinc, with the strongest induction
being from copper (393).
Like many Gram-positive bacteria, Mtb copper detoxification is controlled by CsoR
that regulates ctpV, two genes of unknown function, and its own expression (368).
RicR is an additional copper-sensing regulator that regulates the ric regulon, that
encodes RicR and metallothionein MymT (393, 394).
For survival in vivo, an obvious candidate to examine was inner membrane ATPase
CtpV. Infecting mice with a ctpV mutant significantly decreased the severity of
infection, although this was not complementable by restoring the ctpV gene in the
chromosome, leaving the exact contribution of CtpV to Mtb virulence unresolved.
Furthermore, infection of the ctpV mutant and isogenic WT into a guinea pig model of
infection showed decreased bacterial counts at 21 days post infection, yet no other
differences were observed at later time-points (395). Overall, CtpV appears to be
important for the full virulence of Mtb in the early stages of infection; however,its full
contribution to virulence is not delineated.
Deletion of the metallothionein-encoding gene, mymT, showed increased copper
sensitivity of Mtb in vitro, although failed to affect virulence in a mouse model of
infection (393). It was not until the deletion of the outer membrane efflux protein,
mctB, that a significant decrease in survival was observed in both mice and guinea pig
models of infection compared to what was observed with WT (378). These results
demonstrated that copper efflux through outer membrane protein MctB is essential
for Mtb virulence in vivo. No other single mutation of copper detoxification genes had
a role on virulence other than mutation of the regulator ricR, so as to prevent RicR
from binding to copper resulting in constitutive repression of copper detoxification
genes. The constitutive repression of RicR-regulated operons resulted in significant
attenuation in a mouse-lung model of infection (379).
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1.7.6 Copper detoxification in Salmonella
Like many other Gram-negative bacteria, Salmonella spp. encodes the copper efflux
ATPase CopA that secretes copper ions. CopA expression is induced by copper via
CueR, and mutation of copA in S. enterica sv. Typhimurium showed reduced survival
in macrophages (396). CueR/SctR is a transcriptional regulator that controls copA
and cueO genes in response to copper (397). A cueR mutant had decreased resistance
to copper, suggesting that CueR activates the expression of copper resistant
mechanisms, namely CueO. An S. enterica sv. Typhimurium mutant lacking CueO had
increased copper and hydrogen peroxide sensitivity and demonstrated a significant
decrease in growth compared to WT in a murine infection model (398). Interestingly,
the cueO mutation only appeared to affect systemic growth and did not affect the
ability of the strain to invade intestinal epithelial cells or translocate across the
reticuloendothelial system, as the mutant had no growth defect in Peyer’s patches or
mesenteric lymph nodes. In addition, the cueO mutant did not have a defect in growth
in murine macrophages, suggesting that the defect seen in vivo is not due to survival
in the phagosome but is most likely due to host factors that S. enterica sv.
Typhimurium encounters during systemic growth in the host (398).
In vitro, a copA mutant had increased sensitivity to copper; however, ATPasetransporter, GolT, which primarily functions as a gold efflux pump, is also able to
efflux copper in the absence of CopA, and thus compensates for copA-mutant
phenotype in vivo (399). Therefore, it required deletion of both copA and golT to
observe a significant attenuation of growth in a murine infection model, compared to
WT. This attenuation was due to copper, as the growth phenotype of the copA,golT
mutant was restored to WT levels in Atp7aLysMcre mice (382). This suggested that,
unlike the cueO mutant, mutation of copA and golT hindered S. enterica sv.
Typhimurium growth inside the macrophage.

1.8 Copper homeostasis in S. aureus
All sequenced S. aureus genomes contain the copAZ locus which encodes CopA, a
copper-translocating P-type ATPase, and CopZ, a cytoplasmic, copper-binding
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chaperone (400). Previous work has shown that deletion of copA in S. aureus renders
the cell sensitive to high concentrations of copper, and, to a lesser extent, lead, iron,
and hydrogen peroxide in vitro (401). S. aureus CopA contains the conserved CPC
sequence (residues C451-C453), and other conserved motifs such as the N-terminal,
metal binding motif CXXC (sequence CAAC; residues C16-C19 and C83-C86), where
mutation of the cysteines abrogates copper binding abilities (400). Also conserved in
CopA is the nucleotide binding sequence GDGVNDAP (residues G689-P696).
The copAZ locus is regulated by CsoR, which represses the copAZ operon in copperdeplete conditions, but de-represses copAZ after binding to cytoplasmic copper in
copper replete conditions (351, 366). Like all characterized CsoR regulators, the S.
aureus CsoR lacks any canonical DNA regulatory motifs, but forms planar helical
structures comprised of dimers or tetramers. Encoded immediately downstream of
csoR is a 210 bp gene of unknown function, but thought to be a copper chaperone due
to the presence of an ~30 amino acid heavy-metal-associated (HMA) domain,
designated as csoZ (402). The role of csoZ in copper detoxification is currently
unknown, but it may function to bring copper to CsoR, similar to what is observed
with copper chaperone CopZ and transcription factor CopY in E. hirae (338). Figure
1-6 highlights the major copper detoxification mechanisms found in all sequenced
strains of S. aureus.
Previously shown was that copBmco on the pSAP019A plasmid, a member of the S.
aureus accessory genome found only in some clinical isolates, is also regulated by
CsoR (402). The copBmco encodes another P1B-type ATPase, CopB, and other
resistance mechanisms to heavy metals arsenic and cadmium. Disruption of CsoR in
S. aureus results in constitutive expression of copA and copBmco, even in low copper
concentrations. Interestingly, in a csoR mutant strain, copAZ and copBmco gene
expression was notably lower than that of WT, when strains were grown in excess
copper (402). This suggested that with excess copper, CsoR is somehow needed for
full induction of the cop genes or, perhaps, regulates additional genes involved in the
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Fig 1-6. Schematic of S. aureus copper detoxification system. Copper is potentially
brought into the cell through a non-specific cation transporter. Inside the cell, copper
may be sensed by putative copper chaperone, CsoZ, that may deliver copper to the
transcriptional repressor CsoR. Binding of CsoR to copper causes a conformational
change resulting in disassociation from the copAZ promoter region and derepression
of copA and copZ. The copper-chaperone CopZ sequesters free iron in the cytoplasm
and delivers it to CopA, a P1B-ATPase efflux pump that then excretes excess copper
out of the cell.
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copper-induced stress response. Thus, further work is needed to understand the
regulation of copper detoxification systems in S. aureus.
In addition to CsoR, there is another regulator that indirectly regulates copAZ called
CymR. CymR functions as a repressor, and is the master regulator of cysteine
metabolism. cymR mutants have increased copAZ expression as well as increased
expression of superoxide dismutases, sodA and sodM. CymR does not bind to the copA
promoter directly, and thus the mechanism behind CymR regulation of copAZ is
unclear; however, it has been shown to function independently of metal responsive
regulators, Fur and PerR (403).
A transposon library of S. aureus ATCC 12600 that examined genes essential to metal
resistance revealed a multi-copper oxidase (MCO) located downstream of copAZ. This
MCO had 35% amino acid sequence identity to CueO of E. coli; however, this MCO was
identified in only 3 laboratory strains of S. aureus, suggesting that its role in copper
resistance is dispensable (404). A conserved multi-copper oxidase has yet to be
characterized in S. aureus.
In vivo expression technology (IVET) in a renal abscess model that identified S. aureus
virulence genes upregulated during mammalian infection, uncovered copA as having
heightened expression in vivo. This suggested that CopA may play an important role
in virulence (405). Gene expression profiles of S. aureus grown in excess copper
showed that copper induced the expression of stress response genes, such as catalase,
and that proteins in the oxidative stress response are necessary for growth under
copper-rich environments. Moreover, copper repressed the global regulators agr and
sae, key virulence factors in S. aureus, suggesting that copper toxicity has a profound
effect on the cell and that further investigation is necessary to understand the
implications of copper toxicity during infection (406).

1.9 Iron and copper in biology
Iron and copper have similar biological functions and thus have considerable
pathways of convergence in mammalian and bacterial systems. Along with the
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formation of intracellular ROS, leading to destruction of nucleic acids, proteins, and
lipids, one of the most deleterious results of copper toxicity is the irreversible
displacement of Fe in Fe-S clusters (407). Indeed, previous work in E. coli and B.
subtilis demonstrated that the primary targets for copper toxicity are Fe-S clusters
(407–410). Fe-S clusters are essential cofactors for many enzymes; these include
enzymes involved in amino acid biosynthesis, where it was shown in E. coli that a
mutant defective in the major copper detoxification systems (copA,cueO,cusCFBA
strain) was unable to grow in minimal medium in the presence of copper. However,
supplementation of the minimal medium with branched chain amino acids partially
restored growth (407). Moreover, enzymes responsible for Fe-S biogenesis, IscA,
IscU, and SufA, also rely on Fe-S clusters. Displacement of Fe by Cu not only
dramatically alters the biochemistry of the Fe-S cofactor, abrogating enzymatic
activity, but also liberates free iron, perhaps accelerating ROS formation and
subsequent oxidative damage (409).
In contrast, copper-containing enzymes have also been shown to be beneficial to iron
metabolism. Previously described in section 1.6.2, the E. coli multi-copper oxidase,
CueO (YacK) is partly responsible for the oxidation of iron bound to phenolate-type
siderophores, such as enterobactin. This is thought to offset the ratio of copper to iron
in the cell, where CueO serves a dual role in balancing copper and iron homeostasis:
first, it sequesters free copper in the periplasm by binding up to six copper ions, and
secondly, releases iron from phenolate siderophores to increase iron concentrations
(349). In addition to CueO, the siderophore yersiniabactin (Ybt) is another example
of copper and siderophore interaction.
Ybt is a catecholate siderophore that has been shown to bind ferric iron in a 1:1 molar
ratio (411), and is an essential virulence factor for some Gram-negative species (163–
165). In addition to binding ferric iron, recent work has demonstrated a role for Ybt
in extracellular copper chelation in uropathogenic E. coli (412). In this study, Cu2+-Ybt
complexes were detected by mass spectrometry in urine samples from mice and
humans with urinary tract infections, infected with uropathogenic E. coli.
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Furthermore, in copper-supplemented media, the Ybt-deficient strain had
significantly greater sensitivity to copper compared to isogenic WT (412).
Gentamicin-protection assays with RAW264.7 murine macrophages showed that a
Ybt-deficient strain of E. coli was significantly attenuated compared to WT and,
furthermore, Cu2+-Ybt exhibited superoxide dismutase activity suggesting a role in
defense against oxidative burst. These findings demonstrate that Ybt not only aids in
copper resistance in the urinary tract but also in intracellular survival (413). Mass
spectrometry on TBDT FyuA (ferric-Ybt uptake protein A), the outer membrane
transporter for Ybt, showed that FyuA not only imports Fe2+-Ybt, but also recognizes
Cu2+-Ybt and Ga3+-Ybt (414). Lastly, inside the periplasm, copper is liberated from
Cu2+-Ybt most likely by reducing Cu2+ to Cu+, allowing Ybt to be recycled and the
liberated copper to be used elsewhere in the cell, such as for TynA, a periplasmic
copper amine oxidase, that showed enhanced activity with the presence of Cu2+-Ybt
(415). These findings have profound implications in understanding siderophoremediated metal homeostasis outside of the canonical, iron-centered pathways.
Work done in E. coli, Shewanella oneidensis, and Rhodopseudomonas palustris
demonstrated that copper and iron work synergistically to kill bacteria during anoxic
growth. S. oneidensis and R. palustris were chosen for this study as they can tolerate
millimolar concentrations of iron with no obvious growth defect. However, when
grown in environmentally relevant concentrations, the combination of iron and
copper caused growth inhibition, greater than either metal alone. The reason for this
synergistic effect was attributed to iron-interference in copper regulatory
mechanisms or copper efflux (416).
This cross-talk between copper and iron is not limited to microbial systems but is also
important in mammalian metal homeostasis. In humans, it was observed that copper
and iron deficiency, resulting in anemia, had similar manifestations, suggesting that a
common pathway or factor was affected in the disease progressions (417, 418). It was
later discovered that the uptake of iron requires copper (418). Studies in animal
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models have demonstrated that copper deficiency leads to anemia, largely due to
inactivation of copper-binding ferrioxidase ceruloplasmin (419).
Once iron passes the basolateral membrane and enters the circulating iron pool,
ceruloplasmin is involved in reducing ferrous iron to ferric iron which aids in iron
loading to transferrin and ultimately delivery of iron to cells (297). Furthermore, in
macrophages, ceruloplasmin induces the expression of ferroportin (Fpn), a cell
membrane transporter that excretes ferrous iron from the macrophage cytoplasm
(420). Conversely, in persons with aceruloplasminemia (an autosomal recessive
disorder that results in an inability to produce ceruloplasmin), there is an unusually
high concentration of iron stored in the tissues, leading to high serum ferritin and
mild anemia (421).

1.10 Objective of this study
During infection, the host controls the access of essential metals to invading microbes
in a process termed nutritional immunity. The two different transition metals are
examined in this study, iron and copper, that represent two unique facets of
nutritional immunity. Iron is actively sequestered by the host, such that the available
concentrations of free iron are extremely low. In contrast, in macrophages a surplus
of copper is transported into the phagosome to cause microbial killing. Both facets of
metal control represent unique challenges to invading microbes, where a defining
characteristic of successful pathogens is their ability to obtain essential metals, such
as iron, and remove toxic molecules, such as copper.
S. aureus is a serious human pathogen that is able to cause infection in every bodily
niche, and thus is able to overcome aspects of nutritional immunity. The preferred
iron source for S. aureus is heme (422), although prior to this work the mechanism
behind this preference was unknown. A major contributor to S. aureus iron
acquisition is the use of high affinity iron chelators, termed siderophores. S. aureus
produces two main siderophores, staphyloferrin A (SA) and staphyloferrin B (SB),
both of which have been implicated in virulence in murine infection models (169,
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182). In chapter 2, I examine the regulation of synthesis of SB. The biosynthetic
operon for SB synthesis, the sbn operon, encodes nine genes, of which the first eight
genes have been extensively characterized and encode biosynthetic enzymes
(SbnA,B,C,E,F,G, and H) and the SB-specific efflux pump (SbnD). The role of the
terminal gene product, SbnI, however, was unknown and, although having no clear
enzymatic role in SB production, is highly conserved among sbn-encoding S. aureus
strains. Thus the central question in the first portion of this work was to characterize
the function of SbnI in SB utilization.
In chapter 3, I examine the role of copper detoxification systems in S. aureus. Already
known was the function of CopA and CopZ in copper resistance, where CopA is a
copper-translocating efflux pump and CopZ a copper-binding chaperone (400). The
role of these pathways in survival in the host have previously not been characterized.
Furthermore, pandemic CA-MRSA strain USA300 contains another putative metal
transporter encoded on the ACME cassette. Thus, the central hypothesis was that
USA300 contained another copper efflux pump, endowing this strain with heightened
copper resistance, and furthermore, both CopAZ and the ACME-encoded efflux pump
would aid in S. aureus survival in the phagosome.
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Chapter 2
2

A heme-responsive regulator controls synthesis of
Staphyloferrin B in Staphylococcus aureus

2.1 Introduction
Staphylococcus aureus is a formidable human pathogen capable of causing a wide
range of opportunistic infections including endocarditis, meningitis, and
osteomyelitis, and is currently the most frequent cause of bloodstream infections in
Canada and the United States (1–5). Like the vast majority of all characterized
organisms, with the exception of some lactobacilli and spirochaetes (6, 7), S. aureus
requires the use of iron to survive. Iron in a human host, however, is typically not free
as it is bound within host proteins that serve essential host functions and, at the same
time, limits the amount of readily available iron to invading microbes (8, 9). This
process of iron limitation is referred to as host nutritional immunity and is an obstacle
to the survival of microbes, including S. aureus.
To overcome this obstacle, S. aureus has evolved multiple, sophisticated iron uptake
mechanisms (10, 11). Since the predominant source of iron in the human body is iron
bound to heme, representing greater than 70% of all intracellular iron, heme is an
important source of iron during S. aureus infection (12). S. aureus acquires heme from
hemoglobin using proteins of the iron-regulated surface determinant (Isd) pathway
(13). This well-characterized pathway involves a series of cell-wall anchored
proteins, lipoproteins, membrane permeases, and cytosolic proteins that work in
concert to bind and extract heme from hemoglobin at the cell surface, and mobilize
heme through the thick peptidoglycan layer and through the membrane and into the
cytoplasm where iron may be removed through the activity of heme degrading
enzymes (10, 11, 14–16).
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Although representing less than 0.1% of iron in the body, an important extracellular
source of iron is that which is bound by host glycoproteins transferrin and lactoferrin
(9). Through use of small iron-chelating molecules, referred to as siderophores, S.
aureus is capable of removing iron from these glycoproteins and delivering it to the
bacterial cell (10, 11). There are two predominant classes of siderophore synthesis
pathways: non-ribosomal peptide synthetase (NRPS)-dependent and NRPSindependent siderophore (NIS) synthesis (17). NRPS siderophore synthesis has been
well characterized for many siderophores, such as enterobactin (18). S. aureus
produces two NIS, citrate-based siderophores, staphyloferrin A (SA) and
staphyloferrin B (SB). As NIS siderophores, SA and SB are synthesized not in a
stepwise fashion using large, multi-domain/modular proteins, but instead
constructed through use of synthetase enzymes that form siderophores by sequential
condensation reactions of alternating subunits of dicarboxylic acid with aminoalcohols, alcohols, and diamines (19–22).
The biosynthetic enzymes and efflux protein for SA are encoded within the sfa (a.k.a.
sfna) locus (22, 23), where genes sfaA, sfaB, and sfaC form an operon and sfaD is
divergently transcribed to sfaA. SfaB and SfaD are NIS type A-like synthetases that
facilitate the condensation of D-ornithine with two molecules of citrate (22). SfaC is a
PLP-dependent amino acid racemase, and SfaA is an efflux pump that secretes SA into
the extracellular milieu (22, 24).
The 9-gene sbn gene cluster encodes SB biosynthesis and efflux genes, and these
genes have been implicated in virulence in both the mouse bacteremic and the rat
infective endocarditis models of S. aureus infection (25, 26). SbnA and SbnB perform
the first step in SB synthesis with the formation of the precursor molecules L-2,3diamino-propionic acid (L-Dap) and α-ketoglutarate (α-KG) from O-phospho-Lserine and L-glutamate (21), while SbnG acts as a citrate synthase to convert acetylCoA and oxaloacetate into citrate (27, 28); L-Dap, citrate and α-KG are the
constituents of SB. The siderophore synthase enzymes SbnC, SbnE and SbnF facilitate
condensation reactions with these precursors to build the SB molecule, while SbnH is
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a decarboxylase that converts one of the two L-Dap molecules within SB into
ethylenediamine (19). The function of the terminal gene product in the sbn operon,
SbnI, is previously uncharacterized and thus the focus of this study was to determine
the function of SbnI in the cell.
The regulation of genes that encode proteins implicated in iron metabolism in S.
aureus is controlled by the Ferric Uptake Regulator (Fur), a transcriptional regulator
found in many gram-positive and -negative bacteria (29). Functioning as a dimer and
with the use of metal cofactors, Fur binds to an AT-rich, 19-bp palindromic consensus
sequence referred to as the Fur box, located in the promoter region of regulated
genes. Fur bound to the Fur box results in limited transcription of downstream genes
(29, 30).
In the absence of Fur repression during growth in iron-starved conditions, some
bacteria adopt additional regulatory mechanisms for fine-tuning gene expression of
iron-regulated genes. In Ralstonia solanacearum, a soil-borne pathogen that also
utilizes staphyloferrin B for iron acquisition, the synthesis of SB is negatively
regulated by Fur in high iron concentrations and is also negatively regulated in low
iron concentrations by PhcA (31). PhcA is an environmentally responsive
transcription factor that responds to the presence of the autoinducer 3hydroxypalmitic acid methyl ester, a molecule produced as a result of quorum sensing
(31, 32). Thus PhcA is able to afford R. solanacearum an additional level of control for
siderophore synthesis that works in response to environmental cues. In S. aureus,
however, it is unclear as to what regulates expression of many genes implicated in
iron metabolism when cells are growing in limited iron supply.
In this study I report a novel, heme-responsive regulatory protein, SbnI, that controls
expression of the genes in the sbn operon, and thus controls siderophore-mediated
iron uptake. The sbnI mutant demonstrated a SB-dependent growth defect in ironlimited media, owing to delayed and reduced production of SB, due to significantly
decreased transcript levels for genes sbnDEFGH in the mutant. Electrophoretic
mobility shift assays demonstrated that SbnI binds DNA upstream of a newly
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identified promoter within the sbnC coding region. Moreover, I show that SbnI is
capable of binding to heme and heme binding inhibits DNA binding. I propose a model
whereby SbnI is required for transcription throughout the SB biosynthetic operon,
and senses intracellular heme as a means to reduce SB synthesis in favour of heme
acquisition. This model provides additional support to the observations of Skaar and
colleagues who reported that heme is the preferred iron source for S. aureus (12).

2.2 Experimental procedures
2.2.1 Bacterial strains, plasmids, and growth media
All bacterial strains and plasmids used in this study are listed and described in Table
2-1. Strains were stored in 15% glycerol stocks at -80℃ and, prior to use, were
streaked onto tryptic soy broth (TSB) (Difco) agar plates containing the appropriate
antibiotic. Solid media were prepared with addition of 1.5% w/v Bacto agar (Difco).
Concentrations of antibiotics used were as follows: 50 μg/mL kanamycin and
100 μg/mL ampicillin for Escherichia coli selection, 4 μg/mL tetracycline, 5 μg/mL
chloramphenicol, and 3 μg/mL erythromycin for S. aureus selection. E. coli were
grown in Luria Broth (Difco) and S. aureus strains were grown in TSB, or either
chelex-100-treated Tris minimal succinate (cTMS) or Roswell Park Memorial
Institute (RPMI) (Gibco) medium for growth under iron restriction. All solutions and
media where made using water purified with Milli-Q water purification system
(Millipore).
Table 2-1. Bacterial strains, plasmids, and primers used in this study.
Bacterial strains,
plasmids,
oligonucleotides
E. coli
DH5α
BL21(DE3)

Description

F-Ф80 dLacZΔM15 recA1 endA1 nupG gyrA96 glnV44
thi-1 hsdR17(rk- mk+) λ-supE44 relA1 deoR Δ(lacZYAargF)U169
F- ompT gal dcm lon hsdSB (rB- mB+) λ (DE3 [lacI
lacUV5-T7 gene 1 ind1 sam7 nin5])
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Source or
Reference

Promega
Novagen

S. aureus strains
RN4220
RN6390
H306
H984
H1312
H1313
H1317
H1324
H1448
H3387
Plasmids
pET28a(+)
pCN51
psbnI (pAB1)
pGylux
pCM326
pCM328
pCM330
pCM332
Oligonucleotides
Cloning of sbnI from
S. aureus for
pET28a(+)
Cloning of sbnI from
S. aureus for
complementing
vector (psbnI)

rk-mk+ accepts foreign DNA
Prophage-cured wild-type strain
RN6390 sirA::Km; KmR
RN6390 sbnI::Tet; TetR
H984/pSbnI; sbnI mutant complemented with sbnI
H187 containing pCN51
H984 containing pCN51
RN6390 sbn; TetR
RN6390 hts::Tet; TetR
RN6390 arcA::ΦΝΕ; EryR

(33)
(34)
(25)
This study
This study
This study
This study
(23)
(23)
This study

Overexpression vector for 6´His-tagged proteins;
KmR
Cadmium-inducible expression vector; EryR
pCN51-sbnI; pCN51 vector for expression of sbnI;
EryR
Promoterless E. coli/ S. aureus shuttle vector for
luminescence, ApR , CmR
1479 bp sbnA/B cloned into pGylux; ApR , CmR –
(Fragment A)
2322 bp sbnA/B/C cloned into pGylux; ApR , CmR –
(Fragment B)
2389 bp sbnC/D cloned into pGylux; ApR , CmR –
(Fragment C)
2395 bp sbnD/E cloned into pGylux; ApR , CmR –
(Fragment D)

Novagen

GC AGC CAT ATG AAT CAT ATT GCT GAA CAT TTA A
(forward)
TTG TGT CTC GAG TCA TCA TAT TTC CCT CAA CAT
(reverse)
TTG AGC GGA TCC CTT AAG CCA TCC ACA TCC TG
(forward)
TTG CGC GAA TTC TCG CTA TCA ATA CCG TAA ATC
(reverse)

Cloning of Fragment
A

GCC TCC CGGGTCAATAAAATATTTATGATTTACATGC
(forward)
GACTCCCGGGAACTTGCTTCCATAACTGCAATT
(reverse)

Cloning of fragment B

GACTCCCGGGTAATTTAGGCATTGCGTTG (forward)
GACTCCCGGGCTGCAACCATTAAAGG (reverse)

Cloning of fragment C

GACTCCCGGGTGTCTGAACATTGCAG (forward)
GACTCCCGGGAAATGAACGGCGAATAC (reverse)
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(35)
This study
(36)
This study
This study
This study
This study

Cloning of fragment D GACTCCCGGGACTGACAGTACTTGT (forward)
GACTCCCGGGCCTGTGTTACTAAAC (reverse)
RT-PCR: sbnA

ACTTCTGGTAATTTAGGCATTGCG (forward)
TGCATCAGGTTCTTCAACCATTTC (reverse)

RT-PCR: sbnB

CCTGAAAATGGACACATCGC (forward)
CAAAATAATGACGCCACTTGC (reverse)

RT-PCR: sbnC

ATGAATGGGAAGTGGCTCG (forward)
GCTAATGGATGAAATGGACGAT (reverse)

RT-PCR: sbnD

CGTAGAAATACAGTTGTGGAGTGG (forward)
AAATAAGCATACCGCCAAACC (reverse)

RT-PCR: sbnE

CGAATCCATTAGGGCAAACAG (forward)
CTTAACATCGGTGAATCAGGC (reverse)

RT-PCR: sbnF

TTTTATGCGATGGAAGGG (forward)
CGTCGTTTCTACTTTATCTTTGTCG (reverse)

RT-PCR: sbnG

TCATTAAAGTGTTGGATATGGGTGC (forward)
TTAGCCATCTCCATTGCATCAAG (reverse)

RT-PCR: sbnH

CGCTCGCAATGCCAAAGATTC (forward)
TAACGCCTATGCCACCACCAAG (reverse)

RT-PCR: rpoB

AGAGAAAGACGGCACTGAAAACAC (forward)
ATAACGACCCACGCTTGCTAAG (reverse)

GSP1
GSP2
AUAP
UAP

GAAAGCTGATGTGCTGTTAG
GAGCCCGGGTCTAGACGCATACTTGAAGACGACAG
GATACCCGGGCCACGCGTCGACTAGTAC
GGCCACGCGTCGACTAGTACGGGIIGGGIIGGGIIG

Abbreviations: ApR – ampicillin resistance; CmR – chloramphenicol resistance; EryR –
erythromycin resistance; KmR – kanamycin resistance; TetR – tetracycline resistance

2.2.2 Bacterial growth curves
Bacteria were cultured on TSB agar, then several single isolated colonies were picked
and inoculated into 2 mL cTMS (flask:volume ratio of 10:1) and grown for
approximately 8 h at 37℃ with shaking at 220 rpm. The bacteria were then harvested,
resuspended in fresh cTMS medium, and inoculated into 5 mL cTMS medium
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(flask:volume ratio 10:1) to a starting OD600 0.005. For growth curves in microaerobic
conditions, cultures were inoculated into media with a flask:volume ratio 1.2:1 with
lids tightly sealed.
2.2.3 Western Blotting
Bacteria were cultured on TSB agar, then several single isolated colonies were picked
and inoculated into 2 mL cTMS (flask:volume ratio of 10:1) and grown for
approximately 8 h at 37℃ with shaking at 220 rpm. The bacteria were then harvested,
resuspended in fresh cTMS medium, and inoculated into 5 mL cTMS medium
(flask:volume ratio 10:1) to a starting OD600 0.005.
Cells were grown to an OD600 1.0, and 3 x 109 colony forming units were harvested
and resuspended in 0.1 mL lysis buffer (25 mM Tris-HCl, 50 mM glucose, 150 mM
NaCl, 10 mM EDTA, pH 8.0, 5 μg lysostaphin, 1´ Laemmli buffer (60 mM Tris-HCl,
pH 6.8, 2% SDS, 10% glycerol, 5% betamercaptoethanol, 0.01% bromophenol blue))
and incubated at 37℃ for 1 h then boiled for 10 min before being run through a 12%
polyacrylamide gel. Following electrophoresis, proteins were transferred to a
nitrocellulose membrane following standard protocols. Primary anti-SbnI polyclonal
antiserum was used at a dilution of 1:1000, and secondary (anti-rabbit IgG conjugated
to IRDye 800; Li-Cor Biosciences, Lincoln, NE) was used at a 1:20,000 dilution. Rabbit
polyclonal antisera recognizing SbnI were generated by ProSci (Poway, CA) using the
custom antibody production package number 1. Membranes were scanned on a LiCor Odyssey Infrared Imager (Li-Cor Biosciences) and visualized using Odyssey V3.0
software.
2.2.4 RNA isolation and qPCR
S. aureus RN6390 and H984 (RN6390 sbnI) were grown in quadruplicate cultures in
2 mL chelexed Tris minimal succinate (cTMS) medium for 8 h. Cultures were then
harvested and subcultured at OD600 0.005 in 10 mL cTMS and grown to midexponential phase (OD600 ~1.0). Cells equating to an OD600 3.0 were harvested for
each culture and RNA extraction was performed by E.Z.N.A® Total RNA kit according
to the manufacturer’s instructions with the addition of 0.25 μg/mL of lysostaphin to
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the lysis solution. RNA purity was determined by agarose gel and RNA concentration
was determined by NanoDrop® ND-1000 UV-Vis Spectrophotometer. cDNA
preparation was performed using 500 ng of total cellular RNA reverse-transcribed
using SuperscriptTM II reverse transcriptase (Invitrogen) according to manufacturer’s
instructions. For each qPCR reaction, one microgram of cDNA was amplified in a
Rotor-Gene 6000 (Corbett Life Science) using the iScript One-Step RT-PCR Kit with
SYBR Green (BioRad). Gene expression for each sample was quantified in relation to
rpoB expression. A standard curve was generated for each gene examined.
2.2.5 Disc diffusion assays
Concentrated spent culture supernatants were prepared from 10 mL cultures of S.
aureus RN6390. Culture supernatants were taken at 10, 12, 16, 20, 24, and 36 h after
inoculation. Growth was assessed via OD600 and culture densities between replicates
and strains were normalized for each time point. Cells were harvested by
centrifugation, and the supernatant was lyophilized for 12 h. Lyophilized supernatant
was resuspended in 0.5 mL sterile ddH2O. S. aureus cells, the htsA mutant strain or the
sirA mutant strain, were seeded into TMS agar containing 10 μM EDDHA to achieve
1 × 104 cells per mL. For each replicate, 10 μL of concentrated supernatant were
applied to sterile paper disks which were then placed onto the plates containing the
seeded reporter strains, and growth about the disk was measured after 24 and 48 h
incubation at 37°C.
2.2.6 Identification of promoters
Four DNA fragments, spanning the sbn operon from sbnA to sbnE, were cloned into
the promoterless shuttle vector pGylux (36): fragment A of 1479 bp (pCM326),
fragment B of 2322 bp (pCM328), fragment C of 2389 bp (pCM330) and fragment D
(pCM332) of 2395 bp. To measure luciferase activity, individual colonies from S.
aureus carrying these plasmids were inoculated into TMS medium and incubated
overnight at 37°C. Cells were subsequently inoculated into cTMS with or without
1 μM FeCl3 at an OD600 0.1 and incubated for 8 h. At that time, the OD600 and
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luminescence were measured on a SynergyH4 Hybrid Reader (Biotek). Luminescence
values were expressed as cps/ OD600.
2.2.7 Identification of a transcription start site
To identify an initiation of transcription I used rapid amplification of cDNA ends
(RACE). The original mRNA was prepared from S. aureus RN6360 grown in cTMS, as
per the protocol described for qPCR. First strand cDNA was synthesized by incubating
for 50 min at 42℃: 1 μg RNA, 1 μM gene specific primer 1 (GSP1), 50 μM dNTP, and
20 U Superscript II Reverse Transcriptase (Invitrogen). The mRNA was removed by
treating the synthesized cDNA with RNase mix (0.5 U of RNaseH and 50 U of RNaseT1)
for 30 min at 37℃. After purification of the cDNA with the Bio Array cDNApurification
kit (ENZO Life Sciences) it was C-tailed with 20 U of Terminal Transferase (Roche
Diagnostics) and 0.5 mM dCTP as recommended by the supplier. The first PCR
reaction was performed using the universal anchor primer (UAP, Invitrogen) that will
anneal to the C-tailed cDNA and an sbnC specific primer GSP2. The second PCR
(177bp) was performed using the first PCR as a template, a primer that will anneal to
the abridged universal anchor primer (AUAP, Invitrogen) and the same specific
primer GSP2. GSP2 and AUAP contain SmaI restriction endonuclease sites that were
later used for cloning the second PCR product into pGEM7. The pGEM7 clones were
later sequenced to determine the initiation of transcription.
2.2.8 Protein expression and purification
Recombinant SbnI protein was overexpressed and purified essentially as previously
described (37). In brief, cells were grown to mid-log phase at 37℃ with aeration
before the addition 0.4 mM isopropyl-b-D-thiogalactopyranoside (IPTG); the cells
were then grown for an additional 16 h at room temperature with shaking before
harvesting. Cells were resuspended in 50 mM HEPES, 1 mM ditiothreitol (DTT),
pH 7.4 prior to lysis at 25 kpsi in Cell-Disruptor (Constants Systems Ltd.). Cell debris
was pelleted by 15-min centrifugation at 3000 rpm in a Beckman Coulter Allegra®
6R Benchtop Centrifuge that was followed by ultracentrifugation at 50,000 rpm in a
Beckman Coulter Optima® L-900K ultracentrifuge for 45 min. The lysate was filtered
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with 0.45 μM nylon filter (VWR) and then applied to a 1 mL HisTrap column (GE
Healthcare) equilibrated with buffer A (50 mM HEPES, 1 mM DTT, and 50 mM
imidazole, pH 7.4). The His6-SbnI was eluted with 0-80% concentration of buffer B
(50 mM HEPES, 1 mM DTT, and 50 mM imidazole, pH 7.4). Protein was dialyzed in
50 mM HEPES, 1 mM DTT, pH 7.4, at 4℃. Protein purification was determined by SDSPAGE. Protein concentrations were determined through Bradford assay using the
Bio-Rad Protein Assay Dye (Bradford) Reagent Concentrate (5´), samples were read
at absorbance OD595; a standard curve was made for each concentration
determination with 1 mg/mL BSA.
Site-directed mutagenesis of SbnI was performed using Pfu Turbo® polymerase and
the pET28a::SbnI vector as a template. The PCR products were immediately DpnI
(Roche) treated for 45 min to degrade template DNA, and introduced into E. coli
DH5α. Mutations were confirmed by sequencing at the Robarts Research Institute
DNA Sequencing Facility (London, Ontario). Protein purification of the mutated-SbnI
was performed as described above.
2.2.9 Oligomerization analysis
Size exclusion chromatography was performed using a Superdex 200 10/30 GL
column (Amersham) coupled to a FPLC system (Pharmacia). The column was
equilibrated with 300 mM ammonium formate buffer, pH 7.4. SbnI samples, in
300 mM ammonium formate, were run in 500 μL injected into the column and eluted
at a flow rate of 200 μL/min. Protein elution was measured at 280 nm. The column
was calibrated with blue dextran (void volume), b-amylase from sweet potato
(200 kDa), alcohol dehydrogenase from yeast (150 kDa), bovine serum albumin
(66 kDa), carbonic anhydrase from bovine erythrocytes (29 kDa), and cytochrome c
from horse heart (12.4 kDa).
Recombinant SbnI was dialyzed in 300 mM ammonium formate, pH 7.4, and 100 mM
NaCl prior to sedimentation velocity ultracentrifugation analysis. For analysis of SbnI
in the reducing agent, buffer also contained 10 mM DTT added post-dialysis. The
dialysis buffer was retained for use in the reference sector for all runs. Analytical
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ultracentrifugation was carried out in a Beckman XL-A Analytical Ultracentrifuge
with a four-hole An-60Ti rotor and double-sector cells with Epon charcoal
centerpieces. Centrifugation was carried out at 5℃. A total of 60 absorbance
measurements were taken at 280 nm at 5 min intervals at 0.002 cm radial steps, and
averaged over 3 readings. The rotor speeds were 35,000 rpm for SbnI in 100 mM NaCl
and 45,000 rpm for SbnI in 20 mM DTT. Data were analyzed using non-linear
regression in Sedfit software and fit to a c(s) distribution, to determine sedimentation
coefficients corrected to 20°C and in H2O. All data were fit to a root-mean-square
deviation (r.m.s.d.) equal or less than 0.007.
2.2.10 DNA-binding assays
Electrophoretic mobility shift assays (EMSA) were performed with purified SbnI and
double stranded, fluorescently-labeled, DNA. The DNA probe was amplified through
PCR with IRDye® 700-labeled custom primers purchased from Integrated DNA
Technologies (IDT®). Protein and DNA were incubated in a 25 μL volume that
contained 120 ng of fluorescently-labeled DNA, 50 mM HEPES, 240 μg/mL bovine
serum albumin (BSA), 15.2 μg/mL Poly[d(I-C)], and SbnI, at room temperature for
45 min. Samples were separated on 6% non-denaturing polyacrylamide gels in TBE
buffer (10 mM Tris, 89 mM TrisBorate, 2 mM EDTA, pH 8.3) at 120 volts for 1.5 h.
Competition EMSAs used 120 ng labeled sbnC probe and 1,200 ng of either unlabeled
sbnC or rpoB probe. For EMSAs containing heme, a 4 mM heme stock was diluted to
250 μM in 50 mM HEPES, pH 7.4, just prior to use. For preparation of heme stock, see
section 2.2.11.
2.2.11 Heme titrations
Heme stocks were prepared as follows. Bovine heme (Sigma) was resuspended to
5 mM in 0.1 N NaOH (i.e. 0.00326 g/mL) and vortexed vigorously until in solution.
The solution was sterilized by filtration through a 0.2 μM filter. A series of dilutions
were prepared in 0.1 N NaOH and scanning UV-Vis spectra were taken on the solution.
The post-filtration concentration was determined on this solution using the molar
extinction coefficient for hemin in 0.1 N NaOH of 58400 cm-1 M-1 at 385 nm (38). Heme
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solution was aliquoted and stored at -20°C. Heme stocks were diluted just prior to
use, in the buffer or media appropriate to the experiment.
Heme titrations, using UV-Vis spectroscopy, were performed using 1 μM SbnI and
increasing concentrations of heme. SbnI was in 300 mM ammonium formate, pH 7.4,
and incubated for 5 min at room temperature with heme concentrations ranging from
0.2 μM to 2 μM, with 0.2 μM increase after each reading. Heme stocks (2.5 mM) were
prepared from hemin chloride (Sigma) by adding NaOH, which were further diluted
with 300 mM ammonium formate, pH 7.4, to working concentration 200 μM. UV-Vis
spectra were recorded using Cary 50 Bio UV-visible spectrophotometer with
background correction for buffer and for each heme concentration. Triplicate
samples were recorded.
Magnetic circular dichroism measurements were taken with 10 μM SbnI prepared in
300 mM ammonium formate, 10 mM DTT, pH 7.4. Measurements at room
temperature were made in 1-cm cuvettes at 5.5 T in an Oxford Instruments SM2
superconducting magnet, aligned in a Jasco J810 CD instrument. The MCD were
calculated as 2 ´ MCD(+) minus the apo signal (CD correction). Peak absorbance was
always near 400 nm.
ESI-MS was performed by using 50 μM of recombinant SbnI, stored in 300 mM
ammonium formate and 10 mM DTT, pH 7.4, titrated with molar equivalents of heme.
Heme, for both the MCD and ESI-MS measurements, was prepared in a 1 mM stock by
dissolving 10 mg of hemin in concentrated NH4OH neutralized with 10 mM
ammonium formate, pH 6. The average incubation time for SbnI and heme was 3 min.
Spectral data were recorded with Bruker Micro-TOF II (Bruker Daltonics, Toronto,
ON) operated in the positive ion mode set for soft ionization. Scan parameters where
set for 500-4000 m/z, and the spectra were collected for minimally 1 min and
deconvoluted using the Maximum Entropy licence for the Bruker Compass
DataAnalysis software.
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2.2.12 Generation of an arcA mutant
The arcA mutants were generated by transducing the arcA::ΦΝΕ insertion mutation
from the Nebraska transposon library, into Heinrichs laboratory RN6390 WT and
sbnI strains using bacteriophage Φ80α (Table 2-1) (36, 37). Colonies were selected
by plating on TSA containing erythromycin. The mutation was confirmed through
PCR with primers specific to regions outside the transposon site.
2.2.13 Oxygen radical resistance assays
S. aureus strains were grown in cTMS overnight, washed and resuspended in fresh
cTMS with 10 mM methyl viologen (Sigma) to an OD 0.2 into 1 mL culture media (flask
to volume ratio 12:1). Samples were shaken at 37°C at 220 RPM for a maximum of
60 h. Viability was determined by plating for CFU on TSA plates at designated timepoints.

2.3 Results
2.3.1 Requirement of iron-regulated SbnI for SB production in S. aureus
SB can be synthesized entirely in vitro using purified sbn-derived enzymes (19–21,
27). Indeed, SB can be synthesized from the activities of SbnA, SbnB, SbnC, SbnE, SbnF,
SbnG, and SbnH when provided with O-phospho-L-serine, glutamate, oxaloacetate,
and acetyl-CoA as substrates (19–21, 27). Despite its product seemingly having no
essential enzymatic role in SB synthesis, sbnI, the ninth gene in the sbn operon (Fig. 21), is conserved in S. aureus strains, along with the rest of the sbn operon. This
suggests it may play an important role in SB biosynthesis. Searches of the protein
databases revealed that the protein shared limited sequence similarity with the DNA
partitioning proteins ParB and Spo0J.
To assess the functional role, if any, of SbnI in SB synthesis, I knocked out sbnI by
insertion of a tetracycline-resistance cassette into the middle of the gene. As part of
the initial studies into the functional role of SbnI, I first confirmed its expression
profile in WT S. aureus. A canonical Fur box is situated upstream of sbnA and, as such,
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Fig. 2-1. The sir-sbn locus schematic. The sbnI gene is situated as the 9th and terminal gene
of the operon.
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expression of the genes within the operon is regulated by iron concentrations.
Quantitative real-time PCR (qPCR) was used to confirm that expression of the
predicted terminal gene of the operon, sbnI, is similarly regulated by iron levels (Fig.
2-2A). Western blot analysis, using a-SbnI antisera, corroborated the qPCR findings,
demonstrating that SbnI protein expression was controlled by iron (Fig. 2-2B).
Western blots also confirmed that the sbnI insertion mutant (H984) lacked detectable
expression of SbnI (Fig. 2-2B).
With the confirmed sbnI::Tet mutant strain, H984, growth kinetics were recorded,
comparing the relative growth of the WT, H984, H984 + psbnI, and the Δsbn (i.e.
complete operon knockout) strains grown in RPMI, an iron-restricted, chemically
defined medium. In this medium, and in comparison to the WT and complemented
strains, H984 had a severe growth defect, similar to the growth defect observed for
strain H1342, the Δsbn strain (Fig. 2-3). Since previous work has shown that
production of SA is repressed in RPMI (28), these results suggested that SbnI was
critical for SB-mediated iron acquisition.
Since WT S. aureus strains have the ability to produce both SA and SB under
conditions of iron starvation, and since their activity can be readily detected in
bioassay experiments (20, 21, 27, 28), a disc diffusion bioassay was performed to
examine SB production in RN6390 (WT), H984, and the complemented strain (H984
+ psbnI). For these experiments, bacteria were grown in cTMS medium which, as
opposed to RPMI, does not result in inhibition of SA or SB. As shown in Figure 2-4, in
this medium the growth was comparable among the three strains tested, throughout
the duration of the experiment. Spent culture supernatants were taken at six
designated time points, 10, 12, 16, 20, 24, and 36 h post-inoculation. The supernatants
were then applied onto sterile paper discs on agar seeded with the sirA or htsA mutant
strains. The sirA strain is unable to uptake SB and thus relies on SA uptake for growth;
whereas the htsA strain is unable to uptake SA, and thus its growth is reliant on SB.
The data demonstrated that, compared to WT RN6390, H984 seemed to make
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Fig. 2-2. Expression of sbnI is regulated by iron. A. qPCR data showing significant
increase in gene expression of sbnA and sbnI in WT RN6390 when grown in iron
restricted medium versus iron-replete medium (*P < 0.01). All strains were grown in
cTMS with (+Fe, solid bars) or without (-Fe, clear bars) 50 μM FeCl3. Gene expression
of strains grown in iron replete is used as comparator and is arbitrarily set to 1.
Statistics were performed using Students unpaired t-test. B. Western blot with a-SbnI
antisera demonstrating iron-regulated control of SbnI. WT RN6390 cells were grown
in cTMS medium with (+Fe) or without (-Fe) addition of 50 μM FeCl3 (left panel).
Immunoblotting also confirmed the lack of expression of SbnI in the sbnI mutant
strain carrying pCN51 (vehicle control; vector), and complementation of expression
in the mutant carrying psbnI (carries sbnI gene).

121

Fig. 2-3. Growth kinetics of S. aureus strains in Roswell Park Memorial Institute
medium (RPMI). RN6390 and derivatives were grown in RPMI incorporating 0.2 μM
EDDHA to further enhance iron restriction. Vehicle control (veh) was empty pCN51.
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Fig. 2-4. Disc diffusion assay demonstrating requirement of sbnI for SB production.
RN6390 and derivatives were grown in cTMS medium with 0.1 μM EDDHA. Triplicate
spent culture supernatants were analyzed at indicated time points post inoculation.
Supernatants were concentrated and resuspended in sterile dH2O and placed onto
sterile paper discs subsequently placed on cTMS agar seeded with either the sirA (A)
or the htsA (B) strain. Growth around the disc was an indication of the presence of SA
(A), or SB (B). All strains were grown in cTMS medium in which growth, as measured
by OD600 (right y axis), was comparable.
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detectable quantities of SA sooner in the growth cycle (Fig. 2-4A). However, more
striking, and in agreement with data in Figure 2-3, while RN6390 produced detectable
quantities of SB by 10 h, I was unable to detect SB from supernatants of H984 until at
least the 24-h time point. This defect was complemented by supplying sbnI in trans
(Fig. 2-4B). These results suggest that SbnI plays a critical role in the synthesis of SB,
particularly at early time points, and that the absence of SbnI does not hinder SA
production, but rather may result in increased production of SA.
2.3.2 Expression of the SB biosynthetic and efflux genes requires SbnI
In accordance with the idea that SbnI affected synthesis of SB, despite having no clear
enzymatic function in the biosynthetic pathway (20, 21, 27), and given that SbnI
shares low sequence similarity to the DNA-binding proteins ParB and Spo0J, I
theorized that SbnI may function as a regulatory protein that impacted expression of
SB biosynthetic genes. To evaluate this, RNA levels were measured for each of the
genes throughout the sbn operon, comparing levels in WT to those in H984. Strikingly,
these experiments revealed a dramatic drop (90-99% decrease) in RNA transcripts
for genes sbnD through sbnH in H984 compared to RN6390 (Fig. 2-5).
2.3.3 Identification of an internal promoter in the sbn operon
Since SbnI had a drastic effect on the expression of genes downstream of sbnC, I
theorized that SbnI may be regulating expression of genes downstream of sbnC by
regulating the activity of a promoter internal to the operon. In an attempt to
demonstrate this, I cloned several DNA fragments spanning the region from sbnA
through sbnE upstream of the promoterless luciferase genes in the vector pGylux (Fig.
2-6A). The constructs were then introduced into strains RN6390 and H984, and the
bacteria grown in cTMS medium with or without added iron. As expected,
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Fig. 2-5. Mutation of sbnI results in altered expression throughout the sbn operon.
RN6390 and its sbnI::Tet derivative were grown in cTMS with 0.1 μM EDDHA, a
medium in which growth was comparable between the two strains. qPCR was used
to measure RNA levels for each gene, where WT gene expression was set to 1.
Statistics were performed using the Students unpaired t-test. *P < 0.005
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Fig. 2-6. Identification of a promoter within the sbnC coding region. A. DNA fragments,
spanning genes sbnA-E, were cloned into the pGylux vector and luciferease activity
was measured. Activity was expressed at cps/OD600. Statistical analyses were
performed for each respective fragment, comparing the luciferase activity of either
the sbnI strain without iron (sbnI - Fe) to WT without iron (WT-Fe), or WT with iron
(WT+Fe) to WT without iron (WT-Fe). Statistics were performed using Student's
unpaired t-test; *P < 0.01, ns = not significant. B. Identification of initiation of
transcription. Using the 5'RACE method A81175 (based on S. aureus Newman genome
sequence) was identified as the +1 site, and is located 625-bp downstream of the sbnC
start codon. Two PCR products of approximately 760 bp (AUP/GSP1) and 117 bp
(AUAP/GSP2) were generated and the 117-bp product was cloned into pGEM7 and
sequenced. The location of the primer GSP2 and the -10 and -35 sites are indicated.
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these experiments showed that there was robust promoter activity in the fragment
carrying the promoter region upstream of sbnA, and this activity was approximately
40% decreased in H984 (Fig. 2-6A), in agreement with the qPCR data in Figure 2-5.
Further, in agreement with the presence of a canonical Fur box upstream of sbnA, the
activity from the sbnA promoter was significantly (P<0.01) attenuated when the cells
were grown in medium containing iron versus in the same medium but iron deplete
(Fig. 2-6A). In addition to DNA fragment A carrying the sbnA promoter region, I
observed that DNA fragment C also had fairly strong promoter activity that was also
significantly (P<0.01) regulated by iron concentrations in the growth medium.
Moreover, this activity was abrogated in H984, indicating that it was SbnI-dependent.
This phenotype was complemented in the H984 carrying sbnI in trans (data not
shown).
Rapid Amplification of cDNA Ends (RACE) was performed for fragment C in order to
elucidate the transcription start site present within the fragment. The experiment
was repeated on multiple biological samples for robustness, and demonstrated the
presence of a confirmed transcription start site at position A82356 (based on genome
S. aureus Newman), which is located 772 bp downstream of the start of the sbnC
coding region (Fig. 2-6B).
2.3.4 SbnI forms dimers and is able to bind DNA region upstream of sbnD
Based on SbnI-dependent regulation of an internal promoter within the sbn operon, I
next investigated whether SbnI controlled gene expression through direct binding to
nucleic acids. However first, since DNA binding proteins frequently form dimers or
oligomers, I investigated for this property. His6-tagged SbnI was purified by metal
affinity chromatography (Fig. 2-7A) and used to evaluate the oligomerization status
of the protein in solution. Size-exclusion chromatography and sedimentation
velocity-analytical ultracentrifugation determined that SbnI forms dimers and
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Fig. 2-7. SbnI forms dimers and tetramers in solution. A. Purification of recombinant
His6-SbnI. Various samples during the purification process are run through a
polyacrylamide gel, starting with pre-column (load), flowthrough (flow), wash
fraction (wash), and elution fractions 1-4. The identity of the three bands labeled with
an asterisk was confirmed as SbnI using MALDI. B. Size exclusion chromatography of
SbnI. Chromatogram represents size-exclusion data of SbnI run in 300 mM
ammonium formate, pH 7.4, at flow rate of 0.2 mL/min across Superdex 200 FPLC
column. Elution volumes of known protein standards are shown at the top and are
used to generate a standard curve (inset). C-D. sedimentation velocity-analytical
ultracentrifugation was performed on SbnI run in 300 mM ammonium formate, pH
7.4, 100 mM NaCl. In panel C. 10 mM DTT was included.
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tetramers in non-reducing conditions and primarily monomers with limited dimer
conformation under reducing conditions (i.e. in the presence of 10 mM DTT) (Fig. 27 B-D).
Electrophoretic mobility shift assays (EMSAs) were performed with purified His6SbnI, in non-reducing conditions so as to promote oligomerization of the protein.
Based on luciferase assay and RACE data suggesting an internal promoter in the sbnC
region, I sought to find a DNA fragment upstream of sbnD that could be bound by SbnI.
Multiple EMSAs were performed using 250-300 bp fragments located within and
upstream of the region identified as fragment C in Figure 2-6. A 271-bp probe located
772 bp upstream of the transcription initiation site internal to the sbnC coding region
was identified as a binding site for SbnI (Fig. 2-8). The inability of denatured protein
(SbnI incubated for 10 min at 100℃) and His6-SbnG to bind this DNA fragment (Fig.
2-8, lanes 3 and 6, respectively), confirmed binding specificity of SbnI for this
fragment, and ruled out the possibility of non-specific interactions with the IRDye700 molecule. Binding specificity to this probe was confirmed by showing that excess
unlabeled sbnC DNA fragment, but not excess non-specific (i.e. rpoB) unlabeled DNA,
could interfere with the binding of SbnI to the labeled fragment.
2.3.5 SbnI binds heme
The Iron response regulator (Irr) protein of Bradyrhizobium spp. is a DNA-binding,
transcription factor regulating gene expression. The protein binds heme which
results in substantially decreased affinity for DNA (41, 42). This interaction is aided
by a HxH motif located central to the Irr protein (43). Since SbnI contains the
sequence HIHEH (i.e. tandem HxH motif) at its extreme N-terminus, I investigated the
possibility that, in similar fashion to Irr, SbnI was capable of an interaction with heme.
Heme titration experiments were performed using both UV-Vis spectroscopy (Fig. 29A) and ESI-MS (Fig. 2-9B), and both techniques demonstrated that SbnI was indeed
capable of binding to heme, with saturation occurring at approximately a 1.5:1 heme
to protein ratio.
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Fig. 2-8. Identification of a DNA binding site for SbnI. A. Schematic identifying the
location of a 271-bp DNA fragment that was used for the EMSA experiment illustrated
in panel B. The base numbering is from the genome sequence for S. aureus strain
Newman. B. Electrophoretic mobility shift assay demonstrating SbnI binding to DNA
fragment shown in panel A. Each sample contained 120 ng of fluorescently-labeled,
270-bp, ds-DNA, as well as the following: Lane: 1, DNA alone; 2, 25 μM SbnI; 3, 25 μM
denatured SbnI; 4, 25 μM SbnI with 100:1 unlabeled sbnC probe to labeled probe; 5,
25 μM SbnI with 100:1 unlabeled rpoB probe to labeled probe; 6, 25 μM SbnG.
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Fig. 2-9. SbnI binds heme. A. UV-Visible difference absorbance spectra recorded
following addition of increasing concentrations of heme to 1 μM SbnI in 300 mM
ammonium formate, pH 7.4. The absorption spectra were measured at 22℃. The shift
in spectral maxima coincident with the absorption spectrum of the protein-bound
heme with increasing heme concentrations is indicated by the arrows. The
concentration of the heme at the end of the titration was 1.6 μM, at which the increase
in soret peak is due to non-specific heme stacking, as SbnI optimally binds heme at a
1:1 molar ratio heme:SbnI, as indicated by ESI-MS data shown in panel B. B.
Deconvoluted electrospray ionization mass spectral data of SbnI in 300 mM
ammonium formate, pH 7.4, and 2 mM DTT as a function of increasing heme
stoichiometry (0 mol eq (bottom) to 1.5 mol eq added heme (top)). The heme solution
was freshly prepared prior to the measurement. The apo-SbnI has a mass of 29,914
Da. Heme binding to the holo-SbnI results in a new mass at 30,531 Da. The relative
abundance of the apo-SbnI decreases as the heme concentration increases. The holoSbnI with a single heme bound (mass 30,531 Da) is the major species even with excess
heme (top).

134

135

To examine which amino acid residue(s) were responsible for heme binding,
magnetic circular dichroism (MCD) was performed on purified SbnI. Results of MCD
did indeed confirm that a histidine residue was responsible for SbnI’s interaction with
heme. MCD indicated a 6-coordinate low-spin ferric with a histidine residue (His),
donated from SbnI, in the proximal position and free amine (donated from the buffer)
occupying the 6th position (Fig. 2-10A).
To investigate the role of the 3HIHEH7 motif in binding to heme, I mutated all three of
the histidines to alanine to create the sequence 3AIAEA7 in the N-terminus of SbnI.
The protein was overexpressed and purified, and used in heme titration experiments
using UV-Vis spectroscopy. These analyses demonstrated that the protein was still
capable of binding heme as a Soret peak was observed as heme was titrated into the
protein solution (Fig. 2-10B). These data suggest that heme binding by SbnI is not
attributed to the presence of an HxH motif, as it is with the B. japonicum Irr protein.
2.3.6 Heme obviates the SbnI:DNA interaction
Given that SbnI is capable of binding both DNA and heme, I next sought to determine
whether the interaction of SbnI with heme would alter its DNA binding properties, as
it does with the Irr protein (42). To examine this, EMSAs were repeated using SbnI
protein that was pre-incubated with increasing concentrations of heme. As shown in
Figure 2-11, the ability of SbnI to bind the sbnC DNA fragment was diminished with
increasing concentrations of heme. Moreover, at a 1:1 molar ratio of protein to heme,
DNA binding was completely inhibited (Fig. 2-11).
2.3.7 SbnI bound to heme is primarily monomeric
Most DNA-binding proteins require the proper tertiary structure for interaction with
nucleic acids. Therefore, as heme abrogated the ability of SbnI to interact with DNA, I
questioned if heme altered SbnI’s oligomerization properties. To investigate this,
sedimentation velocity-analytical ultracentrifugation was performed with SbnI with
the addition of heme, at a 1.5:1 molar equivalence of heme to protein. In the
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Fig. 2-10. SbnI binds heme through a histidine residue. A. Overlayed magnetic circular
dichroism (MCD) absorption results for the heme titration of 10 μM SbnI in 300 mM
ammonium formate. MCD traces were base lined and CD corrected. Assignment of
MCD indicates 6 coordinate low-spin ferric with a histidine (His) in the proximal
position and amine (from the buffer or from ammonia used to dissolve heme)
occupying the 6th position. B. UV-Vis absorbance spectra recorded upon titration of 1
μM mutated-SbnI (SbnI containing alanine to histidine mutations in the putative
heme binding motif (3AIAEA7)) in 300 mM ammonium formate, pH 7.4, with
increasing concentrations of heme. Absorbance was measured at 22℃. The shift in
spectra with increasing heme concentrations is indicated by the arrows.
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Fig. 2-11. Heme decreases affinity of SbnI for DNA. EMSA was performed as described
for Fig. 2-8. Each sample contained 120 ng of the fluorescently-labeled, ds sbnC probe.
Lanes: 1, DNA alone; 2, 25 μM SbnI; 3, 25 μM SbnI with 0.2:1 molar equivalent (eq) of
heme to SbnI; 4, 25 μM SbnI with 0.5:1 eq of heme to SbnI; 5, 25 μM SbnI with 1:1 eq
of heme to SbnI.
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presence of heme, SbnI was primarily monomeric, with limited dimer formation (Fig.
2-12); however, SbnI did not form defined tetrameric structures, unlike what was
previously observed with SbnI in buffer alone (Fig. 2-7C). Therefore, this result may
provide an explanation as to why SbnI binds to DNA more poorly in the presence of
heme, as heme prevents SbnI from forming higher molecular structures that may be
necessary for DNA binding.
2.3.8 Extracellular heme controls SB synthesis
Although previous studies have demonstrated that S. aureus preferentially uses heme
as an iron source (12), no studies have yet investigated the effect of heme on the
synthesis of siderophores. Moreover, data showing that SbnI is required for SB
synthesis, and that heme obviated the DNA-binding ability of SbnI, led me to
investigate how exogenously supplied heme may affect SB production.
To investigate the effects of heme on SA and SB production, a disc diffusion assay was
performed to determine the relative amounts of each siderophore produced during
growth of WT RN6390 in cTMS medium with either 1 μM FeCl3 (WT + Fe) or 1 μM
heme (WT + heme). As previously described in section 2.3.1, the spent culture
supernatants were spotted onto cTMS agar seeded with either sir or hts mutants to
examine for the presence of SA or SB, respectively. As shown in Figure 2-13A, the
relative amounts of SA were comparable between supernatants from cultures grown
in equivalent concentrations of FeCl3 versus heme. However, in agreement with the
results described above, spent supernatants from cultures grown in heme, versus
FeCl3, showed decreased amounts of SB during the early stages of growth, until at
least the 16 h time-point, a point at which that cultures were entering stationary
phase. As opposed to the global suppressive ability of iron on iron-regulated genes, in
a Fur-dependent fashion, results indicate that heme specifically suppresses the
synthesis of SB. I suggest that this regulation functions through heme's ability to
inhibit DNA-binding of SbnI, whose function is required for transcription of genes
within the sbn operon (i.e. SB biosynthesis/secretion genes).
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Fig. 2-12. SbnI forms monomers and dimers in the presence of heme. Sedimentation
velocity-analytical ultracentrifugation was performed on SbnI run in 300 mM
ammonium formate, pH 7.4, 100 mM NaCl, with1.5:1 molar equivalence of heme to
SbnI.
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Fig. 2-13. Heme reduces staphyloferrin B production. Disc diffusion assay was
performed as previously described, and all strains where grown in cTMS with either
the addition of 1 μM FeCl3 or 1 μM heme. A. Growth radius from SA secretion was
comparable between WT + heme and WT + Fe for all time points. B. Disc diffusion
assay demonstrating reduced amount of SB in culture supernatants at 10 and 12 h of
growth from WT grown in 1 μM heme when compared to WT grown in 1 μM FeCl3.
Optical density of cultures at the various time-points is plotted above the disc
diffusion assay results (right Y axis).
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2.3.9 SbnI regulates genes outside of the sbn operon
RNAseq was performed on the H984 (sbnI mutant) to determine if SbnI regulated
genes outside of the sbn operon. Unexpectedly, comparing the genome-wide
transcription profile of H984 to that of WT RN6390, I found that 34 genes were
upregulated between 3.8 to 20-fold, and 38 genes, other than those on the sbn operon,
were downregulated between 3.8 to 10-fold. I did not identify, however, regulation of
genes involved in heme biosynthesis or heme uptake.
Unexpectedly, there was a substantial (~16 fold) increase in the expression of arcA,
and downstream genes in the arc operon, in H984 strain. As an alternative energy
source, S. aureus is able to transport and metabolize arginine through proteins
encoded on the arc operon (44, 45). The arc operon contains five genes in total, arcA,
arcB, arcD, arcC, and arcR. ArcA, ArcB, and ArcC are catabolic enzymes, that convert
arginine into ammonium, L-ornithine, carbon dioxide, and one molecule of ATP.
Arginine is transported into the cell by the arginine/ornithine antiporter ArcD, and
the entire operon is regulated by ArcR and, divergently transcribed, ArgR (46).
As also determined by qPCR analysis, the over-expression of the arc operon in H984
was reproduced in the RNAseq results, and could be complemented by providing sbnI
in trans (Fig. 2-14A,B). I was interested to determine if arc expression was linked to
SbnI alone or was a result of decreased SB. To examine this, I performed qPCR on an
sbnA mutant, a strain that would still express sbnI but does not produce SB. Data
revealed that arcA was also upregulated in an sbnA mutant (Fig. 2-14C), suggesting
that arc is regulated in response to SB. arcA, however, is not regulated in response to
iron directly, as arcA expression did not change in WT cells grown either with or
without the addition of 30 μM FeCl3 (Fig. 2-14D). For qPCR analysis that involved the
sbnA mutant and FeCl3, gene expression of sbnD was measured as a SbnI- and ironresponsive control. As expected, sbnD expression was not altered in a sbnA mutant
but was downregulated in H984 under the same growth conditions (Fig. 2-14C); and
sbnD gene expression was substantially increased in iron deplete versus iron-replete
conditions (Fig. 2-14D).
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Fig. 2-14. arc operon is upregulated in a sbnI-deficient strain. A. qPCR results show
significant upregulation of the arc operon in H984. B. Complementation of H984 (sbnI
+ pSbnI) restores expression of arcA. C. Upregulation of arcA, in H984 and sbnA
mutants suggests that regulation is in response to SB deficiency. D. arcA gene
expression is not altered in the presence of FeCl2. A-C. All strains were grown in cTMS
to mid-exponential phase, and grew similarly. Gene expression of WT was arbitrarily
set to one and gene expression of the mutants was in relation to WT. D. Gene
expression of WT + Fe was set to one and expression of WT-Fe was in relation to WT
+ Fe. All gene expression was normalized to rpoB expression. Statistics were
performed using Student's unpaired t-test; *P < 0.01, ns = not significant
145

2.3.10 arc operon is not involved in SA synthesis
As mentioned, a byproduct of arginine catabolism is ornithine, which is an essential
substrate for the biosynthesis of staphyloferrin A. Therefore, I postulated that the
upregulation of the arc pathway in a SB-deficient strain, could be a compensatory
mechanism by which the cell promotes the synthesis of SA. To examine this, I
generated an arcA mutant by transducing an erythromycin cassette into the arcA gene
using phage transduction and performed a bioassay to look at the siderophore profile
of the arcA mutant. Spent culture supernatant was taken from four strains, WT, H984,
arcA, and sbnI,arcA double mutant, at 24 h post inoculation. The supernatant was
plated onto sterile paper discs on top of iron-restricted agar containing the reporter
strains. Two different reporter strains were used as previously described in section
2.3.1: the sir mutant that can use only SA for growth, and the hts mutant that can use
only SB for growth. Growth of the reporter strains indicated the presence of the
siderophore in the supernatant.
As previously seen in Fig. 2-4, I observed heightened production of SA in H984;
however, this was also observed in the sbnI,arcA double mutant demonstrating that
the arc operon does not contribute to SA production (Fig. 2-15). Furthermore, there
was no observable difference between the WT and arcA mutant for either SA or SB
secretion. Therefore I concluded that SA synthesis is independent of the arc operon.
2.3.11 Arginine catabolism does not confer sbnI mutant with a growth advantage
To observe phenotypic differences between the arc mutant and WT, I grew the arcA
mutant microaerobically in nutrient-rich medium (TSB), supplemented with high
concentrations of arginine (50 mM). These were conditions previously shown to
exacerbate the arc-dependent phenotype (44). As anticipated, I observed that the
arcA mutant had a growth defect under these conditions compared to WT and H984.
This growth defect correlated with a change in pH, where the medium of the arcA
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Fig. 2-15. SA production is independent of arcA. Disc diffusion assay was performed
as previously described, and all strains where grown in cTMS for 24 h. Cell spent
supernatant was taken and plated onto agar seeded with reporter strains. Growth
radius from SA secretion was comparable between WT and arcA mutant, with a slight
increase in SA production for the sbnI and sbnI,arcA mutants. As previously observed
in Fig. 2-4, SB production was greatly reduced in the sbnI mutants.
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mutant underwent acidification, dropping from pH 7.4 to pH 6.0, whereas the
medium of the WT and H984 strains did not change in pH (Fig. 2-16A). This result
suggested that arc plays an important role in alkalization of the media during growth,
potentially through the production of NH4+, a byproduct of arginine catabolism.
However, when grown in nutrient-limited media (cTMS), in microaerobic conditions
with arginine supplementation, all tested strains, WT, H984, and arcA mutant grew
poorly and had no notable differences in growth (Fig. 2-16B). Thus, upregulation of
arc in H984 does not appear to confer a growth advantage in nutrient poor medium.
2.3.12 sbnI mutant has increased sensitivity to oxidative stress
As the overexpression of arc did not enhance the synthesis of SA, nor confer a growth
advantage to H984 in low pH, microaerobic conditions, I tested if arginine catabolism,
and the subsequent production of ammonia, perhaps aided in ROS toxicity. To
examine this, the WT, H984, sbnI + psbnI, and arcA strains were used in a killing assay
with methyl viologen (MV), a compound that induces intracellular production of ROS.
For the killing assays, strains were grown in cTMS overnight and then inoculated into
cTMS with 10 mM MV, and survival was carried out for 48 h. Results showed that
H984 displayed a notable sensitivity to MV compared to WT; this phenotype was
complementable by expressing sbnI in trans (Fig. 2-17A). The arcA mutant had a
similar survival to that of WT (Fig. 2-17A).
Previous work has demonstrated that manganese chloride (MnCl2) is able to detoxify
intracellular ROS and, as an essential cofactor to SodA and SodM, also enhances
superoxide dismutase activity (47). Therefore, to confirm that decreased survival of
H984 in MV was due to ROS production and not to other potential deleterious effects
of the compound, killing assays were repeated in the presence of 4 μM MnCl2. In the
presence of excess manganese, all strains, including H984, had complete survival
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Fig. 2-16. arcA mutant has a severe growth defect in TSB, but not in cTMS,
supplemented with arginine and grown in micro-aerobic conditions. A,B. Strains were
grown in TSB (A) or cTMS (B) + 50 mM arginine with limited oxygen availability.
Changes in pH of the media were measured for TSB growth analysis.
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Fig. 2-17. SbnI has increased sensitivity to ROS. Methyl viologen killing assay of
strains grown in cTMS to stationary phase then inoculated into cTMS with 10 mM MV
(A) or 10 mM MV + 4 μM MnCl2 (B). CFUs were enumerated at designated time points
by plating samples on TSA plates.
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and were unaffected by MV (Fig. 2-17B). These results indicated that SbnI enhances
resistance of S. aureus to oxidative stress; however, the role of arc in this process
remains unclear.

2.5 Discussion
The capacity of S. aureus to establish an infection is reliant on its ability to acquire
iron from the host. The expression of many genes encoding proteins involved in iron
metabolism is 'iron- regulated' through the activity of the global regulatory protein,
Fur. Fur-mediated regulation of gene expression is widespread in both Gram-negative
and Gram-positive bacteria (29, 30). Indeed, expression of the sbn operon is
repressed by Fur during growth in iron-replete media. However, S. aureus is unlikely
to encounter iron replete conditions during infection of the host, given that the host
actively sequesters iron from pathogens (48, 49). Moreover, since S. aureus possesses
multiple iron acquisition strategies, all regulated at a minimum by Fur, additional
mechanisms are likely to exist for fine-tuning of the response of S. aureus to the
availability of different iron chelates during iron starvation conditions. This is
especially true in light of previous work demonstrating that S. aureus prefers to utilize
heme as an iron source (12). The identification of SbnI as a transcriptional regulator
of sbn operon expression, in response to heme, is the first such identification of a
molecular mechanism underpinning a manner by which S. aureus 'senses' heme to
control siderophore synthesis. The model provides some mechanistic insight in
support of the observations of Skaar and colleagues who reported that heme is the
preferred iron source of S. aureus (12).
In this study I show that SbnI is a regulatory protein with DNA and heme binding
capabilities. SbnI regulates transcript levels of genes in the sbn operon, particularly
genes including and downstream of sbnD. Thus under iron starvation conditions, SbnI
is required to allow expression of the gene encoding the SB efflux pump, SbnD, and
essential biosynthetic genes, sbnE-H, ultimately serving to increase production of SB,
but also to ensure that once SB synthesis has been initiated by the activity of SbnA
and SbnB enzymes (19–21) that the efflux pump is expressed so as to not result in
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cytoplasmic accumulation of SB and potentially its intermediates. Regulatory control
of efflux versus biosynthesis has been documented for the biosynthesis/efflux of the
antibiotic actinorhodin in Streptomyces coelicolor (50). Ensuring expression of the
efflux pump prior to synthesis of the end product ultimately serves to ‘protect’ the
cell from an overabundance of cytosolic antibiotic. SB is a high-affinity iron chelator
that, if located in high abundance in the cell cytosol, could negatively impact cellular
function by binding to intracellular iron. Thus the SbnI-dependent upregulation of
sbnD and downstream genes may serve to ensure expression of the efflux pump prior
to complete synthesis of the SB molecule. The early steps of SB synthesis, which result
in the formation of L-Dap by SbnA and SbnB (20, 21), may also be important for SbnI
function, and I am currently investigating the possibility that SB intermediates,
including L-Dap, work as co-regulators by binding with SbnI.
This is the first study to investigate the importance of SbnI in siderophore synthesis
and the data clearly implicate a role for SbnI in transcription control from regions
within the sbn operon. The mechanisms underlying the function of SbnI in DNA
binding and transcriptional control are areas of interest. The similarity of SbnI with
ParB/Spo0J may provide some insight. The Spo0J protein has been demonstrated to
bind DNA at disparate locations and, along with its ability to self-associate, can cause
DNA bending within higher order nucleoprotein complexes (51). In the case of SbnI,
there may be additional locations throughout the sbn operon that SbnI may bind in
forming regulatory complexes that control transcription. These, along with the
identification of exact nucleotide binding sequences for SbnI, are priorities for
ongoing studies.
Along with demonstrating that SbnI is a regulatory protein of SB efflux and
biosynthesis I suggest that SbnI controls production of SB in response to heme since
in this study I showed that SbnI is capable of binding to heme, and when complexed
with heme is unable to interact with nucleic acid, at least the region I identified
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Fig. 2-18. Proposed model of SbnI-mediated gene regulation in response to heme. In
conditions of low iron and low heme, SbnI dimer binds to DNA within the sbnC coding
region and promotes expression of genes sbnD-H. Under conditions of low iron and
high heme, heme binds to SbnI, preventing binding of SbnI to DNA and thereby
resulting in decreased expression of genes sbnD-H.
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within the sbnC coding region. In this manner, SbnI may represent a novel mechanism
by which S. aureus regulates siderophore synthesis and utilization in response to the
presence of heme (Fig. 2-18), perhaps as a sophisticated method to transition from
SB-mediated iron uptake to heme-mediated iron uptake. In support of this
hypothesis, I was able to demonstrate that providing extracellular heme to S. aureus
resulted in a decrease in SB production, but not SA production. Although I favor the
hypothesis that this effect is mediated through SbnI, the data cannot as of yet
conclusively support this contention. When provided exogenous heme, it is difficult
to determine how much of the heme is taken in to the cell and remains intact and
capable of binding to proteins like SbnI. Moreover, it is as yet unknown the role that
intracellular heme biosynthesis plays in regulating metabolic processes such as
siderophore biosynthesis. Ultimately, the ability to sense intracellular heme may be a
mechanism whereby S. aureus conserves energy by not utilizing siderophoremediated iron uptake unnecessarily when heme can be used as the primary iron
source. Should heme no longer be accessible as an iron source, I hypothesize that
'active' SbnI would allow transcription of downstream sbn genes, and that pre-formed
L-Dap in the cell would allow for a rapid transition to SB-mediated iron uptake.
Lastly, RNAseq analysis showed that SbnI regulated genes on the arc operon. The role
of arginine catabolism in virulence is poorly defined, although it has been suggested
that the production of ammonia from arginine may aid in alkalization of acidic pH and
neutralization of ROS (45). In testing whether Arc affected ROS sensitivity, I observed
that the sbnI mutant had increased sensitivity to methyl viologen, a compound that
induces intracellular superoxide. Although it has been well established that increased
intracellular iron exacerbates ROS production through Fenton chemistry (52), and
thus somewhat contradictory that a strain with reduced iron uptake is more sensitive
to ROS, this result was not wholly unexpected. Previous work has shown in S. aureus
that a sirA mutant (a strain incapable of SB uptake) was more sensitive to oxidative
stress than WT, although the reason for this was not delineated (53). Moreover, a link
between siderophore production and ROS sensitivity has been established in other
species: protochelin and azotochelin of Azotobacter vinelandii, salmochelin in
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Salmonella enterica sv. Typhimurium, and enterobactin in E. coli, aid in resistance
against oxidative stress by chelating extracellular, and more importantly,
intracellular iron (54, 55).
Additionally, many enzymes involved in the oxidative stress response, such as
superoxide dismutase and catalase A require metal cofactors, like iron. In the fungi
Aspergillus fumigatus and Alternaria alternata, intracellular siderophores bring iron
to catalases and peroxidases, demonstrating the necessity for siderophores in proper
iron utilization (56, 57). Therefore, in the case of SB in S. aureus, I propose that this
siderophore is important for oxidative stress resistance via two possible
mechanisms: i) SB chelates intracellular iron thereby reducing intracellular Fenton
chemistry, and ii) SB delivers iron to enzymes that aid in resistance to oxidative stress
such as SodM (a cambialistic SOD capable of using either iron or manganese as an
essential cofactor (58)).
Therefore, I propose a model where SB is involved in resistance to oxidative stress,
and in the absence of SB, other responses, like arginine catabolism, may be
upregulated. Arginine catabolic enzymes, encoded on the arc operon, may be induced
to increase the production of ammonia that neutralizes ROS, as perhaps a
compensatory mechanism when SB is not present (45). Further work is required to
fully understand the mechanism behind SB-mediated resistance to oxidative burst.
This finding has overall importance in the context of intracellular survival, where
oxidative burst by neutrophils and other innate immune cells offers a challenging
growth obstacle. Thus, future work in this area would be to examine the survival of
SB deficient strains in neutrophils, where I would expect a marked growth
disadvantage due to heightened ROS sensitivity.
From this study, I have identified SbnI as a heme-binding transcriptional regulator of
the sbn operon, whereby it fine-tunes expression of SB-mediated iron-acquisition in
response to intracellular heme. The fine tuning of SB and heme uptake systems in S.
aureus is of interest since both sbn and isd genes have been implicated in virulence in
S. aureus models of infection (16, 25, 26, 59–62). Furthermore, I demonstrate a role
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for SbnI, or rather the utilization of SB, in resistance to ROS, which may have
important implications for S. aureus intracellular survival and resistance to oxidative
burst.
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Chapter 3
3

Characterization of copper efflux systems in S. aureus

3.1 Introduction
Copper is an essential nutrient for most microorganisms and is a required cofactor
for many metalloproteins involved in metabolism (1). Despite this, like many other
transition metals, copper is toxic to biological systems at high concentrations as it
readily accepts and donates electrons in the transition from cuprous (Cu+) to cupric
(Cu2+) states. This reactivity results in membrane damage, intracellular formation of
reactive oxygen species (ROS) and subsequent DNA damage, and irreversible
displacement of Fe in Fe-S binding enzymes, abrogating enzymatic activity (2–4). Due
to these toxic effects, copper is a potent antimicrobial agent. In select settings, copper
is used in water treatment and as a coating for hospital surfaces and medical devices,
where it has been shown to reduce bacterial counts and risk of hospital acquired
infections (2, 5, 6).
In addition to copper being used as an antimicrobial agent in the environment, copper
toxicity is also exploited at the host-pathogen interface by the efflux of copper into
pathogen-containing phagosomes (7–9). Following macrophage phagocytosis,
interferon-g (IFN-g) induces the expression of the Cu+ importer copper transport
protein receptor 1 (CTR1), which transports copper from the extracellular milieu into
the macrophage cytoplasm. Inside the macrophage, Cu+ is picked up by the copper
chaperone ATOX1, where it is brought to the ATPase copper efflux transporter,
ATP7A, located on the phagosomal membrane. ATP7A then effluxes Cu+ into the
bacteria-containing phagosome where it exerts bactericidal effects (7, 10).
To combat this process, many pathogens have developed sophisticated mechanisms
to avoid copper intoxication. Previously shown during growth in the phagosome,
Escherichia coli, Mycobacterium spp., and Salmonella enterica sv. Typhimurium rely
on copper-responsive ATPase efflux pumps, in concert with copper-binding
chaperones, to pump excess intracellular copper outside of the cell (7, 9, 11). The
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notorious human pathogen Staphylococcus aureus survives and replicates
intracellularly in macrophages (12), and thus its ability to remove excess copper from
the cell cytoplasm may contribute to its survival within the phagosome.
S. aureus contains the copAZ locus, which encodes CopA, a copper-translocating Ptype ATPase, and CopZ, a cytoplasmic, copper-binding chaperone (13; Fig. 3-1).
Previous work has shown that deletion of copA in S. aureus renders the cell sensitive
to high concentrations of copper, and to a lesser extent, lead and iron in vitro (13).
The copAZ locus is regulated by the copper-sensitive operon repressor, CsoR, that
represses the copAZ operon in copper-deplete conditions, but derepresses copAZ
after binding to cytoplasmic copper in copper replete conditions (14, 15).
S. aureus strain USA300 is a highly transmissible and virulent strain of S. aureus that,
since 2011, has become the most common cause of MRSA infections in all bodily sites
(16). The ability of USA300 to cause such severe infections is thought to be due to its
acquisition of novel virulence factors. Unique to USA300 is the arginine catabolic
mobile element (ACME) cassette (17–19). The contribution of the ACME cassette to
USA300 virulence is poorly defined. Located on the ACME cassette is an additional
putative copper transporter (Fig. 1), that has a 36% identity to the chromosomal copA
gene and 99% identity to copB from Staphylococcus capitis. This putative efflux pump,
here named copB, has been characterized on the staphylococcal cassette chromosome
(SSC) mec mobile genetic element found in many livestock-associated (LA) MRSA
strains, where it provides these strains with greater resistance to copper (20, 21).
Immediately downstream of copB is a putative lipoprotein of unknown function. The
function of copB and associated lipoprotein has previously not been characterized in
a human-infectious strain of MRSA. Moreover, the contribution of copper
detoxification systems to S. aureus intracellular survival in the macrophage has not
been investigated.
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Fig. 3-1. Schematic of copper detoxification pathways. Copper efflux ATPase, CopA,
and copper chaperone, CopZ, are common to strains of S. aureus. USA300 has an
additional putative copper efflux transporter, CopB, and associated lipoprotein, CopL,
encoded on the ACME cassette.
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Thus in this study, I provide the first evidence of copper detoxification machinery on
the ACME cassette that confers USA300 with increased resistance to copper
compared to other S. aureus strains. Furthermore, I demonstrate that the cop genes
play a key role in intracellular survival of USA300 inside the macrophage.

3.2 Experimental procedures
3.2.1 Bacterial strains, plasmids, and growth media
All bacterial strains and plasmids used in this study are listed and described in Table
3-1. Strains were stored in 15% glycerol stocks at -80℃ and, prior to use, were
streaked onto tryptic soy broth (TSB) (Difco) agar plates containing the appropriate
antibiotic. Solid media were prepared with addition of 1.5% w/v Bacto agar (Difco).
Concentrations of antibiotics used were as follows: 50 μg/mL kanamycin and
100 μg/mL ampicillin for Escherichia coli selection, 4 μg/mL tetracycline, 5 μg/mL
chloramphenicol, and 3 μg/mL erythromycin for S. aureus selection. E. coli were
grown in Luria Broth (Difco) and S. aureus strains were grown in TSB, or either
chelex-100-treated Tris minimal succinate (cTMS) or Roswell Park Memorial
Institute (RPMI) (Gibco) media for growth under metal restriction. All solutions and
media were made using water purified with Milli-Q water purification system
(Millipore).
Table 3-1. Bacterial strains, plasmids, and primers used in this study.
Bacterial strains,
plasmids,
oligonucleotides
E. coli
DH5α
BL21(DE3)
S. aureus
RN4220
USA300
RN6390
Newman

Description

Reference

F-Ф80 dLacZΔM15 recA1 endA1 nupG gyrA96 glnV44 Promega
thi-1 hsdR17(rk- mk+) λ-supE44 relA1 deoR Δ(lacZYAargF)U169
F- ompT gal dcm lon hsdSB (rB- mB+) λ (DE3 [lacI lacUV5- Novagen
T7 gene 1 ind1 sam7 nin5])
rk-mk+ accepts foreign DNA
USA300 LAC cured of antibiotic resistance
Wild-type prophage-cured laboratory strain
Wild-type clinical osteomyelitis isolate
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(27)
(28)
(29)
(30)

Mu50
Mn8

(31)
(32, 33)

MW2
SH1000
copAZ
copB
copL
copBL
copAZB
copA
csoR

Wild-type surgical wound isolate
Wild-type clinical isolate from patient with toxic shock
syndrome
Wild-type CA-MRSA USA400
Wild-type NCTC 8325-4 rsbU+ laboratory strain
USA300 ∆copAZ (SAUSA300_2494-5)
USA300 ∆copB (SAUSA300_0078)
USA300 ∆copL (SAUSA300_0079)
USA300 ∆copBL
USA300 ∆copAZ, copB::ΦΝΕ: EryR
RN6390 copA:: ΦΝΕ; EryR
USA300 csoR:: ΦΝΕ: EryR

Plasmids
pET28a(+)
pET28a(+):csoR
pALC2073
pcopAZ
pcopBL

Overexpression vector for 6xHis-tagged proteins; KmR
Vector for overexpression of recombinant His6-CsoR
E. coli/Staphylococcus shuttle vector: AmpR CmR
pALC2073-copAZ; vector for expression of copAZ; CmR
pALC2073-copBL; vector of expression of copBL; CmR

Novagen
This study
(37)
This study
This study

Oligonucleotides
Cloning of ∆copAZ GGG GAC AAG TTT GTA CAA AAA AGC AGG CTA TGG
for pKOR1
AAA TTA AGT GGA TGT GTC G (Upstream arm
forward)
GGA CCT CCG CGG CAC AAC AAT CTC TCT ACT TAG
CAT C (Upstream arm reverse)
GGA CCT CCG CGG GAT GAC AGT AAA GTT GCT GTA TC
(Downstream arm forward)
GGG GAC CAC TTT GTA CAA GAA AGC TGG GTG AGT
GTA CGT GAT GAA GAT AGT C (Downstream arm
reverse)
Cloning of csoR TTT TTT GCT AGC GCT ATG ACT GAA CAA GAT AAT GC
from for pET28a(+) (forward)
TTT TTT CTC GAG CTC CTT TAG TCT TTA ATC AAT
TTT TGA AA (reverse)
Cloning of copAZ for GAT CGA GCT CGA ATC ACA GGG AGG CAA TAA TG
complementing
(forward)
vector (pcopAZ)
GAT CGA ATT CGT TGG GAT TCT CAT CAG TTC G
(reverse)
Cloning of copBL for GAT CGG TAC CGA GCA TAA TCA TCA AAA TCA CAT
complementing
GAA TC (forward)
vector (pcopBL)
TTT TGA GCT CCG TAT CGG TTA ATG ATG CGG
(reverse)
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(34, 35)
(36)
This study
P. Planet
P. Planet
P. Planet
This study
This study
This study

RT-PCR: copA

GAT ATC ACT GGT ATG ACT TGT GC (forward)
GGT TAT ACT CAA CAG TTG CTT TCT (reverse)

RT-PCR: copZ

TTA AAT GTT GAA GGT ATG AGC TGT G (forward)
GAG ATA CAG CAA CTT TAC TGT CAT (reverse)

RT-PCR: copB

CAT TCC AAT CAA ATG CAT CAT GAT AAC (forward)
AGG TAA GTT AAC ACC CAT CAG T (reverse)

RT-PCR: copL

GGA TCA TTA CTA ATA TTA TCA GCT TGC (forward)
CTT TAA ATT CAC CCT CAT TAG TCG (reverse)

EMSA: copA
promoter

CAA TGT TTG CAC GGC AAT (forward)
CAC ATT ATT GCC TCC CTG T (reverse)

EMSA: copB
promoter

GGA CGT GTA GAT ATA AGG TTC G (forward)
TCA AAT TAA CCC CTC CTA ATG AAA ATG (reverse)

Abbreviations: AmpR – ampicillin resistance; CmR – chloramphenicol resistance; EryR –
erythromycin resistance; KmR – kanamycin resistance

3.2.2 S. aureus growth curves
To determine the metal minimum inhibitory concentation (MIC), bacteria were
cultured on TSB agar (TSA), then several single isolated colonies were picked and
inoculated into 2 mL RPMI with 0.3 µM EDDHA (flask: volume ratio of 10:1) and
grown for approximately 8 h at 37℃ with shaking at 220 rpm. The bacteria were then
harvested, washed, and resuspended in fresh RPMI medium, and inoculated into 2 mL
RPMI with 0.2 µM EDDHA medium (flask: volume ratio 10:1) to a starting OD600 0.01.
Metals used for MIC analysis were purchased from Sigma-Aldrich: cadmium chloride
(CaCl2), cobalt chloride (CoCl2), copper sulfate (CuSO4), nickel chloride (NiCl2), lead
nitrite (Pb(NO3)2), and silver nitrate (AgNO3).
3.2.3 Cloning and mutagenesis of S. aureus
Oligonucleotides used to generate the copAZ mutation are listed in Table 3-1. An inframe, markerless deletion was generated using the pKOR1 plasmid using methods
previously described (22). Briefly, ~800 bp regions located just upstream and
downstream of the copAZ genes were PCR amplified with primers listed in Table 3-1.
The upstream reverse primer and downstream forward primer encoded for SacII
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restriction sites, allowing the two fragments to be digested and ligated together using
SacII restriction enzyme (New England Biolabs (NEB)) and T4 DNA ligase (NEB),
respectively. Both the forward-upstream primer and reverse-downstream primer
contained attB sites that then allowed the ligated upstream and downstream product
to be introduced into pKOR1 using site-specific recombination, generating a
pKOR1∆copAZ clone. The vector was constructed in E. coli DH5

and passaged

through S. aureus RN4220 at 30℃ before being electroporated into USA300.
Recombination was performed as previously described (22) and formed a 3.035 kb
deletion of the copAZ genes. Successful mutants were chloramphenicol-sensitive,
indicating the removal of the pKOR1 backbone following homologous recombination.
Mutation of copAZ was confirmed using PCR with primers located just outside of the
region of deletion.
The copAZB mutant was generated by transducing an erythromycin cassette, located
within the copB gene, into the copAZ mutant background. The copB transposon was
taken from the Nebraska transposon library and transduced by Φ80α bacteriophage
such that it produced a polar mutation that also prevented the functional expression
of downstream gene, copL. The copA and csoR mutants were also generated through
transduction of an erythromycin cassette, taken from the Nebraska transposon
library, into our WT RN6390 and USA300 background strains, respectively (23, 24).
Proper transduction of the transposons was confirmed using PCR. The copB, the copL,
and the copBL mutants were markerlessly deleted similar to protocol described and
donated to us by Paul Planet (25).
3.2.4 Complementation of copAZ and copBL genes
Complementation vectors were designed using plasmid pALC2073 (26).
Complementation was performed using the annotated copAZ and copBL loci from
USA300. The genes were PCR amplified using primers (containing either SacI or KpnI
restriction sites) listed in Table 3-1. Gene products were digested with SacI and KpnI
(NEB) and ligated into digested pALC2073 using T4 DNA ligase (NEB). As with the
pKOR1 plasmid, pALC2073 clones were constructed in E. coli DH5α and passaged
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through S. aureus RN4220 strain at 37℃ before electroporation into target USA300
strains.
3.2.5 RNA isolation and qPCR
S. aureus strains were grown in 2 mL Tris minimal succinate (TMS) or RPMI media
for 8 h. Cultures were then harvested and subcultured at OD600 0.005 in 10 mL
minimal medium and grown to mid-exponential phase (OD600 ~1.0). Cells equating to
an OD600 of 3.0 were harvested for each culture and RNA extraction was performed
by Aurum™Total RNA Mini Kit (Bio-Rad) according to the manufacturer’s instructions
with the addition of 0.25 µg/mL of lysostaphin to the lysis solution. RNA purity was
determined by agarose gel and RNA concentration was determined by NanoDrop®
ND-1000 UV-Vis Spectrophotometer. cDNA preparation was performed using 500 ng
of total cellular RNA reverse-transcribed using SuperscriptTM II reverse transcriptase
(Invitrogen) according to manufacturer’s instructions. For each qPCR reaction, 1 µg
of cDNA was amplified in a Rotor-Gene 6000 (Corbett Life Science) using the iScript
One-Step RT-PCR Kit with SYBR Green (BioRad). Gene expression for each sample
was quantified in relation to rpoB expression. A standard curve was generated for
each gene examined.
3.2.6 Protein expression and purification
Recombinant His6-CsoR protein was overexpressed and purified essentially as
previously described (38). In brief, cells were grown to mid-log phase at 37℃ with
aeration before the addition 0.4 mM isopropyl-b-D-thiogalactopyranoside (IPTG); the
cells were then grown for an additional 16 h at room temperature with shaking before
harvesting. Cells were resuspended in 50 mM Tris, pH 7.4, and 1 mM dithiothreitol
(DTT), prior to lysis at 30 kpsi in Cell-Disruptor (Constants Systems Ltd.). Cell debris
was pelleted by 15-min centrifugation at 3000 rpm in a Beckman Coulter Allegra®
6R Benchtop Centrifuge, followed by ultracentrifugation at 50,000 rpm in a Beckman
Coulter Optima® L-900K ultracentrifuge for 45 min. The lysate was filtered with
0.45 μM nylon filter (VWR) and then applied to a 1 mL HisTrap column (GE
Healthcare) equilibrated with buffer A (50 mM Tris, 300 mM NaCl, 1 mM DTT, and
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50 mM imidazole, pH 7.4). The His6-CsoR was eluted with 0-80% concentration of
buffer B (50 mM Tris, 300 mM NaCl, 1 mM DTT, and 500 mM imidazole, pH 7.4).
Protein was dialyzed in 50 mM Tris, 300 mM NaCl, 1 mM DTT, and 4 mM EDTA pH
7.4, at 4℃. Protein purity was assessed by SDS-PAGE. Protein concentrations were
determined through Bradford assay using the Bio-Rad Protein Assay Dye (Bradford)
Reagent Concentrate (5´), and samples were read at absorbance OD595. A standard
curve was made for each concentration determination with 1 mg/mL BSA.
3.2.7 DNA-binding assays
Electrophoretic mobility shift assays (EMSA) were performed with purified CsoR and
double stranded DNA. The DNA probe was amplified through PCR with primers listed
in Table 3-1. Protein and DNA were incubated in a 25 μL volume that contained
100 ng DNA, 50 mM Tris, 240 μg/mL bovine serum albumin (BSA), 15.2 μg/mL
Poly[d(I-C)], and CsoR, at room temperature for 15 min. Following this 15-min
incubation, samples with metal-loaded CsoR underwent a 10-min incubation with
CuSO4 or ZnCl2, or equal amount of sterile water for samples with apo-CsoR. Samples
were separated on 6% non-denaturing polyacrylamide gels in TBE buffer (10 mM
Tris, 89 mM Tris Borate, 2 mM EDTA, pH 8.3) at 120 volts for 1.5 h. DNA was
visualized by incubating gel in 0.5 μg/mL ethidium bromide for 15 min, followed by
two washes with water and 10 min submergence in 1 mM MgSO4 to reduce
background signal.
3.2.8 Mammalian cell culture
RAW 264.7 macrophages from the American Type Culture Collection were grown in
RPMI 1640 buffered with sodium bicarbonate and 25 mM 4-(2-hydroxyethyl)-1piperazineethanesulfonic acid (HEPES) supplemented with 5% (v/v) Fetal Bovine
Serum (FBS). Macrophages were cultured in 37℃ with 5% CO2. RAW264.7 ∆ATP7A
were generated using CRISPR-CAS system to remove the ATP7A gene, and were
generated and donated to us by Michael Petris (25).
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3.2.9 Gentamicin protection assays
RAW264.7 WT and ΔATP7A macrophages were activated with 10 μg/mL IFN-γ
(PeproTech Inc.) for 20 h prior to infection. S. aureus strains precultured overnight in
TMS with 0.2 μM EDDHA and 20 μM CuSO4 were harvested, washed and re-suspended
in fresh TMS to an OD 0.1. Infections were done at an MOI of 0.1. Cells were infected
for 30 mins in serum-free RPMI, washed with sterile PBS, and treated with serumfree RPMI with 100 ng/mL gentamicin for 1 hour. Following gentamicin treatment,
macrophages were washed twice with PBS and then incubated with RPMI with 5%
(v/v) FBS at 37℃ with 5% CO2. At designated time-points gentamicin-protected
bacteria were enumerated by lysing infected macrophages with 0.1% (v/v) Triton X100 in PBS. Macrophage lysates were serially diluted and plated on TSA plates.

3.3 Results
3.3.1 CopB is homologous to other copper ATPases
HHpred analysis of the predicted product of the ACME-encoded copB, USA300 strain
FPR3757 gene SAUSA300_0078, showed that it had high structural similarity to
cation-transporting P1B-ATPases (Table 3-2; Fig. 3-2;), and a 36% amino acid
identity to copper-transporting ATPase copA (SAUSA300_2495). CopB possesses two
of the common motifs to P-type ATPases: the conserved GDGINDAP (G577-P584)
nucleotide binding motif and a CPH intramembranous motif (C336-H338), conserved
among P-type ATPases and essential to metal transport. ACME encoded CopB,
however, does not have the canonical CXXC metal-binding motif. Downstream of copB
on the ACME cassette is a YdhK-family lipoprotein (SAUSA300_0079), herein named
copper-responsive lipoprotein (copL) (Fig. 3-2; Table 3-2). CopL contains a lipobox
motif, LSAC (L16-C19), essential for membrane anchoring (40). YdhK-family
lipoproteins have been observed in other species, such as C. glutamicum, Listeria
monocytogenes, and E. faecalis, in the same operon as copB (41).
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Table 3-2. HHpred analysis of CopB (SAUSA300_0078) and downstream lipoprotein, CopL (SAUSA300_0079) from USA300
strain FPR3757 (18)
Protein
SAUSA300_0078
(CopB)

Organism

Similar Protein

PDB ID

Identity
(%)

Similarity

E value

Legionella pneumophila

Copper Efflux ATPase

4BBJ

36

0.602

3.7e-110

Archaeoglobus fulgidus

CopA, copper-exporting P-type
ATPase A

3J08

32

0.579

4.4e-100

Shigella sonnei

Zinc-transporting ATPase

4UMW

25

0.378

8e-92

Arabidopsis thaliana

P-type ATPase proton transport

5KSD

23

0.298

1.3e-73

Sus scrofa

Potassium-transporting ATPase
alpha

3IXZ

20

0.246

1.6e-70

Squalus acanthias

Na, K-ATPase alpha subunit

2ZXE

20

0.242

2.8e-70

Oryctolagus cuniculus

Sarcoplasmic/endoplasmic
reticulum calcium ATPase

3AR4

22

0.230

5.4e-69

Neurospora crassa

Proton pump, plasma membrane
ATPase

1MHS

21

0.303

7.5e-70

Sulfolobus solfataricus

Copper-transporting ATPase

2YJ3

31

0.501

3.9e-28

Homo sapiens

Copper-transporting ATPase 1

2KIJ

36

0.562

2.2e-24

Escherichia coli

Potassium-transporting ATPase B
chain

1SVJ

18

0.194

8.2e-18

Mycobacterium avium

Phosphoserine phosphatase

5IS2

17

0.276

3.7e-12
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SAUSA300_0079
(CopL)

Bacillus subtilis

Uncharacterized protein YdhK

4MDW

48

0.820

1e-60

Homo sapiens

AT-rich interactive domaincontaining protein 4A

2MAM

19

0.217

0.16

Escherichia coli

Tran protein; cell adhesion,
bacterial secretion

3ZBI

39

0.814

0.029

Streptococcus penumoniae

Lipoprotein

5CYB

18

0.309

0.025
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Fig. 3-2. Schematic representation of SAUSA300_0078 and 0079, designated copB and
copL, respectively, on the ACME cassette downstream of opp3. Open reading frame
numbers are from sequence USA300 strain FPR3757 complete genome (44).
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Immediately upstream of copB, is a putative oligopeptide permease (opp3) transport
system that is suggested to be responsible for transport of peptides and potentially
metals (Fig. 3-2) (42). Copper irreversibly displaces iron in Fe-S clusters, which are
essential cofactors in many enzymes that synthesize amino acids (4, 43). Therefore,
the proximity of the opp3 system to copBL may suggest an increase in peptide import
to compensate for potential loss of amino acid biosynthesis as a result of copper
toxicity, although further investigation is required. qPCR analysis of opp genes in WT
USA300 grown in the presence of copper, however, did not suggest that this operon
is copper-regulated (data not shown).
3.3.2 USA300 has increased copper resistance
To determine if copBL conferred USA300 with increased resistance to copper toxicity
and perhaps a growth advantage in copper-rich environments, minimum inhibitory
concentration (MIC) analysis was performed with eight S. aureus strains and
increasing concentrations of copper sulfate (CuSO4). The growth of USA300 was
compared to other MRSA and MSSA S. aureus isolates: Mu50, RN6390, RN4220,
Newman, SH1000, MW2, and MN8, strains that possess copAZ as the only
characterized copper detoxification system. In chemically defined minimal medium,
RPMI, I observed that USA300 had a 1-fold greater MIC (2000 μM) than the other
seven S. aureus strains tested (MIC of 1000 μM) (Fig. 3-3), suggesting that the
additional putative copper efflux pump (CopB) and lipoprotein (CopL) may play
additive roles in copper resistance.
3.3.3 CopBL enhances copper resistance in S. aureus
As I hypothesized that CopBL is directly responsible for USA300’s increased
resistance to copper, I measured the MIC of isogenic USA300 strains containing
mutations to the copper detoxification proteins. All USA300 experimental strains,
WT, copAZ, copB, copL, copBL, and copAZB, plus complemented strains,
copAZ+pCopAZ, copBL+pCopBL, copAZB+pCopAZ, and copAZB+pCopBL, were grown
in RPMI with increasing concentrations of copper sulfate (CuSO4) to determine MICs.
Minimal medium was used for all MIC growth analysis, as growth in nutrient rich
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Fig. 3-3. USA300 has a higher copper MIC compared to other S. aureus isolates.
Minimal inhibitory concentration (MIC) growth analysis with copper sulfate (CuSO4)
taken 24 h post inoculation showed increased resistance of USA300 strain (MIC of
2000 μM) compared to seven other S. aureus isolates (MIC of 1000 μM).
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media, tryptic soy broth (TSB), resulted in heightened resistance to copper with MIC
concentrations greater than 4 mM for all strains (data not shown). In RPMI, mutants
copAZ, copL, and copBL had an MIC of 1000 μM, a 1-fold lower MIC than that of WT
and the copB single mutant at 2000 μM . The copAZB mutant had a 4-fold lower MIC
(125 μM) compared to WT. Mutations were complemented by providing genes back
in trans (Fig. 3-4A). These results demonstrate that CopBL is important for copper
resistance, but that it is CopL, and not CopB, that provides USA300 with increased
resistance to copper.
In addition to examining the ability of USA300 strains to grow in the presence of
copper, I wanted to explore the bactericidal effects of copper. A kill curve analysis was
performed with the WT, copAZB, and complemented strain, copAZB+pCopAZ, with
increasing concentrations of copper. The CuSO4 concentrations ranged from 25400 μM, which correlated to the copper concentrations calculated within the
phagosome during infection (45). I observed that the WT and complemented strain
had a slight reduction in survival at 200 and 400 μM CuSO4, whereas the copAZB
mutant displayed reduced survival in as low as 25 μM with no detectable viability at
concentrations above 100 μM CuSO4 (Fig. 3-4B). These results demonstrate an acute
copper sensitivity of the copAZB mutant, and suggest a decreased survival inside the
phagosome.
3.3.4 ACME-encoded CopBL complements copA mutation in RN6390
To determine if the ACME-encoded genes copBL could be utilized by other S. aureus
strains, an MIC was performed with RN6390. RN6390 is a MSSA isolate that contains
copAZ as the sole characterized copper detoxification pathway. As previously
observed, the CuSO4 MIC of WT RN6390 is 1000 μM, 1-fold lower than that of WT
USA300 (Fig. 3-5). To my surprise, expressing copBL in trans in WT RN6390
(WT+pCopBL) did not confer this strain with greater copper resistance compared to
RN6390 WT alone. This may be due to additional intrinsic factors used by USA300 to
overcome copper toxicity that are not present in RN6390. copBL, however,
complemented the copA mutant (MIC of 62.5 μM) to a growth phenotype the same as
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*

Fig. 3-4. CopBL confers resistance to copper toxicity in chemically defined, metalchelated media, RPMI. A. USA300 background strains were grown in RPMI + 0.2 μM
EDDHA for 24 h with increasing concentrations of copper sulfate (CuSO4) to
determine the minimal inhibitory concentration (MIC). B. A kill curve assay
performed in sterile saline with increasing concentrations of CuSO4 for 24 h showed
increased sensitivity of the copAZB mutant to physiological concentrations of copper.
Statistics were performed using Student’s unpaired t-test; *P < 0.01.
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Fig 3-5. ACME-encoded copBL complements copA mutation in RN6390. MIC growth
analysis with copper (CuSO4) taken 24 h post inoculation showed decreased
resistance of copA mutant (MIC of 62.5 μM) compared to WT. This phenotype was
complementable when either copAZ or copBL were provided in trans. The addition of
copBL in WT (WT+pCopBL) did not increase the MIC above normal WT.
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WT (MIC of 1000 μM), establishing that RN6390 can utilize CopBL in copper
detoxification in lieu of CopAZ (Fig. 3-5).
3.3.5 Cop efflux pumps increase resistance to lead, cadmium, and silver
Many copper-translocating ATPases are not dedicated copper transporters but are
able to secrete additional transition metals (46). To examine CopA and CopB efflux
substrates, MIC growth analyses with five different metals, cadmium, cobalt, lead,
nickel, and silver, were performed with the USA300 WT and copAZB mutant. Not
surprisingly, the copAZB mutant, compared to WT, had a slightly increased sensitivity
to lead, consistent with what has been previously observed with the copA mutant in
SH1000 strain (Fig. 3-6C; 47). Sensitivity to lead decreased at higher concentrations
due to precipitation of the Pb(NO3)2 in the medium after 24 h, permitting growth of
both strains.
I also observed an increased sensitivity for copAZB strain with increasing
concentrations of cadmium and silver. For growth in cadmium, copAZB had an MIC of
25 nM, with a severe reduction in growth at 12.5 nM CdCl2, whereas the WT MIC was
50 nM (Fig. 3-6A). Silver MIC for copAZB was 2000 nM, 1-fold lower than that of WT
which had reduced but detectable growth at 4000 nM AgNO3 (Fig. 3-6E). Previous
work observed that the CopA metal binding site is capable of binding both cadmium
and silver in vitro (47), although no analysis had yet to show a role for CopA in
cadmium and silver detoxification during growth. Therefore, these results are the
first to demonstrate that copAZ and copBL are needed for detoxification. Further
investigation, however, is required to determine the role that each ATPase efflux
pump plays individually, and their ability to transport heavy metals in the presence
of copper. No notable differences in sensitivity between strains were observed for
cobalt and nickel (Fig. 3-6B, D).
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Fig. 3-6. Cop efflux pumps confer increased resistance to cadmium, lead, and silver.
WT (black bars) and copAZB double mutant (clear bars) grown in RPMI + 0.2 μM
EDDHA with increasing concentrations of cadmium (CdCl2) (A), cobalt (CoCl2) (B),
lead (Pb(NO3)) (C), nickel (NiCl2) (D), and silver (AgNO3) (E), 24 h post-inoculation.
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3.3.6 Copper induces expression of cop genes
Previous work showed that the copAZ genes in S. aureus were regulated in response
to copper via the transcriptional repressor, CsoR. Real time quantitative PCR (qPCR)
analysis in S. aureus strain SH1000 showed that, in the presence of copper salts, copA
expression increased roughly 6-fold; furthermore, studies with ∆csoR mutant showed
a 15-fold induction of copA suggesting that CsoR is a key repressor in copA expression
(15). To examine if copBL was also induced in response to copper via CsoR, qPCR was
performed on WT USA300 grown in metal deplete (MD) RPMI with the addition of
50 μM CuSO4 and 250 μM CuSO4. Similar to copAZ, copB and copL were upregulated
roughly 2.5- to 7-fold in the presence of 50 μM and 250 μM CuSO4, respectively (Fig.
3-7A).
Previous work in C. glutamicum demonstrated that copB and downstream lipoprotein
were upregulated in response to zinc (41), and showed a clear cross-talk occurring
between zinc and copper for multiple cation-translocating ATPases in Acinetobacter
baumannii (48). Therefore, to assess if zinc affected the expression of cop genes, WT
USA300 was also induced with 5 μM ZnCl2. Unexpectedly, copAZ and copBL genes
were upregulated 10- to 30-fold in the presence of zinc (Fig. 3-7A). It was unclear,
however, whether zinc interacts with CsoR directly and thereby causes depression of
genes in a similar mechanism to copper, or if another transcriptional regulator was
involved. Additionally, qPCR was performed on a csoR mutant, where I anticipated
drastic upregulation of the cop genes. The csoR mutant grown in TMS in the absence
of copper or zinc had increased gene expression of copA and copB, 7 and 18-fold,
respectively, compared to WT (Fig. 3-7B). This data suggests that both loci, copAZ and
copBL, are regulated in response to copper via the CsoR regulator.
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Fig. 3-7. cop genes are upregulated in response to copper and zinc, and in the csoR
mutant. A. qPCR analysis of WT USA300 grown in metal deplete (MD) RPMI to early
exponential phase and then either kept in MD media or induced for 2 h with 50 μM
CuSO4, 250 μM CuSO4, or 5 μM ZnCl2. MD gene expression is arbitrarily set to 1 and
gene expression of WT grown in copper or zinc is in relation to MD. B. qPCR analysis
of WT and csoR mutant grown in MD media. Gene expression of WT is arbitrarily set
to 1 where gene expression of csoR strain is in relation to WT. Statistics were
performed using multiple Student’s t-test, *P £ 0.05; for all samples significance was
determined in relation to the WT gene expression.
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3.3.7 CsoR binds the promoter of copAZ and copBL operons
To further explore CsoR-regulation of copBL, DNA binding assays were performed to
determine if CsoR regulation of cop genes was through direct binding to promoter
regions. Using nickel-affinity chromatography, recombinant (His6)-CsoR was purified
and stored in 4 mM EDDHA to chelate excess metal ions. Identified upstream of the
copZ locus in B. subtilis was 25 bp DNA-binding sequence for CsoR (49, 50), and a
similar CsoR-binding sequence was identified in S. aureus upstream of the copAZ
operon (15). Upstream of copBL I pinpointed a similar 25 bp sequence that I predicted
to be the DNA-binding site of CsoR (Fig. 3-8C). Therefore, for the DNA-binding assays,
I designed 120 bp oligonucleotide fragments upstream of copAZ and copBL that
encompassed the predicted CsoR binding sites (primers listed in Table 3-1).
Recombinant apo-CsoR was incubated with the promoter sequences of copAZ and
copBL operons and binding was observed through electrophoretic mobility shift
assays (EMSA). I observed that CsoR bound to both the copAZ and copBL promoters;
furthermore, DNA-binding was abrogated in the presence of copper in a 2:1 molar
equivalence of copper to protein. Binding was unaffected in response to zinc at a 2:1
molar equivalence of zinc to CsoR (Fig. 3-8A,B). These data suggest that CsoR binds
DNA directly upstream of cop genes and that this regulation is responsive to copper.
The drastic upregulation of the cop genes in response to zinc observed through qPCR
(Fig. 3-8A); however, is mostly likely not due to the derepression of CsoR, but perhaps
through activation by an alternative regulatory element.
3.3.8 The copAZB mutant has attenuated growth in murine macrophages
Copper-detoxification systems are critical for the intracellular survival of many
pathogens; this is due to the import of free copper into the phagosome through
ATPase copper transporter, ATP7A, localized on the phagosomal membrane (7, 9, 11).
To evaluate whether S. aureus experiences copper toxicity within the phagosome and
thus requires copper efflux for survival, infections were performed with WT and the
cop mutants in murine macrophage cell line, RAW264.7. Results showed that WT had
a significantly greater fold increase in CFUs from the 1.5 h to 10 h time-point versus
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Fig. 3-8. CsoR binds to copA and copB promoter regions. A,B. Electrophoretic mobility
shift assay (EMSA) with 100 ng of 120 bp DNA fragment and recombinant (His6)CsoR. DNA was visualized using ethidium bromide stain. Lanes: 1, DNA alone; 2, 2 μM
apo-CsoR; 3, 3 μM apo-CsoR; 4, 3 μM CsoR + 6 μM CuSO4; 5, 3 μM CsoR + 6 μM ZnCl2.
C. Sequence alignment of predicted CsoR binding region in S. aureus copB promoter
(Sa copB) to the identified CsoR binding sites in copZ promoter of B. subtilis (Bs copZ)
and S. aureus copA promoter (Sa copA).
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the copAZB mutant. The growth phenotype of the copAZB stain was complemented
by providing copAZ in trans (copAZB+pCopAZ) (Fig. 3-9A). The single mutants, copAZ
and copBL, had a similar fold change in CFU to WT (Fig. 3-9A). These results showed
that USA300 relies on copper efflux in the phagosome, and that either copAZ or copBL
are necessary for fitness inside the macrophage.
I predicted that the growth phenotype of the copAZB mutant was due to copper efflux
into the phagosome mediated by the copper transporter, ATP7A. Thus, to determine
the role ATP7A plays in S. aureus intracellular survival, I performed infections in
ATP7A-deficient macrophages. Unexpectedly, the copAZB strain still had a lower fold
change in CFUs compared to the WT (Fig. 3-9B), and furthermore, the growth
phenotype of all strains in ΔATP7A RAW264.7 was similar to what was observed in
WT RAW264.7. This suggested that factors in the phagosome are responsible for the
copAZB growth defect inside the macrophage.

3.4 Discussion
USA300 is the predominant CA-MRSA worldwide and is the causative agent of
moderate to severe infections in humans (51). Unique to USA300 is the presence of
the ACME cassette, for which its exact role in USA300 virulence is poorly defined.
Encoded within the ACME cassette, I identified a putative copper efflux pump, named
copB, and a downstream lipoprotein of unknown function, designated copL. Due to its
high redox potential, copper homeostasis is critical to survival of pathogens,
especially in an intracellular context as macrophages utilize copper as an
antimicrobial agent inside the phagosome (52, 53). S. aureus is capable of flourishing
inside the macrophage (12), although the mechanisms behind this survival have not
been fully characterized. Thus, this study set out to determine if the additional copper
detoxification mechanisms on the ACME cassette conferred USA300 with greater
resistance to copper, and if copper efflux plays a role in S. aureus intracellular
survival.
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Fig. 3-9. cop genes are important for intracellular survival in murine macrophages.
A,B. Gentamicin protection assays with RAW264.7 WT (A) and ΔATP7A (B) murine
macrophages infected with USA300 strains. Dotted line represents CFU enumeration
1.5 h post-infection (normalized to log 1), where data points represent the fold
change in CFU from 1.5 h. Statistics were performed using Student’s t-test;*P ≤ 0.01.
+pCopAZ is background copAZB strain containing the complementing vector,
pALC2073-pCopAZ.
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In this study, I demonstrated that the copBL locus, in concert with copAZ, contributed
to copper detoxification in vitro using MIC analysis with copper sulfate. This
contribution, however, was largely due to the copper-regulated lipoprotein, CopL,
and not the efflux pump, CopB. The necessity of CopL in copper detoxification was
unexpected as it has no clear mechanistic role in copper efflux. CopL homologs have
been observed in other species, namely C. glutamicum, Macrococcus caseolyticus,
Listeria monocytogenes, and E. faecalis, where it is also encoded in the same locus as
copB (41). Its role in these species in connection to heavy metal toxicity, however, is
unresolved. I theorize that CopL may decorate the cell surface with copper binding
activity and, thus, protect against the influx of copper.
Through qPCR and EMSAs, I showed that both cop loci were regulated in response to
copper via CsoR. Since its initial discovery in M. tuberculosis, CsoR has been
characterized in many other bacterial species as a copper-responsive, onecomponent regulator of copper detoxification pathways (14, 54). Interestingly, the
cop genes were also regulated in response to zinc. EMSAs clearly showed that the
copper-dependent regulation was through CsoR binding to the promoter regions of
copAZ and copBL operons, where CsoR binding to copper abrogated its DNA-binding
ability. It is unclear if CsoR is able to interact with zinc directly, or if a different zincresponsive transcriptional regulator is involved. Binding of zinc by copperdetoxification regulators has been previously characterized, including CsoR in C.
glutamicum, and CopY in E. hirae (41, 55). Therefore, the possible role of the cop genes
in zinc detoxification requires further investigation, in particular inside the
phagosome.
This is the first study to demonstrate that copper detoxification pathways aid in S.
aureus survival inside the macrophage. I show that both copAZ, in concert with copBL,
contribute to S. aureus survival in the phagosome, as a strain deficient in both
pathways (copAZB mutant) had a significant reduction in recoverable CFUs in murine
macrophage cell line, RAW264.7. The importance of copper detoxification systems
has been shown in other pathogens, such as M. tuberculosis, E. coli, and S enterica sv.
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Typhimurium where deletion of copper-resistance pathways resulted in attenuation
of growth inside the macrophage (7, 56, 57). In these studies, the attenuated
phenotype of the copper detoxification mutants could be restored to WT levels in
macrophages lacking ATP7A. This was anticipated, as the ability of macrophages to
transport copper into the phagosome is largely dependent on this copper transporter
localized to the phagosomal membrane (7, 56–58).
Unexpectedly, the copAZB mutant phenotype in murine macrophages was not
restored to WT levels but was still attenuated in an ΔATP7A deficient line of
RAW264.7. This suggested that the growth defect in the phagosome was not due
solely to copper toxicity, but perhaps due to toxicity of some other molecule or metal
inside the phagosome. Although there is a plethora of antimicrobial effectors present
in the phagosome, the copAZB mutant phenotype may be linked to zinc toxicity. As
mentioned, I demonstrate that all four genes, copAZ and copBL are regulated in
response to both copper and zinc, suggesting cross-talk between copper and zinc
homeostasis in S. aureus. Additionally, like copper, macrophages utilize the
antimicrobial properties of zinc to kill engulfed pathogens in the phagosome. Zinc
accumulation in the phagosome was observed in murine macrophages infected with
Mycobacterium avium in response to pro-inflammatory cytokines TNFα and IFNγ, and
also in phagosomes containing Mycobacterium tuberculosis (59, 60). Furthermore,
Mtb zinc efflux pump, CtpC, was induced inside the macrophage (60), and the ZntA
zinc exporter in E. coli was essential for optimal resistance to bacterial killing inside
the macrophage, suggesting a high zinc environment inside the phagosome (61, 62).
Although not fully characterized, zinc transport in mammalian cells is facilitated
through ZnT- or ZIP-family transporters, and is independent of ATP7A (62). Although
zinc is generally regarded as less toxic than copper, it may exert bactericidal activity
by functioning as a metal antagonist in the cell. Such is the case in S. pneumoniae,
where zinc is shown to irreversibly bind to the extracellular manganese binding
protein, PsaA, preventing Mn2+ transport (63, 64). Whether or not zinc is a
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Fig. 3-10. Schematic of copper transport in macrophages and the S. aureus USA300
copper, and potentially, zinc detoxification mechanisms during intracellular growth
in the phagosome. Copper is shuttled from the serum by CTR1 and shuttled by copper
chaperone ATOX1 to ATPase transporter, ATP7A, on the phagosomal membrane.
ATP7A effluxes copper into the phagosome containing USA300. USA300 combats
copper toxicity by potentially binding free copper outside of the cell by lipoprotein
CopL, or effluxing copper from the cytoplasm through ATPases CopA and CopB. Zinc
effluxed into the phagosome may be bound on the cell surface by CopL, or be taken
up by S. aureus, and in a manner similar to copper, removed from the cytoplasm by
CopA and CopB efflux pumps.
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contributing factor to S. aureus survival in the phagosome is an interesting aspect that
warrants further investigation (Fig. 3-10).
As the contribution of the iron-regulated lipoprotein, CopL, to copper resistance was
a novel discovery, future work will focus on examining the properties of this
lipoprotein and its metal-binding capabilities. CopL is most likely capable of binding
to copper, and perhaps zinc, at the surface of the cell. The USA300 Latin-American
Variant (USA300-LV), as well as a human MRSA isolate from West Australia, both
encode copB and additionally the downstream copL, yet do not contain any other
genes from the ACME cassette. Thus, the retention of both copB, and perhaps more
importantly, copL, in these strains suggests that this locus may play important role in
virulence in animal models of infection (42, 65, 66). In collaboration with Paul Planet,
I plan to look at the contribution of the cop genes in vivo in murine infection models.
Of particular interest is the role of the ACME encoded copBL genes in virulence.
In this study, I show that ACME encoded CopBL functions additively with CopAZ to
combat copper overload in vitro, and thus provides USA300 with increased resistance
to copper compared to other S. aureus isolates. This work thus shows greater insight
into the role of ACME cassette in USA300 virulence. In addition, I am the first to report
a role for the cop-encoded, copper-detoxification systems in S. aureus phagosome
survival. This finding demonstrates that copper-translocating ATPases, and copperresponsive lipoprotein, are key virulence factors in intracellular survival, and,
furthermore, may confer USA300 with greater resistance inside the phagosome. The
ability of microbes to remove excess copper is important for virulence and is a key
characteristic of professional pathogens (7, 10, 11). Thus, this work highlights the
adaptability of the human pathogen S. aureus to overcome defenses posed by the host,
and sheds light on the enhanced virulence of the epidemic CA-MRSA USA300 strain.
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Chapter 4
4 General Discussion
4.1 Characterizing the heme-responsive regulator SbnI
The ability of S. aureus to adapt to such different environmental niches is undoubtedly
due, in part, to its profound capacity to acquire essential nutrients such as iron.
S. aureus produces two siderophores, staphyloferrin A and staphyloferrin B, that
function to acquire free ferric iron or remove ferric iron from human glycoproteins.
In this study, I characterize the regulation of SB biosynthesis. The biosynthetic
enzymes for SB are encoded on the sbn operon, which encodes nine genes, sbnA-I.
Prior to this study, the biological function of only the first 8 genes had been
characterized: sbnA, sbnB, sbnC, sbnE, sbnF, sbnG, and sbnH all encode for biosynthetic
enzymes, and sbnD encodes the SB-specific transporter (1–3). The function of the
terminal gene in this operon, sbnI, was previously unknown, and although appearing
to have no biosynthetic enzymatic function, was highly conserved among
Staphylococcal strains that possessed the sbn operon. Therefore, the foundational
question of this study was to elucidate the role of SbnI.
4.1.2 Regulation of the sbn operon by SbnI
In this work, I discovered that SbnI is a transcriptional regulator of the sbn operon.
Growth kinetic assays showed that the sbnI mutant was unable to grow in medium
where SB was required for iron acquisition. Moreover, disc diffusion assays that
examined siderophore profiles revealed that at 12 hours post-infection the sbnI
mutant had no detectable levels of SB, in contrast to WT. The inability of the sbnI
mutant to produce SB to the same levels as WT was explained through qPCR analysis,
where I determined that SbnI significantly affected the expression of genes
downstream and including sbnD. Using multiple biochemical assays, namely RACE,
luciferase assays, and EMSAs, I discovered a promoter region located just upstream
of sbnD that contained a SbnI binding site. This finding suggested that SbnI specifically
regulated the efflux pump, SbnD, and enzymes in the final steps of SB synthesis.
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Directed regulation of efflux pumps has been observed in the biosynthesis of other
molecules, particularly in the case of antibiotics where high intracellular
concentrations would be detrimental to the cell (4, 5). In Streptomyces coelicolor the
antibiotic, actinorhodin, is regulated by a positive feedback loop. The efflux pump of
actinorhodin, ActA, and downstream gene that encodes the final biosynthetic enzyme
in the actinorhodin synthesis pathway, ActII-ORF3, are regulated by ActR. ActR, a
TetR-like regulator, binds to an intermediate precursor to initiate expression of ActA
and ActII-ORF3; thus production of complete actinorhodin is coordinated with the
expression of the efflux pump and final biosynthetic enzyme to avoid intracellular
accumulation of the active form of the antibiotic (6, 7). Other examples include the
secretion and final biosynthetic steps of gougerotin in Streptomyces graminearus (8),
simocyclinone D8 in Streptomyces antibioticus (9), the phenazine pyocyanin in
Pseudomonas aeruginosa (10), and intracellular metabolites, like indole, in Vibrio
cholerae (11). SB is a high-affinity iron chelator and intracellular accumulation of
functional siderophore would be detrimental to cell physiology (12–14). Thus, I
speculate that the product of SbnA and SbnB, L-DAP, may serve as a binding partner
to SbnI to signal upregulation of the efflux pump, SbnD, thereby preventing
accumulation of SB inside the cytoplasm and deleterious chelation of intracellular
iron.
4.1.3 The role of heme in SbnI-mediated regulation
Additionally, I discovered that SbnI regulated expression of the sbn operon in
response to heme. SbnI interacts with heme via binding to the coordinating ferric iron
through an unidentified histidine residue. Binding to heme abrogates the ability of
SbnI to interact with nucleic acid, possibly by preventing tetrameric oligomerization
of the protein. This finding has striking similarity to the iron response regulator (Irr)
of Bradyrhizobium spp. Irr is a member of the Fur superfamily and, like SbnI, is active
in iron-deplete conditions, capable of interacting with heme and, when complexed to
heme, loses DNA-binding capacity (15, 16). Irr in B. japonicum interacts with heme
through an HxH motif (15) and, thus, a putative HxH motif in tandem at the Nterminus of SbnI, sequence 3HIHEH7, led me to propose that SbnI-heme interaction
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may occur through the same motif as Irr. Site directed mutagenesis of SbnI that
converted histidines to alanines, generating the sequence 3AIAEA7, demonstrated
that even in the absence of this motif, SbnI could still bind heme. Thus, a binding motif
different than that utilized by Irr is responsible for heme binding.
S. aureus grown in the presence of heme had reduced secretion of SB similar to what
I observed with the sbnI mutant under normal growth conditions. This finding
strongly suggested that SbnI was not active when the cells were grown in heme, and
indicated that SbnI is a regulatory switch for iron acquisition. Therefore under iron
(and heme) deplete conditions, SbnI binds within the sbn operon, leading to
upregulation of genes sbnD-I and enhanced SB synthesis. In the presence of heme,
perhaps transported by the Isd system, SbnI binds to heme, preventing SbnI from
binding to nucleic acid, resulting in decreased SB synthesis (Fig. 4-1).
An aspect of iron metabolism that is not directly examined in this study, but has
important implications in iron utilization, is the biosynthesis of heme. Like iron, heme
is essential for proteins involved in oxidative respiration, and thus S. aureus
endogenously produces its own heme through a series of enzymes encoded by hem
genes (17, 18). Also like iron, heme is toxic to the cell at high concentrations as it
causes production of ROS. Therefore, in addition to binding exogenous heme
imported through the Isd system, SbnI may bind to excess amounts of cytoplasmic,
endogenously synthesized, heme. This may play a role in reducing intracellular ROS,
where SbnI may bind to endogenously produced heme to both sequester excess free
heme found in the cytoplasm and reduce SB-mediated iron uptake to limit excess iron
inside the cell.
4.1.4 Future directions
Oligomerization studies of purified SbnI demonstrated that it forms higher molecular
weight structures, namely tetramers or dimer of dimers. SbnI has low homology to
ParB and Spo0J transcriptional regulators, which also form high molecular weight
oligomers. Indeed, a distinctive feature of ParB homologs is their ability to form large
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Fig. 4-1. Proposed schematic of SbnI-mediated regulation of SB synthesis. During
growth in heme-deplete, iron-poor environments, SbnI is “active” and upregulates
transcription of the sbn operon, specifically efflux pump SbnD, and downstream genes
(sbnD-I). When heme is present in the environment, heme is taken up, most likely
through the Isd pathway, and once in the cytoplasm is bound by SbnI rendering it
“inactive”. Bound to heme, SbnI does not upregulate genes in the sbn operon, resulting
in decreased SB secretion.
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nucleoprotein complexes that can consist of >20 dimers that loop and bridge large
segments of DNA, referred to as ParB spreading (19, 20). Techniques such as proteininduced fluorescence enhancement (PIFE), have been previously used to examine DNAbinding by ParB proteins. In brief, this technique immobilizes cyanine 3 (Cy3) labeled
DNA in a microfluidic flow cell and measures the fluorescence of Cy3 with addition of
ParB, where fluorescence is enhanced with each DNA and protein interaction (20, 21).
The power of this technique is that it does not require any modification of the protein,
can be used for both DNA and RNA, and measures both binding of protein to DNA and
formation of DNA secondary structures, such as looping (21). In the case of SbnI, I would
be interested to determine if there are additional SbnI binding sites on the sbn operon,
using the entire operon fragment as the binding template, and additionally determine if
SbnI conforms the DNA. These binding experiments could be done in the presence of LDAP, a pathway intermediate in SB synthesis, or in the presence of heme, where I have
already observed changes to SbnI oligomerization.
Further experiments are needed to identify the residues in SbnI that are responsible for
heme binding. Magnetic circular dichroism elucidated that SbnI bound to heme through
a histidine residue. In addition to S. aureus, I have looked at SbnI in a different species,
Staphylococcus pseudintermedius, a coagulase-positive staphylococci that is known to
cause severe skin infections in domesticated animals (22). SbnI from S. pseudintermedius
is also capable of binding heme, as determined through UV-vis heme titration assays
(work unpublished). SbnI sequence alignment of S. aureus and S. pseudintermedius
showed a 69% sequence similarity, and four conserved histidines, H19, H42, H61, and
H91. Listed in Table 4-1 are 12 additional Staphylococcal species that contain SbnI. SbnI
in each species contains the same 4 conserved histidine residues. Therefore, future work
will begin by mutating H19, H42, H61, and H91 to alanines and testing for heme-binding
both in vitro with purified protein, and inside the cell, by expressing the mutated SbnI
protein on a plasmid in the sbnI mutant, and then looking at SB production via discdiffusion assays.
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Table 4-1. Sequence alignment of SbnI from twelve staphylococcal species aligned to SbnI
from S. aureus.
Species

Identity (%)a

Similarity (%)a

e-value

S. agnetis b

66

75

2e-125

S. argenteus

98

98

0.0

S. delphini

61

70

1e-114

S. EGD-HP3

63

75

3e-120

S. HGB0015

64

74

2e-124

S. hyicus

66

75

3e-125

S. intermedius

60

69

1e-113

S. OJ82

65

78

1e-128

S. pseudintermedius

60

69

1e-113

S. arlettae

63

75

1e-120

S. equorum

65

78

2e-127

S. schleiferi

64

74

2e-123

Coagulase Positive

Coagulase Negative

a.
b.

Representative of overall identity or similarity across the entirety of the protein.
Coagulase-variable staphylococci.

Additionally, I demonstrated that the sbnI mutant had increased sensitivity to reactive
oxygen species (ROS). This finding corroborated with previous work that showed that a
S. aureus sirA mutant (a strain incapable of SB uptake) was more sensitive to oxidative
stress than WT, although the reason for this was not characterized (23). Therefore, I
propose that SB works to either chelate intracellular iron, thereby reducing intracellular
Fenton chemistry, or carries iron to enzymes involved in the oxidative stress response.
Future work on this finding is to see if the sbnI mutant has decreased survival in
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neutrophils compared to WT, due to the heightened oxidative burst utilized by
neutrophils in bacterial clearance.
4.1.5 Significance of this study
The regulatory model of SB synthesis, mediated by the DNA- and heme-binding protein
SbnI, is the first characterized system in bacteria to demonstrate a regulatory link
between siderophore-mediated iron acquisition and heme uptake. The importance of SB
in vivo has previously been demonstrated, where an sbnE mutant had a significant
reduction in CFUs in a murine kidney abscess model of infection (24). Therefore, as a
regulator of the sbn operon, SbnI is a key virulence factor that may play a critical role in
bacteremia model of infection. The discovery of SbnI also explains why heme is the
preferred iron source of S. aureus (25), where I demonstrate that siderophore-mediated
uptake is turned off in response to heme.

4.2 The role of copper detoxification systems in S. aureus
Unlike iron that is actively sequestered away from invading pathogens, copper is found
at the host-pathogen interface in excess. Cells of the innate immunity, namely
macrophages, transport copper into bacteria-containing phagosomes through the efflux
pump ATP7A (26). Excess copper in the phagosome causes membrane damage to
bacteria and forms ROS, resulting in damage to lipids, nucleic acids, and proteins (27).
S. aureus is capable of flourishing inside macrophages; however, the mechanisms
involved in this process have not been fully delineated (28). All sequenced S. aureus
strains encode for a copper efflux ATPase, copA, and on the same operon a cytoplasmic
copper chaperone, copZ (29). CopA has been shown to be critical for copper
detoxification in vitro; however, prior to this study, its role in the context of intracellular
survival in the phagosome had previously not been investigated.
CA-MRSA strain USA300 carries the ACME cassette, which is thought to confer
heightened virulence to this strain. On the ACME cassette is encoded a putative copper
efflux pump, herein named copB, and downstream lipoprotein, designated copL. Prior to
this study, the roles of these genes in heavy metal detoxification were unknown.
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Therefore, the goals of this study were to determine i) the function of the putative copper
detoxification genes on the ACME cassette and their role in USA300 copper resistance,
and ii) if copper detoxification mechanisms are required for intracellular survival of S.
aureus inside the macrophage.
4.2.1 The contribution of copBL in copper resistance
Through MIC growth analysis, I demonstrate that CopB and CopL are involved in copper
resistance. USA300 had a one-fold higher copper MIC (MIC of 2 mM) compared to seven
other MRSA and MSSA S. aureus strains (MIC of 1 mM). Furthermore, I determined that
it was largely CopL, and not the efflux pump CopB, that was essential for this increased
resistance. This was unexpected as the role of surface associated lipoproteins in heavy
metal resistance has been largely undefined. However, in M. tuberculosis, LpqS is
described as a putative lipoprotein that is regulated in response to copper and has been
shown to aid in both copper resistance and Mtb survival in the macrophage (30),
although the mechanism behind this is not known. Lipoproteins are found in the regulon
of many copper-responsive regulators (31), and thus the involvement of lipoproteins in
defense against metal toxicity may be greatly underappreciated and could represent a
new area of interest in understanding bacterial mechanisms of metal resistance.
In this study, I discovered that the copBL operon, like copAZ, is regulated by the copperresponsive transcriptional regulator, CsoR. Additionally, as determined by qPCR, both
cop loci are also regulated in response to zinc, where I saw a notable increase in cop gene
expression in the presence of zinc. Although CsoR in Corynebacterium glutamicum is
capable of binding to both copper and zinc resulting in upregulation of cop genes (32),
EMSA results in this study suggested that this may not be the case in S. aureus: CsoR
interaction with the copA and copB promoter fragments was unaffected in 2:1 molar ratio
of zinc to protein. This raises an interesting question: is there is an additional zincresponsive, transcription factor that regulates the cop loci?
4.2.2 cop genes are needed for full virulence inside the phagosome
Through gentamicin protection assays in murine macrophages, I demonstrate that the
copAZ and copBL loci are important for growth in the macrophage, where a copAZB
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mutant strain had a significant decrease in recoverable CFUs 10 h post-infection,
compared to WT. This is the first study to demonstrate a need of copper detoxification
pathways in S. aureus survival inside the macrophage. This has previously been observed
in E. coli (33), M. tuberculosis (34–36), Salmonella enterica sv. Typhimurium (37–39), and
Listeria monocytogenes (40), where strains containing mutations to central copper
detoxification pathways had severe reduction in macrophage survival compared to
isogenic WT. In S. aureus USA300, strains that lacked only one cop loci, either copBL or
copAZ, had a similar growth phenotype to WT, indicating that the presence of one cop
detoxification system is sufficient for survival.
4.2.3 Future experiments to examine the role of cop genes in intracellular survival
Future work on this project will examine the expression of the copAZ and copBL genes
during intracellular growth using qPCR. Transcriptome analysis of intracellular bacteria
following macrophage infection has been performed in other species, such as Listeria
monocytogenes (41), Salmonella enterica sv. Typhimurium (42), Francisella tularensis
(43), and Streptococcus gallolyticus subspecies gallolyticus (44). I will look at cop gene
expression in S. aureus following infection in both WT and ΔATP7A RAW624.7 cells. This
will allow me to confirm that cop genes are turned on in the phagosome, and looking at
multiple time-points during infection I can observe their expression at different growth
stages in the macrophage.
Additionally, further experiments are needed to look at the biological relevance of the
upregulation of the copAZ and copBL genes in the presence of zinc. MIC growth analyses
and kill curves with increasing concentrations of zinc will allow examination of the zinc
sensitivity of the copAZB mutant compared to WT. Previous work has shown that
macrophages also efflux zinc into the phagosome following phagocytosis, and
furthermore, the bacterial zinc efflux pump, ZntA, is important for intracellular survival
of E. coli (45–47). Therefore, along with looking at cop gene expression following
macrophage infection, I’ll also examine the expression of other zinc regulated genes in
the phagosome. This will be particularly interesting in the ΔATP7A RAW624.7 cells,
where, if I see upregulation of zinc-responsive genes and cop genes, despite minimal
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copper concentrations in the phagosome, I can infer that S. aureus encounters a high zinc
environment in the phagosome and may use CopA and CopB to efflux excess zinc.
Although the murine macrophage cell line RAW264.7 functions as a consistent model for
gentamicin protection assays with S. aureus, future work will also explore the ability of
the copAZB mutant to replicate in clinically relevant cells, primary human macrophages.
S. aureus infections in primary human macrophages have been performed in my lab
previously (28), and serve as important model to look at the role of virulence genes in a
more accurate representation of human infection.
Lastly, the role of copper detoxification systems is generally investigated in the context
of macrophages and intracellular pathogens, and thus the role of these pathways in other
infection models, such as in skin colonization, is poorly defined. Virulence factors that
contribute to skin colonization and infection are of particular interest, as S. aureus is the
most common agent of skin infections (48). Moreover, the strain USA300 is considered
hypervirulent as a skin pathogen, due to the ACME cassette that is generally regarded as
an acquired element that enhances virulence primarily in skin infection and bacterial
transmission (49). Of interest to this study, the Latin-American variant of USA300, also
known for causing severe skin infections, lacks the ACME cassette, and instead possesses
the mobile genetic element, COMER; this cassette carries genes that are thought to aid in
copper and mercury resistance and thus contains both copB and copL genes (50).
Therefore, the retention of the copBL genes in two hypervirulent skin pathogens suggests
that they play an important role in skin infections. Thus, future areas of interest with the
copAZB mutant would be to examine its fitness in a murine skin abscess model.
4.2.4 Significance of this study
In this study, I identify a novel copper-detoxification mechanism, CopBL, encoded on the
ACME cassette in S. aureus strain USA300. CopBL, in concert with CopAZ, works to
detoxify copper in the cytoplasm and decrease the copper sensitivity of USA300. I show
that the cop genes are required for full virulence inside the macrophage. This finding has
important implications for the copAZ and copBL loci for S. aureus survival in vivo and its
escape from innate immune cells following phagocytosis.
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Outside of the innate immunity context, there is an increase use of copper-coating on
hospital surfaces and medical devices. Preliminary work that looked at the role of
copper-coating in hospitals to limit microbial spread showed a significant decrease in the
overall microbial population; however, only nominally worked against highly antibiotic
resistant strains, such as ciprofloxacin-resistant S. aureus (51,52). Therefore, coppercoated surfaces in the medical care environment may select over time for highly resistant
strains, like USA300, and thus, understanding the mechanisms of copper resistance is
critical in order to design copper-based surfaces that are effective for contact killing.

4.3 Iron and copper interplay
In this work, I describe two different mechanisms by which S. aureus maintains
homeostasis of essential transition metals, iron and copper. Despite the similarities of
iron and copper usage by bacteria, the host uses two completely different facets of
nutritional immunity to restrict bacterial proliferation. Iron is actively sequestered by
the host to restrict the access of free iron to microbes to concentrations far too low to
support bacterial growth (53). Therefore S. aureus relies on iron-uptake strategies, like
SB utilization, to scavenge for iron. The mechanism of nutritional immunity by the host,
with respect to copper, is opposite to that of iron. In the macrophage, free copper is
transported into bacteria-containing phagosomes where excess copper causes
membrane damage to bacteria, and readily causes the formation of ROS. Thus, in contrast
to siderophores that are needed to bring in iron that is scarce in the host, S. aureus inside
the phagosome encounters a surplus of copper that requires detoxification systems.
These two pathways of metal homeostasis in S. aureus, although discussed separately in
this study, do have some points of convergence. In B. subtilis and E. coli, copper toxicity
is largely due, not to the formation of ROS, but to the irreversible displacement of iron by
copper from iron-sulfur (Fe-S) clusters (54–56). Iron-sulfur clusters are essential
cofactors to many enzymes in the cell, many of which are involved in amino acid
biosynthesis, and the irreversible exchange of Fe to Cu renders these enzymes inactive.
In E. coli, the addition of excess branched chain amino acids to the medium significantly
decreased the copper sensitivity of a copper-detoxification pathway mutant (56). I have
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observed indications of this in the study, where the copper MIC of WT and copAZB mutant
are greatly increased in nutrient-rich media, such as TSB or RPMI with the addition of
casamino acids (data not shown). The differences in MIC could be due to the addition of
excess amino acids or excess free iron, and thus future work should look the contribution
of iron and amino acids to copper resistance and possible regulation of cop genes.
A recent discovery in iron homeostasis is how bacteria use promiscuous siderophores
for uptake of metals other than iron, such as copper (57). One of the best examples of this
is yersiniabactin (Ybt), a siderophore produced by many Enterobacteriaceae, including
some strains of uropathogenic E. coli, which binds both iron and copper. LC-MS/MS
analysis of urine from patients suffering from a urinary tract infection by E. coli, revealed
Ybt-Cu(II) complexes in the urine sample. This finding demonstrated that Ybt binds
copper during infection, as a way to either transport copper into the cell, or perhaps to
sequester extracellular copper and reduce the formation of ROS and membrane damage
(58). In S. aureus the nicotianamine siderophore, staphylopine, has a higher affinity for
copper than iron, as determined in vitro (59). Biologically, staphylopine has been
observed to bind to zinc, and as such is considered a zincophore (60); its role in copper
transport or sequestration during growth, or inside the phagosome, has not been
characterized. Thus, further work is needed to investigate the potential role of
staphylopine in copper metabolism and copper resistance.
Overall, this study has important implications in understanding S. aureus pathogenicity,
as both SB and copper detoxification are key pathways linked to virulence. Many
instances have been observed for a copper-iron interplay in both bacterial and
mammalian metal homeostasis (61, 62), and thus future work is needed to investigate
the potential crosstalk of these two complex systems in S. aureus.
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